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Abstract  
 
Insecticide-based vector control strategies have greatly contributed to malaria control, yet their 
success is hindered by the spread of resistance. It is thus essential to discover the molecular 
basis of resistance to use the current insecticides effectively and to search for new ones 
informatively. In Anopheles gambiae, overexpression of single detoxifying enzymes of the 
P450 (CYP) family has been strongly associated with resistance, yet in vivo analysis has only 
been performed in the fruit fly. Furthermore, patterns of P450 overexpression that lead to 
resistance, which are crucial to identify detoxification pathways, remain unclear. This study 
aims to investigate the role of two genes, Cyp6m2 and Cyp6p3, in conferring resistance in vivo 
in An. gambiae when overexpressed tissue-specifically in the midgut, oenocytes, or 
Malpighian tubules or in multiple tissues.  
To obtain spatially-controlled gene overexpression the GAL4/UAS system was employed. 
Responder lines for the expression of Cyp6s were created by PhiC31-RMCE and crossed with 
two tissue-specific drivers specific for the midgut or the oenocytes. Resistance phenotype 
assessment, conducted according to WHO guidelines, revealed no difference in mortality 
between mosquitoes overexpressing Cyp6 genes and controls after exposure to four different 
insecticides, suggesting that overexpression confined to these tissues is not sufficient to drive 
resistance. 
We therefore aimed to examine overexpression in the Malpighian tubules and in multiple 
tissues. Since promoters for these locations had not been characterised, putative regulatory 
regions were isolated from genes showing desired patterns of expression. Two main 
candidates, PUBc and GPI, were chosen after assessing their activity by luciferase assay in 
mosquito cells, and were used to create driver lines using the piggyBac transposon. Random 
insertion was chosen to identify single genomic sites able to sustain widespread expression 
and at the same time create new PhiC31 docking lines at these permissive sites. Patterns of 
expression induced by PUBc drivers carrying single insertions were investigated by crossing 
with a responder UAS:mCherry line. Two drivers were isolated that induced multi-tissue 
expression in all life stages and both sexes at relatively higher (A10) and lower (A8) levels. In 
similar experiments, the ubiquitous GPI and the Malpighian-specific VATG candidate 
promoters did not show visible mCherry expression. 
The PUBc driver lines were finally used to assess resistance resulting from multi-tissue 
overexpression. Ubiquitous expression of Cyp6m2 under the control of the A10 driver 
correlated with acquisition of WHO levels of resistance to pyrethroids, while that of Cyp6p3 
with resistance to pyrethroids and bendiocarb; DDT resistance was not affected. Lower levels 
of overexpression driven by A8 did not significantly alter the resistance phenotype except for 
permethrin resistance when Cyp6m2 is overexpressed. Furthermore, Cyp6 overexpression 
driven by A10 or A8 caused an increase in susceptibility to the pro-insecticide malathion, 
supporting the role of specific CYP6s in providing negative cross-resistance between 
insecticide classes.  
This study provides the first in vivo evidence of the role of Cyp6s in causing WHO-defined 
resistance in An. gambiae, suggesting that location and level of overexpression are critical. 
Overall, this work contributed to the optimisation of a system for in vivo functional analysis in 
transgenic An. gambiae through the characterisation of a novel ubiquitous promoter and the 
ability to modulate level of expression using alternative drivers. Such a system is 
physiologically more relevant than the current Drosophila-based system for in vivo validation 
of mosquito resistance gene. In addition, metabolically resistant lines created here can be 
included alongside field-caught populations for screening new insecticides. 
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1. Chapter 1  
Introduction 
 
1.1 Malaria and mosquito vectors  
 
1.1.1 The disease  
Malaria is a parasitic vector-borne disease which imposes a major human health 
burden in tropical and subtropical regions of the world. In 2015 transmission was 
active in 91 countries with 212 million cases and 429,000 deaths estimated, 92% of 
which occurred in Sub-Saharan Africa (WHO, 2016a). 
The disease is caused by protozoa of the Plasmodium genus and transmitted to 
humans by female Anopheles mosquitoes. Five Plasmodium species are responsible 
for human infections: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. 
P. falciparum is responsible for most malaria-related deaths and is predominant in the 
African continent, but it is also extensively found in South-East Asia (Sinka et al., 
2011). Outside Africa, P. vivax is the most common malaria parasite (WHO, 2016a), 
with almost half of the worldwide population at risk of P. vivax infection living in India 
(Sinka et al., 2011).  
For the parasite life cycle to complete, it must encompass two hosts, a human and a 
mosquito. In the human host, asexual replication takes place in the liver 
(asymptomatic stage) and in red blood cells (symptomatic stage). Blood stage 
replication recurs cyclically and determines erythrocyte lysis which causes peaks of 
fever characteristic of the disease. In the most severe P. falciparum cases where the 
parasitic load is high, asexual forms can clog brain capillaries (cerebral malaria) 
causing neurological complications and death. In the mosquito host, sexual 
reproduction occurs with the formation of mature gametes that fuse forming a mobile 
ookinete which attaches to the outer epithelium of the mosquito midgut forming an 
oocyst. The infective stage sporozoites develop within the oocyst before bursting out 
and migrating to the salivary glands where they are transmitted to a human host via 
an infectious bite from a female. The parasite life cycle in the mosquito (sporogonic 
cycle) typically lasts 10-18 days depending on ambient temperature (CDC, 2015a). 
    Chapter 1 – Introduction 
2 
 
1.1.2 The vectors 
Vectors responsible for human malaria transmission are mosquitoes of the genus 
Anopheles (order Diptera, family Culicidae, sub-genus Cellia) and, while there are 
over 400 species of anophelines, only 41 are known to transmit human malaria (Hay 
et al., 2010).  
Anopheles species are distributed worldwide (Figure 1.1). In Africa, the dominant 
vector species are members of the An. gambiae complex (An. gambiae sensu stricto, 
An. coluzzi, An. arabiensis, An. merus, An. melas) as well as An. funestus, An. 
moucheti and An. nili (Sinka et al., 2010a). Dominant vector species in the Asian-
Pacific region are difficult to define due to the complex co-existence of multiple 
species including An. stephensi, An. dirus, An. minimus, and An. sinensis (Sinka et 
al., 2011). Anophelines most commonly found in the Americas are An. albimanus, An. 
darling and An. freeborni (Sinka et al., 2010b). In European and Middle-Eastern 
regions, where malaria transmission is rare, An. messeae shows the largest 
distribution across northern countries (Sinka et al., 2010a). 
 
 
Figure 1.1 Worldwide distribution of malaria vectors (taken from Sinka et al., 2012). 
 
Only adult females are responsible for disease transmission as they inoculate 
sporozoites while taking a blood meal that is essential for egg production. Therefore, 
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transmission dynamics are largely dependent on the number of infective bites 
received, which, in turn, changes with mosquito population size. This is overall 
dependent on weather conditions (temperature, humidity, rainfall) suitable for 
successful development of mosquitoes through egg, larva, and pupa stages into 
adults, as well as the longevity of females for completion of the sporogonic cycle. Part 
of the reason why Africa accounts for the highest malaria morbidity and mortality is 
that it hosts the most effective vectors that transmit P. falciparum, An. gambiae 
mosquitoes. These exist in close contact with humans as they are primarily attracted 
by human blood (anthropophilic) and preferentially feed at night and rest indoor 
(endophagic and endophilic) (CDC, 2015b). 
A remarkable amount of financial resources (US$ 2.9 billion in 2015) and efforts have 
been spent in malaria control programs with the aim of reducing human infections 
(WHO, 2016a). These include vector control strategies, preventive therapeutic 
interventions, early diagnosis and prompt drug treatment. Taken together, these 
resulted in a reduction of malaria incidence by 40%, equalling 663 million fewer 
malaria cases between 2000 and 2015 (Bhatt et al., 2015). Relative contributions of 
anti-malaria interventions were calculated to be ~68% from insecticide-treated bed 
nets, ~22% from artemisinin-based combination therapy, and ~10% from indoor 
residual spraying of insecticides (Bhatt et al., 2015). While encouraging, the 
emergence and spread of resistance to insecticides and to antimalarial drugs, along 
with the lack of a vaccine, pose real threats to these achievements.  
 
1.2 Vector control strategies  
 
1.2.1 Insecticide-based vector control  
Most vector control interventions rely on the use of chemical insecticides to kill adult 
mosquitoes. These strategies include the distribution of insecticide-treated bed nets 
(ITNs) and indoor spraying (IRS), but also outdoor fogging, treatments of surfaces 
such as curtains, window screens and eave baffles, and the used of 
insecticide‑treated durable wall lining (WHO, 2016a; Killeen et al., 2017; Messenger 
& Rowland, 2017). Insecticides such as organophosphates are also use to control 
larval stages by treating the water in which mosquitoes breed; similarly, synthetic 
chemicals such as the juvenile hormone analogue pyriproxyfen (PFF) are found to be 
effective larvicides (WHO, 2016a).  
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1.2.1.1 Insecticides used in vector control   
Currently four main classes of insecticides sharing two modes of actions are used for 
vector control. All classes can be used for indoor spraying, but only pyrethroids are 
approved to be used on bed nets (WHO, 2006).  
Organochlorines include organic compounds containing covalently bonded atoms of 
chlorine. Two main groups exist with different modes of action: DDT-like compounds 
(e.g. DDT) (Figure 1.2) and alicyclic compounds (e.g. dieldrin) (Figure 1.2). Both 
organochlorine types affect nerve impulse and cause death by paralysis by interfering 
with the physiological function of the voltage-gated sodium channel (VGSC) (DDT) or 
the gamma-aminobutyric acid (GABA) receptor (dieldrin) (Coats, 1990; Anthony et al., 
1993). DDT was the first synthetic insecticide introduced in public health in the 1940’s. 
Although very effective in combatting vector-borne diseases, its environmental impact 
as an organic pollutant caused the Environmental Protection Agency to ban it from 
agriculture and restrict its use to indoor spraying campaigns according to WHO 
recommendations (Mellanby, 1992). The use of dieldrin was banned due to similar 
issues. 
Organophosphates are esters of phosphoric acid that bind covalently and 
irreversibly to the acetylcholinesterase enzyme (AChE), which is responsible for the 
termination of the nerve impulse through degradation of the neurotransmitter 
acetylcholine. Their binding to AChE results in persistent neuronal firing and insect 
death by paralysis (Fukuto, 1990). They are deployed in their non-insecticidal form 
and need to be activated by oxidation in their toxic -oxon forms (Cohen, 1984) (Figure 
1.2). Organophosphates such as temephos and fenthion have been successfully used 
as larvicides (WHO, 2006).  
Carbamates are chemically characterised by the presence of a carbamate ester 
group (Figure 1.2). They share the same mode of action of organophosphate 
insecticides (Fukuto, 1990), although their binding to AchE is reversible. 
Pyrethroid insecticides are synthetic chemicals derived from natural organic 
compounds produced by Pyrethrum flowers. They are neurotoxins that target the 
VGSC and share the same mechanism of action of organochlorine insecticides 
(Vijverberg et al., 1982). This class is the most exploited in public health due to its low 
mammalian toxicity and rapid knock down effect on insects, which make pyrethroids 
the only class allowed for treating bed nets (WHO, 2006). There are two chemically 
distinct forms: type I (lacking a cyanide group), such as permethrin (Figure 1.2), and 
type II (containing a cyanide group), such as deltamethrin (Figure 1.2).   
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Figure 1.2 Structural representatives of the four classes of insecticides used in public health to control 
Anopheles mosquitoes.  
 
1.2.1.2 Insecticide Treated Nets (ITNs) 
Sleeping under an insecticide-treated bed net combines the protection from a physical 
barrier that prevents the vector from making contact with the human host, with that of 
a chemical barrier with killing and repellent insecticidal properties (WHO, 2006; 
Kawada et al., 2014). Therefore, ITNs have the dual aim of reducing human-vector 
contact while decreasing mosquito density by killing female indoor night biters. 
Pyrethroids used for ITNs include α-cypermethrin, cyfluthrin, etofenprox, λ-cyhalothrin 
deltamethrin and permethrin (WHO, 2006), of which the latter two were most often 
used in the first wave of bed nets production.  
A new version of ITNs, long-lasting insecticidal nets (LLINs), has improved issues 
related with longevity of activity and durability (WHO, 2011).  LLINs that have received 
full WHO approval are Olyset® (permethrin), Interceptor® (α-cypermethrin), 
PermaNet®2.0 and Yorkool®LN (deltamethrin) (WHO, 2012a). While nets undergoing 
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preliminary assessment include Olyset®Plus and PermaNet®3.0 which contain 
permethrin and deltamethrin respectively coupled with the synergist piperonyl 
butoxide (PBO) (WHO, 2015b). PBO does not have insecticidal properties but 
synergises the activity of pyrethroids by inhibiting the activity of P450 enzymes that 
are responsible for pyrethroid breakdown. Similarly, trials are ongoing for the 
assessment of Olyset®Duo, which contains permethrin and the juvenile hormone 
analogue PFF which acts as a sterilising agent in adult mosquitoes (Tiono et al., 
2015).  
 
1.2.1.3 Indoor Residual Spraying (IRS) 
Vector control through IRS consists of spraying insecticides on internal household 
surfaces (walls, eaves, ceiling) that the malaria vector is likely to contact. Therefore, 
this intervention targets specifically females that rest indoors after a blood meal and 
thus aims to reduce lifespan and subsequently overall vector density (WHO, 2006). 
Spraying is carried out by trained personnel at intervals that usually coincides with 
seasonal peaks of abundance of vectors in a specified geographic location (WHO, 
2015a). Members from all classes of insecticides can be used for IRS, therefore the 
compound to be used should ideally be chosen based on the susceptibility status of 
the local malaria vector. IRS procedures are standardised according to guidelines 
from the WHO Pesticide Evaluation Scheme (WHOPES) which specifies, among 
others, insecticide concentrations and formulations to be used (WHO, 2009; WHO, 
2015a). 
 
1.2.2 Alternative insecticide-free vector control 
Insecticide-free strategies have been developed that are safer to humans and non-
target wildlife and for which resistance development is less likely (David et al., 2013). 
Such interventions include biological control targeted at eliminating the larval stage 
using bacterial toxins from Bacillus thuringiensis israelensis, fungal pathogens, and 
natural mosquito predators such as fish, nematodes, and amphibian tadpoles 
(Raghavendra et al., 2011). Recently, biological control of Aedes mosquitoes using 
Wolbachia has been suggested as mosquitoes carrying this bacterial symbiont 
showed reduced viral replication (Moreira et al., 2009) and longevity (McMeniman et 
al., 2009). Furthermore, cautious environmental management aimed at modifying or 
disrupting natural mosquito habitats and preventing the creation of artificial breeding 
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sites, plays a key role as part of integrated vector control strategies (Raghavendra et 
al., 2011). Finally, with the recent advancement in transgenic mosquito technologies, 
control strategies based on genetically-modified organisms and intended for 
suppression or replacement of wild populations open promising perspectives (Gabrieli 
et al., 2014). Suppression strategies are based on reducing vector populations, 
usually by modifying insect mating/fertility or subsequent development. The first of 
such strategies was the Sterile Insect Technique (SIT) (Knipling, 1955) which consists 
of releasing sterile males. However, this intervention has been argued to be costly, 
laborious, and difficult to sustain (Papathanos et al., 2009a; Alphey et al., 2010). An 
enhancement of the SIT technology, called RIDL (Release of Insects with Dominant 
Lethality), was later introduced which is based on the conditional expression of lethal 
genes (Thomas et al., 2000; Phuc et al., 2007). After the release of the Ae. aegypti 
OX513A RIDL strain in Brazil suppression of 95% of the local Aedes population was 
achieved over a 1-year period (Carvalho et al., 2015). In An. gambiae, a strategy for 
population suppression via sex distorsion called X shredder was designed that relies 
on the selective cleavage of essential genes located in the X chromosome 
(Windbichler et al., 2008). Population suppression can be achieved by the expression 
during male spermatogenesis of the homing endonuclease IPop-I or via 
CRISPR/Cas9 directed mutagenesis, both resulting in individuals able to produce only 
male offsprings (Galizi et al., 2014, 2016).  
An alternative to mosquito population suppression is its replacement with genetically-
modified individuals displaying reduced vectorial capacity. This is achieved by 
rendering mosquitoes less susceptible or refractory to parasite infection via the 
expression of antipathogen effectors such as antibodies (De Lara Capurro et al., 
2000; Isaacs et al., 2011, 2012), antimicrobial proteins (Kim et al., 2004), synthetic 
peptides (Meredith et al., 2011), or by altering pathways that regulate parasite 
development (Luckhart et al., 2013). 
In order to efficiently spread and maintain these modifications across mosquito 
populations, gene drive systems are being developed that induce super-Mendelian 
inheritance whereby a transgene can be driven at rates greater than expected as a 
result of a normal Mendelian cross (Sinkins & Gould, 2006). The most successful 
gene drives tested in Anopheles rely on the use of the CRISPR/Cas9 technology and 
achieved 91-99% efficiency in cage experiments (Gantz et al., 2015; Hammond et al., 
2016). 
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1.3 Insecticide resistance  
Insecticide-based vector control strategies continue to be the cheapest, most widely-
implemented and most effective option so far (White et al., 2011; Bhatt et al., 2015) 
and are likely to remain the frontline malaria control interventions. Therefore, the 
spread of resistance is concerning, and monitoring and understanding the 
mechanisms of resistance developed by mosquito vectors is essential to effectively 
use and manage the classes of insecticides available. 
Insecticide resistance in dominant African Anopheles vectors has been recorded to 
all the insecticide classes (Figure 1.3), with 60 malaria endemic countries reporting 
resistance to at least one class (WHO, 2016a). Furthermore, mosquito populations 
from West Africa, such as Tiassalé from Côte d’Ivoire and VK7 from Vallée du Kou in 
Burkina Faso, displayed high levels of resistance to permethrin, deltamethrin, DDT, 
bendiocarb, with Tiassalé also showing resistance to fenitrothion (Edi et al., 2012; 
Toé et al., 2014).  
 
 
Figure 1.3 Resistance status of main malaria vector species in 
Africa. Data are shown for An. arabiensis, An. coluzzii, An. funestus 
sensu latu and An. gambiae sensu latu. They were obtained by WHO 
tube and CDC bottle bioassays to all insecticide classes between 
2000 and 2017. Map was generated by IR Mapper 
(www.irmapper.com). 
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With the remarkable spread of insecticide resistance across Africa new strategies for 
operational management must be considered as outlined in the Global Plan for 
Insecticide Resistance Management in Malaria Vectors (GPIRM) (WHO, 2012b). 
These include a tighter regulation of insecticide use and dosage, insecticide rotation, 
and insecticide combinations. Moreover, there is an urgent need to develop new 
active molecules. In the effort to better design new insecticides and manage the ones 
that are available, it is crucial to fill the gap in our knowledge on the molecular and 
genetic causes of insecticide resistance, and how these can be overcome.   
Extensive research over the past 60 years has led to the identification of four main 
mechanisms of insecticide resistance (Figure 1.4): target-site and metabolic 
resistance, which are the most commonly characterised, and behavioural and 
cuticular resistance, which are thought to be less common, or at least less 
investigated (Liu, 2015). 
A single mode of resistance resulting in insensitivity to more than one class of 
insecticides is well known. This may result from the physical alteration of a target site 
shared by more than one insecticide, such as mutations in the voltage-gated sodium 
channel (kdrR) causing resistance to DDT and pyrethroids (Williamson et al., 1993), 
and mutations in the Ace-1 gene (ace-1R) which cause resistance to 
organophosphates and carbamates (Ahoua Alou et al., 2010; Essandoh et al., 2013). 
The concomitant presence of kdrR and ace-1R has also been reported in West African 
countries including Côte d’Ivoire (Asidi et al., 2005), Burkina Faso (Dabiré et al., 
2008), and Benin (Djogbénou et al., 2008). In addition, the overexpression of 
metabolically active enzymes with promiscuous substrate binding sites may lead to 
the detoxification of unrelated classes of insecticides. An example of the latter is the 
ability of An. gambiae CYP6P3 to metabolise insecticides belonging to the pyrethroid, 
carbamate and organophosphate classes (Yunta et al., unpublished).  
Multiple resistance mechanisms may co-exist in the same organism that enhance the 
level or broaden the spectrum of resistance (Yewhalaw et al., 2011; Olé Sangba et 
al., 2017). The presence of mosquito populations showing multiple resistance (i.e. 
target-site and metabolic), has been reported in 50 malaria endemic countries (WHO, 
2016a). 
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Figure 1.4 Schematic representation of the four mechanisms of resistance 
found in mosquitoes (taken from Lapied et al., 2009). In susceptible insects 
(a) insecticide molecules penetrate the cuticle and, although part of them are 
excreted and/or degraded, enough molecules are able to act on their target 
to exert toxicity. In resistant insects (b) modifications of the behaviour, 
reduced penetration of insecticide molecules through the cuticle, mechanisms 
of enhanced detoxification and excretion, and mutations in the insecticide 
target work alone or in combination to determine insensitivity to one or more 
classes of insecticides.  
 
1.3.1 Target-site resistance  
Target-site resistance results from the presence of a mutated target site that renders 
the binding of the insecticide less effective.  
 
1.3.1.1 Mutations in the Voltage-Gated Sodium Channel (VGSC) (kdrR) 
Under physiological conditions, VGSCs operate between an inactive state, in which 
the channel is closed at resting potential and ion flux is impeded, and an active state, 
in which the channel is open allowing the influx of ions and therefore membrane 
depolarisation. The binding of insecticide molecules to specific VGSC residues 
prevents the inactivation of the channel, resulting in constant depolarisation and, in 
turn, insect paralysis and death (Davies et al., 2007).  
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Neuronal VGSCs are the target of pyrethroid and DDT insecticides, and mutations in 
these sites determine resistance and in some cases cross resistance to both classes 
(Williamson et al., 1993). Certain mutations in the VGSC are known as knock down 
resistance (kdrR) mutations as they result in a reduction in the rapid paralytic effect 
that causes inability to fly or even stand on vertical surfaces (knock down) that is the 
typical response to pyrethroids. Kdr mutations characterised in pyrethroid-resistant 
An. gambiae and An. coluzzii so far include: two mutations in the transmembrane 
domain, L1014F in West Africa (Martinez-Torres et al., 1998) and L1014S in East 
Africa (Ranson et al., 2000), and a mutation in a linker domain, N1575Y, found in 
West and Central Africa (Jones et al., 2012) (Figure 1.5). Kdr mutations have been 
also identified in Ae. aegypti, C. pipiens, and Ae. albopictus (Hemingway et al., 2004; 
Nkya et al., 2013), but not in An. funestus (Menze et al., 2016).  
 
 
Figure 1.5 Schematic representation of VGSC and mutations associated with insecticide resistance 
(taken from Wang et al., 2015). The channel is formed by 4 domains (I-IV) each consisting of six 
transmenbran segments (S1-6). Each domain is connected via intracellular linker loops. Segments 1-4 
are responsible for sensing changes in voltage, while segments 5-6 and linker loops form the channel. 
Mutations associated with insecticide resistance are found in pore-forming regions in position 1014 of 
IIS6 and in position 1575 of the loop connecting domains III and IV.  
 
1.3.1.2 Acetylcholinesterase enzyme (AchE) mutation (ace-1R) 
Under normal physiological conditions, AchEs catalyse the hydrolysis of the 
neurotransmitter acetylcholine that terminates the nerve impulse. The binding of 
insecticide molecules to AchE impairs its function causing constant nerve impulse 
and, in turn, paralysis and death. Non-synonymous mutations in the ace-1 gene 
sequence can cause insensitivity to organophosphate and carbamate insecticides 
(Fukuto, 1990). For example, in An. gambiae, a G119S mutation in exon 5 of the Ace-
1 gene (Weill et al., 2004) was found implicated in resistance to organophosphates 
and carbamates. Resistance can also be conferred by alterations in copy number of 
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the mutated Ace-1 gene, as has been observed in pan-resistant Tiassalé mosquitoes 
(Edi et al., 2014), and in An. arabiensis (Dabiré et al., 2014).  
 
1.3.1.3 Mutations in the GABA type A receptor (Rdl) 
The gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter involved in 
restoring the membrane potential after depolarisation through chloride ions influx 
(Anthony et al., 1993). Mutations on the Rdl gene alter the channel gating properties 
resulting in insect paralysis and death. GABA-receptor mutations have been 
associated with resistance to dieldrin (Hemingway et al., 2004). Specific mutations in 
position 296 of the Rdl gene are found in dieldrin resistant mosquito species: the 
A296S substitution is found in An. arabiensis (Du et al., 2005), An. coluzzii (Lawniczak 
et al., 2010) and An. funestus (Wondji et al., 2011), while the A296G mutation is found 
in An. gambiae (Lawniczak et al., 2010). 
 
1.3.2 Alteration of cuticle composition  
Cuticular resistance originates from modifications in the mosquito cuticle composition 
that diminish or slow down insecticide penetration. While this type of resistance has 
been suggested in some pest species (Ahmad et al., 2006), evidence of cuticle genes 
overexpressed in resistant mosquitoes are recent (Gregory et al., 2011; Fossog Tene 
et al., 2013; Riaz et al., 2013; Ingham et al., 2014). In An. funestus, Wood et al. (2010) 
found a positive correlation between cuticle thickness and permethrin-induced knock 
down time in resistant mosquitoes. In An. gambiae, Balabanidou et al. (2016) recently 
found that deltamethrin resistant mosquitoes display a thicker cuticle compared to 
susceptible mosquitoes, which correlated with the slower internalisation of the 
insecticide. Further analysis also revealed a significant enrichment in cuticular 
hydrocarbons, thought to be produced in mosquito oenocytes, that regulate cuticle 
permeability (Balabanidou et al., 2016). In line with this finding, GAL4-mediated 
oenocyte-specific stable RNAi knockdown of Cyp4g16 and Cyp4g17, both proposed 
to catalyse the final step of hydrocarbon synthesis, resulted in increased death by 
desiccation in An. gambiae (Lynd et al., unpublished).  
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1.3.3 Behavioural adaptations  
Behavioural resistance results from modifications of the mosquito behaviour that allow 
avoidance of exposure to insecticides or reduction of the duration of exposure, most 
notably changes in host-seeking and feeding behaviour to circumvent ITNs and IRS 
(Sokhna et al., 2013). 
Altered feeding patterns were found after 12 years of ITN usage in Tanzanian An. 
gambiae and An. funestus. Here, nocturnal biting was reduced in both species with 
An. funestus also showing reduced indoor biting (Russell et al., 2011). This was 
partially explained by a shift in vector dominance to more adaptable populations with 
An. gambiae being the dominant vector at the time of ITN deployment and An. 
arabiensis found the most abundant 12 years after the start of the intervention 
(Russell et al., 2011). 
A study conducted in Senegal after LLIN deployment showed evidence for An. 
funestus diurnal biting (Sougoufara et al., 2014). Finally, in An. gambiae behavioural 
shifts from endophagy to outdoor biting, and from early evening to morning host-
seeking was found in Bioko Island following IRS (Reddy et al., 2011; Meyers et al., 
2016). The bases of these findings are complex to examine and remain poorly 
investigated. It is unclear to what extent heritable genetic traits that aid insecticide 
avoidance play a role compared to the selection of resistant population with more 
plastic feeding patterns able to fill the niche left by susceptible mosquitoes (Gatton et 
al., 2013). 
 
1.3.4 Metabolic resistance  
Insects showing metabolic resistance detoxify, excrete and/or sequester insecticide 
molecules faster than their susceptible counterparts therefore preventing the 
insecticide from reaching its target site. Faster metabolism can be selected for by 
increasing the quantity of detoxifying enzymes via transcriptional or translational up-
regulation or by expression of catalytically enhanced isoforms (Hemingway et al., 
2004). In some cases, both up-regulation and mutant isoforms have been found in 
resistant mosquito populations (Mitchell et al., 2014; Riveron et al., 2014b).  
Detoxification is often a three-phase process (Xu et al., 2005). Phase I consists of the 
breakdown of the insecticide via oxidation or hydrolysis; such modifications generally 
increase the polarity of the insecticide, which reduces or eliminates toxicity, increases 
their aqueous solubility, and provides reactive species for phase II conjugation. Phase 
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II involves mechanisms that increase the hydrophilicity of phase I metabolites 
primarily through conjugation with endogenous molecules. Finally, phase III 
comprises mechanisms of excretion across cell membranes mediated by ATP-
dependant transporters. In addition, or in conjunction with detoxification, insecticides 
can be sequestered by binding to endogenous molecules, including lipoproteins, that 
prevent them from reaching their targets (Shaw, 1991).  
Enzymes involved in metabolic resistance include cytochrome P450 
monooxygenases (P450s), glutathione S-transferases (GSTs), carboxyl/choline 
esterases (CCEs), and glucosyl/glucuronosyl transferases (UDPGTs). A remarkable 
proportion of the An. gambiae genome (~1.6%) is devoted to metabolism and 
detoxification, with 111 cytochrome P450s, 31 GSTs, 43 CCES and 26 UGTs genes 
annotated in the PEST genome (Holt et al., 2002; Ranson et al., 2002). 
 
1.3.4.1 Glutathione S-transferases (GSTs) 
Insect GSTs are microsomal and cytosolic enzymes, the latter being involved in 
resistance. At least 6 classes of cytosolic GSTs are present in An. gambiae, with the 
insect-specific subfamilies delta (δ, d) and epsilon (ε, e) being the largest (Ranson et 
al., 2002). They have broad substrate specificity which explains their involvement in 
resistance to most classes of insecticides through phase I (organochlorines) and 
phase II (organophosphates and pyrethroids) detoxification.  
Evidence of GST-mediated DDT dehydrochlorination in mosquitoes was reported in 
the 1990s in both Ae. aegypti (Grant et al., 1991) and An. gambiae (Prapanthadara & 
Ketterman, 1993). More recently, in vitro degradation of DDT was shown by 
recombinant orthologues of Gste2 isolated from Ae. aegypti (Lumjuan et al., 2005), 
An. gambiae (Ortelli et al., 2003; Mitchell et al., 2014) and An. funestus (Riveron et 
al., 2014b). In both Anopheles species, mutated GSTe2 alleles were found (I114T 
and L119F respectively) in resistant mosquitoes that displayed increased catalytic 
activity compared to their susceptible counterparts. Finally, increased resistance to 
DDT has been observed following overexpression of the different Anopheles Gste2 
alleles in D. melanogaster (Daborn et al., 2012; Mitchell et al., 2014; Riveron et al., 
2014b). 
Phase II metabolism occurs via conjugation with reduced glutathione which results in 
solubilisation and more efficient excretion (Panini et al., 2016). GST-mediated 
secondary metabolism of organophosphates was suggested in An. subpictus 
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(Hemingway et al., 1991), and that of pyrethroids was found in Nilaparvata lugens 
(Vontas et al., 2001). In addition to phase II metabolism of pyrethroids, indications of 
sequestration were reported in Tenebrio molitor (Kostaropoulos et al., 2001). 
In mosquitoes, despite increased expression of GSTs being consistently found in 
pyrethroid-resistant populations (Nkya et al., 2013), the molecular basis of the 
involvement of these enzymes in resistance to this class remain unclear. For example, 
RNAi interference of Gste7 or Gste2 in resistant Ae. aegypti caused an increase in 
deltamethrin susceptibility (Lumjuan et al., 2011). Conversely, the ubiquitous 
overexpression of An. gambiae Gste2 in D. melanogaster did not modify resistance 
to permethrin (Daborn et al., 2012), while that of An. funestus Gste2 conferred 
resistance to permethrin and deltamethrin (Riveron et al., 2014b). 
 
1.3.4.2 Carboxyl/choline esterases (CCEs)  
CCEs are involved in metabolic resistance through sequestration and phase I 
detoxification of organophosphates and carbamates (Hemingway, 1982a). Most of 
the work aimed at unveiling the molecular basis of CCE overexpression-mediated 
resistance has been conducted in organophosphate-resistant Culex mosquitoes 
(Hemingway & Karunaratne, 1998), and more recently in temephos-resistant Aedes 
mosquito larvae (Poupardin et al., 2014; Grigoraki et al., 2015, 2016). 
In resistant C. quinquefasciatus, quantitative changes in the level of CCE expression 
are suggested to result in increased sequestration (coupled with slow detoxification 
rates) of toxic oxon forms deriving from the oxidation of organophosphates, thereby 
causing resistance by masking toxicity (Ketterman et al., 1992; Karunaratne et al., 
1993). Sequestration of temephos-derived oxon forms by CCEs was recently 
suggested in Ae. aegypti and Ae. albopictus (Grigoraki et al., 2016). 
Qualitative functional changes are found in CCEs overexpressed in malathion-
resistant insects (Campbell et al., 1998; Claudianos et al., 2002), including Anopheles 
species (Hemingway 1982b, Hemingway & Georghiou, 1983; Herath et al., 1987). 
Here, the hydrolytic capacity of the enzyme is enhanced rather than the rate of 
sequestration, therefore these CCEs catalyse the more rapid detoxification of 
insecticides into their corresponding alcohol and acid metabolites which are more 
easily excreted. This altered activity may be the result of single amino acid 
substitutions as found in Lucilia cuprina (Newcomb et al., 1997) and Musca domestica 
(Claudianos et al., 1999), yet its molecular basis remains unclear.  
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Although there are reports of CCE upregulation in permethrin-resistant mosquitoes 
(Hemingway et al., 2004; Vontas et al., 2005), their involvement in pyrethroid 
metabolism has not yet been confirmed by functional analysis.    
 
1.3.4.3 Cytochrome P450 monooxygenases (P450s)  
P450s are a wide family of haem thiolate enzymes present in all organisms from 
bacteria (soluble) to humans (microsome and mitochondria membrane-bound). They 
fulfil a variety of functions catalysing over 50 different chemical reactions (Guengerich, 
2001). As microsomal monooxygenases, they use two electrons provided by NADPH 
to reduce molecular oxygen to water and to hydroxylate a substrate: 
RH + O2 + NADPH + H+   →   R-OH + H2O + NADP+ 
They work as part of the so called “P450 system” where they are coupled to redox 
partners, most notably NADPH cytochrome P450 reductase (CPR) and cytochrome 
b5. 
In insects, P450 functions include metabolism of juvenile hormones, ecdysteroids, 
fatty acids and eicosanoids, biosynthesis of hydrocarbons and pheromones 
(Feyereisen, 1999), and, most notably, the biotransformation of foreign compounds 
(xenobiotics) of both natural (i.e. plant toxins) (Gould, 1984) and artificial (insecticides) 
origin (Ronis & Hodgson, 1989).  
P450s are encoded by genes belonging to the Cyp superfamily which are abundant 
in mosquito genomes: 111 in An. gambiae (Ranson et al., 2002), 160 in Ae. aegypti 
(David et al., 2005), 204 in C. quinquefasciatus (Yang & Liu, 2011). 
In An. gambiae, P450s have been implicated in resistance through phase I 
detoxification of type I and type II pyrethroids (Müller et al., 2008b; Stevenson et al., 
2011) and carbamates (Edi et al., 2014), as well as the activation of 
organophosphates in their toxic oxon forms (Yunta et al., unpublished).  
 
1.3.4.4 Mechanisms of gene overexpression and increased metabolism  
While the validation of role of detoxifying genes in metabolic resistance is actively 
being unveiled, very little is known about the transcriptional and genomic modification 
that lead to their overexpression.  
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In some insects, the presence of transposable elements within the gene promoter has 
been proposed to mediate overexpression. In D. melanogaster, resistance to DDT is 
associated with the presence of a 491 bp insertion within the 5’ UTR of the Cyp6g1 
corresponding to the terminal repeats of a retrotransposon (Accord element) (Daborn, 
2002). Cis-regulatory elements within the retrotransposon, including tissue-specific 
enhancers and xenobiotic-responsive elements, work in concert to induce 
overexpression in the midgut, Malpighian tubules and fat body (Chung et al., 2007, 
2011). Further analysis of the Cyp6g1 locus conducted by Schmidt et al. (2010) 
revealed the presence of additional transposable elements (P and HMS-Beagle) 
associated with resistance to DDT.  
Another example of the implication of transposon elements was found in C. 
quinquefasciatus where Cyp9m10 is upregulated in pyrethroid resistant individuals 
(Komagata et al., 2010) and can metabolise permethrin in vitro (Wilding et al., 2012). 
Wilding et al. (2012) found that the upregulation of this gene in a resistant strain was 
associated with the presence of a partial Culex repetitive element (CuRe1) which is 
absent in the susceptible strain. However, a direct role for the element was not 
supported by cell line luciferase assays, since its deletion had no effect on reporter 
expression suggesting the involvement of further regulative elements.  
Copy number variation of Cyp6g1 was found in Drosophila spp., with up to four copies 
present, and was found associated with DDT resistance (Schmidt et al., 2010; Harrop 
et al., 2014). Similarly, the duplicated D. melanogaster gene Cyp12d1 was involved 
in resistance to caffeine and other xenobiotics (Najarro et al., 2015) and, interestingly, 
transgenic experiments demonstrated that the overexpression of both copies is 
required in vivo to cause resistance (Daborn et al., 2007). In An. funestus, two genes 
are found duplicated, Cyp6p4 and Cyp6p9 (Wondji et al., 2009). Although sequence 
analysis suggests these duplications were not selected by pyrethroid use, the 
presence of multiple copies is argued to play a role in increasing the levels of 
resistance as both isoforms of the Cyp6p9 gene are able to metabolise pyrethroids 
and confer resistance when overexpressed in D. melanogaster (Riveron et al., 2013, 
2014a). In An. gambiae, recent duplication events were detected in the GSTe cluster 
which is implicated with DDT resistance (Ranson et al., 2001; Ding et al., 2003). Gene 
duplication has also been associated with target-site resistance with duplication of the 
Rdl locus in D. melanogaster (Remnant et al., 2013) and Ace-1 in C. pipiens (Labbé 
et al., 2007) and An. gambiae (Djogbénou et al., 2008).  
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Polymorphisms and allelic variation drive the creation of mutated alleles coding for 
detoxifying enzymes with enhanced catalytic activity which are rapidly selected in 
resistant populations. Such events were identified in the Gste2 gene of An. gambiae, 
where the I114T mutation is specific for a DDT resistant allele (Mitchell et al., 2014), 
and An. funestus, where the L199F mutation is found in the pyrethroid resistant allele 
(Riveron et al., 2014b). In these studies, resistant Gste2 alleles from both species 
were reported as metabolically more active than their susceptible counterparts in vitro. 
The precise effect of these mutations is being reassessed further in in vitro and in vivo 
studies (G. Lycett and H. Ismail pers. comm.). 
Alterations in the transcription factor binding domains were found in D. melanogaster 
resistant to phenobarbital via Cyp6a2 overexpression. Here, Misra et al. (2011) found 
that a 15 bp region located upstream of the Cyp6a2 transcription start site is essential 
for inducing expression of a LacZ reporter in transgenic flies after phenobarbital 
exposure. This promoter region contains the binding site of the CncC/Maf-S 
transcription factor heterodimer which is known to regulate the expression of 
detoxifying genes in vertebrates. The inhibition of CncC/Maf-S via RNAi or via the 
overexpression of the Keap1 inhibitor results in lack of phenobarbital-mediated 
induction of Cyp6a2 (Misra et al., 2011). Like in vertebrates, this pathway coordinates 
the induction of multiple detoxifying genes in response to phenobarbital exposure. 
The involvement of the Maf-S transcription factor in metabolic resistance is currently 
being investigated in An. gambiae, where it is found upregulated in pyrethroid-
resistant populations across Africa. Its knockdown in the pan-resistant Tiassalé strain 
resulted in a decreased expression of major detoxifying genes, which, in turn, 
determined an increase in susceptibility (Ingham, 2016). 
A new pathway regulating overexpression has been recently proposed by Liu et al., 
(2015) which is based on the role of G-protein coupled receptors (GPCR) that are 
found overexpressed in pyrethroid-resistant C. quinquefasciatus (Liu et al., 2007). Li 
et al. (2014) demonstrated that the knock-down of GPCR-related genes in two 
resistant strains correlated with a decrease in expression of detoxifying genes and a 
resulting increase in permethrin susceptibility. Further experiments demonstrated that 
the heterologous overexpression of a C. quinquefasciatus rhodopsin-like GPCR in D. 
melanogaster resulted in an increased expression of P450s genes and enhanced 
tolerance to permethrin (Li et al., 2015). 
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1.3.5 Detection of metabolic resistance  
The phenotypic assessment of the resistance status of field-caught mosquitoes is 
traditionally performed by standard methods such as the WHO tube bioassay (WHO, 
2016b). This procedure involves assessing mortality over a 24 h period following 
exposure of adult females to a single diagnostic dose of insecticide for a specified 
length of time.  
To help define the contribution of single or multiple mechanisms of resistance, other 
molecular and phenotypical methods were developed. These include the detection of 
target site mutations by an optimised qPCR-based TaqMan® assay (Bass et al., 2007) 
and assessing the involvement of metabolic resistance via synergism studies. The 
latter studies are often performed with the P450-inhibitor PBO which is thought to 
occupy the P450 active site and inactivate the enzyme by creating a metabolism-
induced inhibitor complex (Feyereisen, 2015). PBO is thought to be active against 
most P450s, and thus, the first step in the WHO guidelines to determine the 
involvement of P450-mediated detoxification is to expose resistant mosquitoes to 4% 
PBO prior to insecticide exposure and compare mortality rates to those obtained in 
the absence of PBO (WHO, 2016b). If an increase in mortality is seen when pre-
exposed to PBO, then good evidence for the degree of P450 involvement is 
generated. However, there is evidence to suggest that PBO can inhibit other 
metabolic enzyme classes (Young et al., 2005; Khot et al., 2008), and so the results 
are not always unequivocal.  
 
1.3.5.1 Identification of genes involved in metabolic resistance 
Phenotypical assessment of metabolic resistance does not provide information on the 
detoxifying enzymes involved in resistance. Therefore, molecular investigations on 
the level of expression of specific genes are required to identify those involved in 
resistance. The publication of the An. gambiae genome (Holt et al., 2002) remarkably 
facilitated such studies, allowing for comprehensive investigations on the 
transcriptome of resistant vs susceptible mosquitoes. 
Early transcriptome experiments were based on small-scale microarrays including 
probes for the detection of major detoxifying families (P450s, GSTs and CCEs). The 
use of these “detoxification chips” was successful in An. gambiae (David et al., 2005) 
and Ae. aegypti (Strode et al., 2008) in identifying candidate genes with differential 
expression in resistant strains within the major detoxification families tested. “Detox 
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chip” approaches were later substituted by the introduction of whole genome 
microarrays (Mitchell et al., 2012), which expanded our knowledge beyond 
detoxification families. Currently, transcriptome analysis is moving away from 
microarray-based experiments to newly-developed transcriptome profiling by RNA-
Seq (Zhu et al., 2014; Bonizzoni et al., 2015). From transcriptome data on differentially 
expressed genes, lists of top candidate genes overexpressed in resistant mosquitoes 
are generated and single-gene approaches undertaken to validate overexpression by 
RT-qPCR and to functionally characterise them.  
Single-gene validation starts with assessing the capability of candidate proteins to 
metabolise insecticides in vitro. This is classically undertaken by obtaining E. coli-
produced recombinant proteins and assaying them for their ability to deplete specified 
quantities of an insecticide in a specified amount of time in vitro. More detailed studies 
will then characterise the identity and kinetics of insecticide metabolite production via 
HPLC analysis (Stevenson et al., 2011; Yunta et al., unpublished), which is often 
coupled to mass spectrometry (Hoi et al., 2014; Stevenson et al., 2012). Potential 
interactions with insecticide molecules can be also determined by in silico modelling 
and molecular docking simulation to explore binding modes (Riveron et al., 2014b; 
Ibrahim et al., 2016a, 2016b). Additional tools to identify P450s with metabolism 
capabilities are synthetic activity-based probes (Wright & Cravatt, 2007) that mimic 
insecticide structures (Ismail et al., 2013). Probes mimicking the structure of 
pyrethroid insecticides have been developed using ‘click chemistry’ (Ismail et al., 
2013). These pyrethroid-mimetic probes (PyABPs) bind irreversibly to P450s that they 
are metabolised by and their click handle used to add a fluorescent reporter. This 
ultimately allows for the identification of potential pyrethroid-metabolising P450s from 
arrays of purified recombination proteins and can be used to define specific interacting 
P450s from complex in vivo extracts (Wright & Cravatt, 2007; Ismail et al., 2013). 
Transcription analysis and data on in vitro metabolic activity are crucial first steps in 
the validation of single genes implicated in resistance, yet in vivo functional 
approaches are needed to conclusively define the role of single genes in causing 
resistance (Ranson et al., 2011). As mosquito genome manipulation is particularly 
challenging, in vivo analysis of insecticide metabolisers has been so far conducted 
via ectopic overexpression of Anopheles genes in D. melanogaster transgenics using 
the GAL4/UAS system (Yang et al., 2007; Daborn et al., 2012).  
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This multi-step approach (Figure 1.6) has been used to assay the top candidate genes 
involved in metabolic resistance in major African malaria vectors, which are 
summarised in Table 1.1. 
 
 
Figure 1.6 Current pipeline for metabolic resistance assessment and functional validation of single 
genes.  
 
However, this approach has limitations. Whole-mosquito transcriptome approaches 
may underestimate the significant contribution of genes that are expressed tissue-
specifically. In support of this observation, Ingham et al. (2014) found that, although 
many of the top candidate gene associated with resistance found by tissue-specific 
comparisons were also identified by whole transcriptome data, over 20 additional 
candidates were revealed as associated with resistance. Moreover, while in vitro 
metabolic studies have proven useful as first functional screening, they are limited to 
proteins with measurable enzymatic properties. In these experiments absence of 
metabolism does not exclude involvement in resistance via other mechanisms such 
as binding or secondary metabolism. Finally, limitations of the Drosophila in vivo 
model lie in its physiology. In such a model, metabolically-inactive proteins involved 
in resistance, such as transcription factors and sensory proteins, are difficult or 
impossible to test rationally. Furthermore, the insecticide dosage used to test for 
resistance is not directly comparable to that used in mosquitoes. To overcome these 
limitations and obtain representative data, an Anopheles in vivo validation model is 
needed.   
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Table 1.1 Functional analysis studies conducted on Anopheles genes. 
Insecticide Gene 
In vitro 
metabolism 
Drosophila 
transgenics 
An. gambiae genes 
Pyrethroids 
Cyp6m2 (1) (2) 
Cyp6p3 (3) (2) 
Gste2 (perm) N/A  (4) 
DDT 
Cyp6m2  (5) (2) 
Cyp6p3  (5) N/A 
Cyp6z1 (14) N/A 
Gste2 (6, 7) (4, 7) 
Bendiocarb 
Cyp6m2  (2) (2) 
Cyp6p3 (2) (2) 
Malathion 
Cyp6m2 (5) N/A 
Cyp6p3 (5) N/A 
An. funestus genes 
Pyrethroids 
Gste2 (perm) (8) (8) 
Gste2 (delta)  (8) (8) 
Cyp6m7 (9) (9) 
Cyp6p9a (9) (10) 
Cyp6p9b (10) (10) 
Cyp9j11 (11) (11) 
Cyp6z1 (13) N/A 
DDT 
Gste2 (8) (8) 
Cyp6p9a  (5) N/A 
Cyp6p9b  (10) N/A 
Bendiocarb Cyp6z1 (13) N/A 
An. arabiensis genes 
Pyrethroids 
Cyp6p4 (perm) (12) N/A 
Cyp6p4 (delta)  (12) N/A 
 
Green ticks represent presence of in vitro depletion or that of resistance in 
vivo. Red crosses represent lack of in vitro depletion or that of resistance in 
vivo. (1) Stevenson et al., 2011; (2) Edi et al., 2014; (3) Müller et al., 2008b; 
(4) Daborn et al., 2012; (5) Yunta et al., unpublished; (6) Ortelli et al., 2003; 
(7) Mitchell et al., 2014; (8) Riveron et al., 2014b; (9) Riveron et al., 2014a; 
(10) Riveron et al., 2013; (11) Riveron et al., 2017; (12) Ibrahim et al., 2016b; 
(13) Ibrahim et al., 2016a (14) Chiu et al., 2008.  
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1.3.6 The CYP6 family 
The P450 CYP6 family is found only in insects and has been widely linked to 
metabolic resistance in several insects. Early studies conducted in D. melanogaster 
reported the upregulation of several Cyp6 genes in resistance to a variety of 
chemicals and their metabolic activity in vitro, including that of Cyp6a2 (Brun et al., 
1996; Saner et al., 1996; Dunkov et al., 1997; Amichot et al., 2004) and Cyp6a8 
(Helvig et al., 2004). The best characterised candidate in the fruit fly is Cyp6g1, whose 
overexpression was reported in DDT and imidacloprid resistant flies (Daborn et al., 
2001). The involvement of this gene in resistance was later demonstrated by its ability 
to metabolise DDT and imidacloprid (Joussen et al., 2008) and via transgenic 
overexpression using the GAL4/UAS system in transgenic flies (Daborn et al., 2002; 
Chung et al., 2007). In the house fly, M. domestica, Cyp6d1 was found overexpressed 
in pyrethroid-resistant flies (Tomita et al., 1995) and Cyp6a1 in phenobarbital-
resistant flies (Cariño et al., 1994) compared to a susceptible strain. Similarly, 
Cyp6cm1 was found overexpressed in imidacloprid-resistant Bemisia tabaci strains B 
and Q (Karunker et al., 2008) and its heterologous overexpression in D. melanogaster 
resulted in acquisition of resistance to imidacloprid (Daborn et al., 2012). More 
recently, Cyp6bq9 was found upregulated in deltamethrin-resistant Tribolium 
castaneum and its involvement in resistance also demonstrated via heterologous 
overexpression in D. melanogaster (Zhu et al., 2010).  
Despite these examples of the ability of individually overexpressed Cyp6s to alter the 
resistance phenotype in vivo, the involvement of single vs multiple genes in 
determining resistance is actively debated (Yang et al., 2007). This is based on the 
observation that multiple, yet not all, P450s metabolise insecticides in vitro (Yunta et 
al., unpublished) and that P450 distribution and abundance vary in different tissues 
(Stevenson et al., 2011; Ingham et al., 2014). Therefore, an interplay of different 
P450s and other enzymes in a multistep mode of action may take place in vivo, similar 
to the separate phases of drug metabolism in mammals (Yang et al., 2007; Daborn et 
al., 2012). 
In mosquitoes, genes encoded by the CYP6M, CYP6P and CYP6Z subfamilies have 
been frequently associated with resistance, with pyrethroid resistance being the most 
widely investigated. Cyp6z genes have been found upregulated in DDT (z1 (David et 
al., 2005) and permethrin (z2 (Müller et al., 2007) and z3 (Müller et al., 2008b)) 
resistant An. gambiae; in deltamethrin resistant Ae. aegypti (z6 and z8 (Strode et al., 
2008)); and in pyrethroid and carbamate resistant An. funestus (z1 and z3 (Irving et 
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al., 2012; Ibrahim et al., 2016a)). Similarly, upregulation of the Cyp6p subfamily genes 
was found in pyrethroid resistant An. gambiae (p3 (Müller et al., 2008b) and p4 (Edi 
et al., 2012)), An. funestus (p9 (Amenya et al., 2008), p4 (Wondji et al., 2009)), An. 
minimus (p7 (Duangkaew et al., 2011)), and An. arabiensis (p3 (Müller et al., 2008a), 
p4 (Ibrahim et al., 2016b)). Finally, transcriptome data also associated An. gambiae 
m2 (Djouaka et al., 2008; Müller et al., 2007), An. funestus m7 (Riveron et al., 2014a), 
and Ae. aegypti m6, m10 and m1 (Marcombe et al., 2012; Poupardin et al., 2012) with 
resistance to pyrethroids. An. gambiae m2 was also found upregulated in DDT 
resistant populations (Mitchell et al., 2012).  
In vitro functional analysis on the recombinant proteins revealed the ability of An. 
gambiae CYP6Z1 to metabolise DDT (Chiu et al., 2008) and that of An. funestus 
CYP6Z1 to metabolise pyrethroids and bendiocarb (Ibrahim et al., 2016a). While a 
lack of pyrethroid metabolism was found for An. gambiae CYP6Z2 (McLaughlin et al., 
2008) and its Ae. aegypti orthologue CYP6Z8 (Chandor-Proust et al., 2013), their 
involvement in resistance was instead attributed to their ability to act as phase II 
enzymes metabolising 3-phenoxybenzoic alcohol, a common product of CCE-
mediated detoxification of pyrethroids (Chandor-Proust et al., 2013). Furthermore, to 
support their role in resistance, the ability of An. gambiae CYP6P3 and CYP6P4 and 
An. funestus CYP6P9a and CYP6P9b to metabolise permethrin and deltamethrin has 
been reported (Müller et al., 2008b; Riveron et al., 2013, 2014a; Yunta et al., 
unpublished) (Table 1.1). Surprisingly, An. arabiensis CYP6P4 was reported able to 
metabolise permethrin but not deltamethrin (Ibrahim et al., 2016b) (Table 1.1). 
In vivo validation of Anopheles genes expressed in D. melanogaster is summarised 
in Table 1.1. This exists so far only for members of the CYP6P and CYP6M 
subfamilies. 
 
1.3.6.1 Cyp6m2 and Cyp6p3: top resistance candidate genes in An. gambiae  
An. gambiae Cyp6m2 and Cyp6p3 are the best studied candidate genes associated 
with metabolic resistance. As mentioned above, their increased expression has been 
reported in mosquito populations resistant to a diverse range of insecticides across 
Africa and their involvement has been supported through in vitro and Drosophila 
studies.  
Upregulation of Cyp6m2 and Cyp6p3 was recorded in mosquitoes resistant to 
permethrin in Southern Benin and Nigeria (Djouaka et al., 2008), to deltamethrin in 
    Chapter 1 – Introduction 
25 
 
southern Benin (Yahouédo et al., 2016), to DDT in Benin (Djègbè et al., 2014) and 
they are also found upregulated in the pan resistant An. gambiae strain Tiassalé from 
Côte d’Ivoire (Edi et al., 2014). Cyp6m2 was additionally found significantly 
upregulated in mosquitoes resistant to pyrethroids and DDT in Ghana (Mitchell et al., 
2012; Müller et al., 2007) and Cameroon (Fossog Tene et al., 2013); while Cyp6p3 
upregulation was additionally reported in mosquitoes resistant to permethrin in Ghana 
(Müller et al., 2008b) and in An. gambiae populations collected from seven villages in 
Vallée du Kou in Burkina Faso that are multi-resistant to pyrethroids, DDT, dieldrin 
and bendiocarb (Kwiatkowska et al., 2013). 
Cyp6m2 and Cyp6p3 orthologues were also found upregulated in An. arabiensis 
mosquitoes resistant to pyrethroids in Cameroon (Müller et al., 2008a), Tanzania 
(Matowo et al., 2014), South Africa (Nardini et al., 2013) and Sudan (Abdalla et al., 
2014). Finally, An. funestus Cyp6p9, the orthologue of An. gambiae Cyp6p3, was 
found upregulated in pyrethroid-resistant mosquitoes from Mozambique (Amenya et 
al., 2008; Riveron et al., 2013), Malawi (Riveron et al., 2013, 2015, 2014a), Zambia 
(Riveron et al., 2014a), Uganda and Kenya (Mulamba et al., 2014). 
To further support the association of these genes with resistance, their recombinant 
proteins were demonstrated to metabolise a variety of insecticides in vitro. 
Specifically, CYP6M2 metabolised the pyrethroids permethrin and deltamethrin 
(Stevenson et al., 2011), and malathion (Yunta et al., unpublished), but not the 
carbamate bendiocarb (Edi et al., 2014). While in previous studies CYP6M2 was 
reported able to metabolise DDT (Mitchell et al., 2012), later investigations revealed 
that metabolism occurred only in the presence of sodium cholate as a solubilising 
factor and that CYP6M2 alone was not metabolically active against DDT (Yunta et al., 
unpublished). CYP6P3 in vitro metabolic activity was demonstrated for permethrin 
and deltamethrin (Müller et al., 2008b), malathion (Yunta et al., unpublished), and 
bendiocarb (Edi et al., 2014). As found for CYP6M2, no insecticide depletion was 
reported against DDT (Yunta et al., unpublished).  
Cyp6m2 and Cyp6p3 are amongst the limited number of genes for which in vivo data 
on the effect of their overexpression in D. melanogaster is available (Edi et al., 2014). 
These experiments confirmed the ability of CYP6M2 and CYP6P3 overexpression to 
confer resistance to pyrethroids, with CYP6P3 also conferring resistance to 
bendiocarb. Furthermore, although lacking in vitro activity against DDT (Yunta et al., 
unpublished) and bendiocarb (Edi et al., 2014), in vivo overexpression of CYP6M2 in 
D. melanogaster increased resistance to these insecticides (Edi et al., 2014). 
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Similarly, the closely related genes Cyp6p9a/b and Cyp6m7 from An. funestus were 
shown to metabolise pyrethroids in vitro and to confer resistance to this class of 
insecticides when overexpressed in D. melanogaster (Riveron et al., 2013, 2014a).  
 
1.3.7 Tissues involved in detoxification  
Identifying the major tissue/s involved in insecticide clearance is pivotal to 
understanding the pathways of detoxification. This is crucial for implementing 
strategies for efficacious insecticide management that incorporate new insecticide 
chemistries and improved formulations that increase uptake, and it is also relevant for 
designing better diagnostic tools (Yang et al., 2007). Yet, despite the growing data on 
the role of specific genes in detoxification, the spatial distribution of their expression 
remains largely unclear. Insect tissues commonly believed to be involved in 
detoxification include midgut, Malpighian tubules, fat body, and brain (Wang et al., 
2004; Chung et al., 2007; Yang et al., 2007; Giraudo et al., 2010; Zhu et al., 2010). 
For example, the expression of D. melanogaster Cyp6g1 is found tissue-specifically 
enhanced in the midgut, fat body and Malpighian tubules of resistant flies. Here, 
tissue-specificity is mediated by enhancers within the Accord retrotransposon situated 
upstream of the transcription start site of the resistant allele (Chung et al., 2007, 
2011). In D. melanogaster, midgut, Malpighian tubules, fat body and brain were also 
suggested as detoxifying tissues by analysing the pattern of induction of Cyp6a2 
expression after phenobarbital exposure (Giraudo et al., 2010).  
The involvement of the brain in detoxification was demonstrated by Zhu et al. (2010) 
in the red flour beetle T. castaneum. Here, deltamethrin-resistant beetles significantly 
overexpressed Cyp6bq9, a P450 able to metabolise deltamethrin in vitro, whose 
knockout by dsRNA injection in the resistant strain caused an increase in susceptibility 
to deltamethrin. Interestingly, Cyp6bq9 was found enriched in the brain of all beetles 
but was specifically overexpressed in the brain of the resistant strain. Finally, 
heterologous overexpression of T. castaneum Cyp6bq9 confined to the brain of D. 
melanogaster was sufficient to cause resistance to deltamethrin as efficiently as that 
driven by the Act5c ubiquitous driver.  
Little is known about tissues specifically involved in detoxification in mosquitoes. 
While transcriptome data from dissected An. gambiae tissues are available (Marinotti 
et al., 2006; Dissanayake et al., 2006; Koutsos et al., 2007; Baker et al., 2011; Padrón 
et al., 2014; Overend et al., 2015) these are not specifically associated with 
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occurrence of insecticide resistance. To date, only one study assessed tissue-
enrichment of resistance-associated genes and compared expression in specific 
tissues of susceptible vs resistant An. gambiae populations (Ingham et al., 2014). 
Although this study was not exhaustive in the tissues and body sections examined, it 
revealed a general abundance of candidate gene ‘detox’ transcripts in the midgut and 
Malpighian tubules of resistant mosquitoes, while other candidate genes had a more 
widespread distribution. 
 
1.3.7.1 Midgut  
The insect midgut has been associated with a role in xenobiotic metabolism as 
suggested by the induction of expression after exposure to various chemicals in D. 
melanogaster (Brun et al., 1996; Chung et al., 2007; Giraudo et al., 2010). In the moth 
P. xylostella, RNAi-mediated knock-down of Cyp6bg1 in the larval midgut through 
dsRNA feeding resulted in an increased susceptibility to permethrin (Bautista et al., 
2009). In An. gambiae, this is supported by the high native enrichment of Cyp6m2 
(Stevenson et al., 2011) and the P450-cofactor CPR in the midgut of susceptible 
mosquitoes (Lycett et al., 2006). However, Cyp6m2 was not found specifically 
enhanced in the midgut of pan-resistant Tiassalé mosquitoes (Ingham et al., 2014). 
Conversely, transcripts from detoxification genes of the CYP6P family, including 
Cyp6p3, were found enriched in the midgut of resistant An. gambiae (Ingham et al., 
2014). Similarly, P450 transcript enrichment was identified in in the midgut of Ae. 
aegypti larvae (Poupardin et al., 2010).  
 
1.3.7.2 Oenocytes  
Insect oenocytes have been associated with a role in detoxification for a long time but 
this has never been fully explored (Clark & Dahm, 1973). Oenocytes are cells of 
ectodermal origin located beneath the abdominal cuticle or scattered in the fat body 
whose function is insects has been compared to that of mammalian liver (Gutierrez et 
al., 2007; Martins et al., 2011). They are implicated in a variety of roles, such as 
cuticular hydrocarbon synthesis, regulation of haemolymph composition, lipid storage 
and metabolism, fatty acid metabolism, insect development, and immunity (Gutierrez 
et al., 2007; Martins et al., 2011; Makki et al., 2014). The role of oenocytes as site of 
detoxification was suggested by Lycett et al. (2006) after reporting that RNAi-
mediated knock-down of the P450-cofactor CPR in this location results in enhanced 
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sensitivity to permethrin in An. gambiae. Consistent with a role in detoxification, 
analysis of the transcriptome of the Ae. aegypti pupal oenocytes revealed that P450s 
represented the most abundant class of transcripts (Martins et al., 2011). The 
candidate Cyp4g17 is enriched in the abdomen integument of An. gambiae resistant 
mosquitoes (Ingham et al., 2014), and was found specifically localised in the 
oenocytes along with Cyp6g16 (Balabanidou et al., 2016). The latter gene product 
was shown to catalyse cuticular hydrocarbon production and thus implication in 
cuticular resistance through cuticle thickening was suggested in An. gambiae 
(Balabanidou et al., 2016). 
 
1.3.7.3 Malpighian Tubules  
Malpighian tubules constitute a major component of insects’ excretory system and are 
responsible for regulation of fluid homeostasis and excretion of products of 
metabolism including toxic compounds such as insecticides (Pachecho et al., 2014). 
In D. melanogaster members of the major detoxifying families P450 and GST are 
upregulated in the Malpighian tubules compared to the whole fly; amongst them, 
Cyp6g1 transcript abundance is ~10 times higher (Wang et al., 2004). Overexpression 
of Cyp6g1 using a GAL4 driver specific for the Malpighian tubule principal cells 
determined a decrease in sensitivity to DDT, conversely tubule-specific knockdown 
caused increased mortality (Yang et al., 2007). In mosquitoes, their involvement in 
detoxification is supported by transcriptome analysis on susceptible An. gambiae 
mosquitoes revealing enrichment of several Cyp6 genes in the Malpighian tubules of 
the Cameroonian N’Gousso strain (Ingham et al., 2014) and that of Cyp6m2 in the 
Kenyan Kisumu strain (Stevenson et al., 2011). Furthermore, several members of 
detoxifying gene families, including P450s, are found upregulated in the Malpighian 
tubules of pan-resistant Tiassalé mosquitoes, here transcripts from the CYP6Z family 
were specifically found enriched (Ingham et al., 2014). The P450-cofactor CPR was 
also found abundant in this organ (Lycett et al., 2006). High native expression of 
several Cyp6 genes was also found in the Malpighian tubules of Ae. aegypti larvae 
(Poupardin et al., 2010).  
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1.4 Functional analysis in mosquitoes 
With the growing abundance of transcriptomic data generated on disease vectors 
such as mosquitoes, tools for in vivo gene functional analysis are increasingly needed 
to examine the role of single genes in affecting a phenotype. Functional analysis of 
mosquito genes through loss of function (RNA interference, gene knockout) or gain 
of function (overexpression) has elucidated key biological pathways mostly in relation 
to genes relevant for parasite transmission.  
 
Loss of function analysis 
Transient RNAi via the injection of dsRNA has been employed most often to 
investigate An. gambiae mosquito immune response to pathogen invasion. Such 
studies assisted in defining roles for, amongst others, genes encoding antimicrobial 
peptides (Blandin et al., 2002), transcription factors such as REL2 (Meister et al., 
2005), and the complement factors TEP1 (Blandin et al., 2004) and LRIM1 (Lombardo 
et al., 2013) in modulating bacterial and Plasmodium infection. Using transient RNAi, 
the list of genes acting as immunomodulators in An. gambiae is growing (Lombardo 
& Christophides, 2016). 
Transient RNAi to investigate P450 genes has not been extensively reported, with 
few examples of successful silencing, including Cyp307a1 shown to be involved in 
ecdysteroid production (Pondeville et al., 2013) and Cyp4g16, which could be 
knocked down in adults but failed to show a role in cuticular hydrocarbon production 
(Balabanidou et al., 2016). Attempts to knockdown in vitro established P450 
candidates in An. gambiae and An. funestus have failed to show effects on insecticide 
sensitivity (G. Lycett pers. comm.). Examples of successful knockdown of other genes 
associated with insecticide resistance are also limited. These include knockdown of 
the P450 partner CPR (Lycett et al., 2006) in susceptible mosquitoes which led to 
increased permethrin sensitivity, the transcription factor Maf (Ingham, 2016) and the 
appendage protein SAP2 (V. Ingham pers. comm.), whose knock down in resistant 
mosquitoes was shown to increase insecticide sensitivity.  
A downside of transient RNAi is that its efficiency most often does not reach 100%. 
Linked to this, An. gambiae, similarl to Drosophila, does not have a systemic RNAi 
response (Tomoyasu et al., 2008), meaning that the interference signal is not spread 
among tissues. In effect this means that knockdown efficiency is tissue dependant, 
with some tissues seemingly more efficiently targeted than others (Lycett et al., 2006). 
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Similarly, Boisson et al. (2006) reported that remarkably high amounts of dsRNA are 
required to affect salivary gland genes, compared to fat body genes. Transient RNAi 
studies in mosquitoes are thus both temporally (one generation) and spatially limited.  
An alternative that allows for stable and inheritable silencing is transgenesis with a 
RNAi-cassette that carries inverted repeats of the targeted gene. Although more 
laborious and relying on the availability of specific promoters, this has the advantage 
of creating continuous lines for analysis. Stable RNAi was demonstrated in D. 
melanogaster (Kennerdell & Carthew, 2000) and proof of principle experiments were 
successfully performed in An. gambiae cell line, and An. stephensi larvae and adults 
by silencing GFP (Brown, 2003a, 2003b). In An. gambiae, stable GAL4-mediated 
RNAi driven by an oenocyte specific promoter was used successfully for the first time 
to demonstrate a role for the cuticular Cyp4g genes mentioned above that failed to 
show an adult phenotype with transient RNAi (Lynd et al., unpublished). In Ae. 
aegypti, stable RNAi is more common and has been used to functionally characterise 
immune genes (Bian et al., 2005), salivary gland proteins (Chagas et al., 2014), and 
sex distorter genes (Hoang et al., 2016). Nevertheless, inheritable RNAi is most often 
not 100% efficient, since it only targets tissues in which the promoter is active. Those 
untargeted tissues will produce normal quantities of protein. This can be overcome to 
some extent by using promoters having much broader expression profiles. 
A loss of function technique that is independent of promoters, is to create null mutants, 
having complete gene knockout. Programmable nucleases such as TALENs, ZFs and 
CRISPR/Cas9 are able to target specific DNA sequences in the germline, which leads 
to the subsequent generation of stable knockouts (Gaj, 2014). Such technologies 
have recently become available for application to a wide variety of organisms, 
including mosquitoes (Aryan et al., 2013; DeGennaro et al., 2013; Kistler et al., 2015). 
Nucleases have been used in Anopheles (Smidler et al., 2013; DeGennaro et al., 
2013; Gantz et al., 2015; Hammond et al., 2016) mainly for vector control methods 
but has yet to be reported for the analysis of insecticide resistance in An. gambiae. 
Stable, colonised resistant lines are an obvious target for the development of such 
technologies in mosquitoes, and once highly efficient systems are developed these 
may be applied to more experimentally limiting field populations. 
 
Gain of function analysis 
The complementary method to investigate gene function is to overexpress genes in 
temporal and spatial patterns derived from specific promoters controlling the effector 
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gene. Again, genetic analysis by gain of function or overexpression has been 
achieved in Anopheles to characterise immune genes and their role in disease 
transmission. These include the overexpression of the antimicrobial peptide Cecropin 
under the control of the midgut-specific promoter carboxypeptidase (Kim et al., 2004) 
and that of TEP1 in the fat body using the blood-meal inducible vitellogenin promoter 
(Volohonsky et al., 2017). Similarly, the transcription factor REL2 was investigated in 
Ae. aegypti transcribed by the vitellogenin promoter (Antonova et al., 2009), and in 
An. stephensi with both carboxypeptidase and vitellogenin promoters (Dong et al., 
2011). Finally, in An. stephensi, sustained activation of the insulin signalling pathway 
via overexpression of Akt (Corby-Harris et al., 2010) and PTEN (Hauck et al., 2013) 
in the midgut was shown to limit Plasmodium infection intensity.  
Nevertheless, as described previously, in vivo functional analysis of Anopheles P450 
genes involved in resistance has only been conducted in D. melanogaster. A major 
limiting step in this development has been the availability of promoters that drive 
expression in tissues that relate to insecticide resistance. 
 
1.4.1 Promoters for gene functional analysis in Anopheles 
As indicated above, effective functional analysis via stable RNAi or overexpression 
depends on achieving controlled spatio-temporal patterns of transgene expression, 
which is largely dependent on the promoter chosen. Endogenous tissue-specific 
promoters available for Anopheles spp. transgenic analysis include: the testes-
specific β2-tubulin promoter (Catteruccia et al., 2005); the salivary gland-specific 
apyrase and antiplatelet protein promoters (Lombardo et al., 2000, 2005; Yoshida & 
Watanabe, 2006); the germline-specific promoters vasa, vitellogenin receptor, and 
nanos (Papathanos et al., 2009b; Biedler et al., 2014); the midgut-specific 
carboxypeptidase (Moreira et al., 2000), cecropin A (Kim et al., 2004), peritrophic 
matrix protein 1 (Abraham et al., 2005), and G12 (Nolan et al., 2011) promoters; the 
blood meal inducible fat body-specific promoters vitellogenin (Nirmala et al., 2006; 
Chen et al., 2007) and lipophorin (Volohonsky et al., 2015, 2017); and the olfactory 
receptor-specific promoter orco (Riabinina et al., 2016). While these promoters are 
currently implemented for functional analysis or generating gene drive systems, 
promoters for other tissues important for mosquito biology research, including ovaries 
and Malpighian tubules, have not been characterised.  
Most notable is the lack of a characterised promoter driving ubiquitous expression in 
An. gambiae. This issue was investigated by Lycett et al. (2012), who characterised 
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the promoter of the An. gambiae α-tubulin-1b gene as a possible ubiquitous 
candidate. AngTubα1b was reported to drive expression in the head, chordotonal 
organs, central nerve cord, and testes, while expression in other tissues varied 
between lines generated and thus appeared to result from positional effect. A non-
endogenous promoter driving widespread expression in An. stephensi (Marinotti et 
al., 2013), as well as D. melanogaster (Masumoto et al., 2012) and B. mori (Masumoto 
et al., 2012) is named hr5-ie1 (Huynh & Zieler, 1999). This naturally controls the 
immediate-early genes of Baculovirus and has been used in An. gambiae to drive the 
expression of transformation markers (Grossman et al., 2001; Meredith et al., 2013). 
Although fluorescence was detectable across the body of larvae and pupae (Meredith 
et al., 2013), the specific pattern of expression driven by hr5-ie1 was not detailed in 
An. gambiae adult tissues. The lack of a fully characterised endogenous ubiquitous 
promoter severely limits functional analysis of genes requiring widespread multi-
tissue expression. 
 
1.4.2 Mosquito germline transformation by embryo microinjection  
A pre-requisite for functional analysis via inheritable modifications is obtaining 
transformant individuals by embryo microinjection. Following the first in vivo 
transformation of an insect genome (Rubin & Spradling, 1982), major advancements 
have been made in insect transgenic technologies that expanded applications from 
model organisms to more demanding non-model organisms such as mosquitoes. The 
introduction of exogenous DNA in insect embryos by microinjection was firstly 
documented by Rubin & Spradling, (1982) who achieved the first successful in vivo 
germline transformation of D. melanogaster. Since then, several species of 
mosquitoes have been transformed by embryo microinjection: Ae. aegypti (Morris et 
al., 1989), An. stephensi (Catteruccia et al., 2000), An. gambiae (Grossman et al., 
2001), C. quinquefasciatus (Allen et al., 2001), An. albimanus (Perera et al., 2002), 
Ae. fluviatilis (Rodrigues et al., 2006), and Ae. albopictus (Labbé et al., 2010). 
Nevertheless, microinjection of mosquito embryos remains a remarkably challenging 
technique subjected to numerous variables, most notably the technical experience of 
the operator for egg set up, injection, and post-injection handling, the quality and 
development of eggs, the toxicity of injected DNA, and timing of injection. 
A somewhat optimised protocol for germline transformation of mosquito embryos was 
reported by Lobo et al. (2006). Here, injections target the dorsal surface of the 
posterior pole of pre-blastoderm stage embryos (Figure 1.7), where the pole or germ 
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plasm is located that contains cells destined to differentiate into the germ line. In 
dipteran eggs, after fertilisation, a syncytial blastoderm is formed through nuclear 
divisions with nuclei then migrating to the periphery of the egg and forming a 
cellularised blastoderm (Williamson & Lehmann, 1996). Since blastoderm 
segmentation occurs within 3 hours from fertilisation at insectary temperatures, 
injections are conducted at room temperature to slow down egg development (Lobo 
et al., 2006).  
 
 
Figure 1.7 Mosquito embryo microinjections (taken from 
Lobo et al., 2006). Eggs are attached to a microscope slide 
using double sticky tape. The target of injection is the 
posterior end of the egg, where cells that will differentiate in 
the germline are located.  
 
While protocols for injection of embryos have been optimised in An. gambiae 
(Lombardo et al., 2009; Pondeville et al., 2014), transformation efficiencies fluctuate 
quite extremely in separate injection experiments. From my experience, this is largely 
due to operator experience, however, Volohonsky et al. (2015) suggest that 
differences in transformation efficiency can be partly explained by the inconsistent co-
delivery of the vector and the helper plasmids in the same germ cell. This was 
supported by the observation that when two plasmids marked with distinct fluorescent 
markers were co-injected, many of the cells of surviving larvae showed episomal 
expression of only one marker. To circumvent this issue, the transposase coding gene 
was instead included in the backbone of the vector plasmid. However, while reporting 
a dramatic improvement in transgenesis rates, co-integration of the transposase gene 
was recorded in 2 out of 5 experimental lines (Volohonsky et al., 2015). The issue of 
delivering a helper plasmid was also addressed in site-specific integration 
experiments by Meredith et al., (2013) who reported increased hatching rates and 
transformation efficiency when using a self-docking strain expressing the PhiC31 
integrase gene.  
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1.4.3 Transposon-based transformation 
Early insect transformation was entirely based on transposable elements. DNA 
transposons are class II mobile elements able to reposition within a genome via a cut-
and-paste transposition process (Tu, 2012). Their general structure comprises a 
transposase gene flanked by inverted terminal repeats of variable length. The 
transposition process is mediated by the transposase and involves creating double-
stranded staggered breaks at both recipient and donor target sites, integration of the 
DNA and end-repair (Tu, 2012). Target sites recognised by transposons are very short 
sequences, which makes the integration process essentially quasi-random 
(O’Brochta et al., 2014). These characteristics have been largely exploited for 
genome modification, as mentioned above, by using a bipartite vector-helper system 
in which the transposon terminal repeats which are recognised by the transposase 
enzyme are left intact, and the transposase gene is replaced with a DNA cassette of 
interest, while active transposase is supplied in trans encoded on a helper plasmid 
(Handler & O’Brochta, 2012). 
Several transposable elements have been isolated from insect genomes and used for 
germline transformation. Among them, the P element was the first transposon ever 
isolated from an insect (D. melanogaster) (Kidwell et al., 1977) and the first used to 
transform one (Rubin and Spradling, 1982). However, P showed no mobility outside 
drosophilids which led to its limited use. Shortly after, the transposon that has 
probably had most widespread success in insect germline transformation, piggyBac, 
was isolated from the Lepidopteran Trichoplusia ni (Fraser et al., 1985) and has been 
used to transform non-drosophilid insects including lepidopteran, dipteran, 
coleopteran, hymenoptera and orthoptera (Atkinson & O’Brochta, 1999; Handler, 
2002; O’Brochta et al., 2014). Following the discovery of piggyBac, members of the 
Tc1/mariner family (Mariner, Mos1, Minos) were isolated from the Drosophila genus 
(Jacobson & Hartl, 1985; Bryan et al., 1987; Franz & Savakis, 1991). While Mariner 
and Mos1 have had a limited use due to their relatively low transposition efficiency, 
Minos has been more widely used and was the first to successfully transform an 
Anopheles mosquito, An. stephensi, by verified transposase mediated mobility 
(Catteruccia et al., 2000). Similarly, amongst the large family of hAT transposons, 
Hermes, isolated from M. domestica (Warren et al., 1994), has been successfully 
used to obtain germline transformation in coleopteran and dipteran, notably Ae. 
aegypti.  
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1.4.3.1 The piggyBac transposon 
Transformation of insect genomes using the piggyBac transposon has revolutionised 
the field of insect genomic manipulation. Since its first application to transform the 
Mediterranean fruit fly (medfly) Ceratitis capitata (Handler et al., 1998), piggyBac has 
been implemented in germline transformation protocols of D. melanogaster but also 
of non-model organisms such as T. castaneum (Berghammer et al., 1999) and B. mori 
(Tamura et al., 2000). In mosquitoes, piggyBac transformation was successfully 
achieved in Ae. aegypti (Kokoza et al., 2001), An. gambiae (Grossman et al., 2001), 
An. albimanus (Perera et al., 2002) and An. stephensi (Nolan et al., 2002). 
The piggyBac transposon was originally studied for its ability to transposase to the 
genome of baculoviruses cultured in T. ni cells (Fraser et al., 1985). The piggyBac 
element shows a symmetrical structure containing inverted repeats at each end, 
inverted sub-terminal repeats, and an internal gene encoding a transposase enzyme 
(Fraser et al., 1995) (Figure 1.8). 
 
 
Figure 1.8 Schematic of the piggyBac element (taken from Handler, 2002). 
The transposon is 2476 bp long and carries two sets of 13 bp inverted 
repeats (one at each end), two sets of 19 bp inverted sub-terminal repeats 
(one at each end), and an internal 1785 bp region coding for a transposase 
enzyme (68 kDa). TTAA is the genomic target site and is present at each 
terminus.  
 
PiggyBac-mediated transposition events occur via a non-replicative cut-and-paste 
mechanism that originates at TTAA target sites in the genome (Elick et al., 1996; 
Fraser et al., 1996; Mitra et al., 2008). Excision is initiated by a DNA double-stranded 
nick and mediated by the formation of a hairpin at the terminal repeats of the piggyBac 
transposon. DNA is then inserted and covalently joined by target site repair which 
restores the TTAA sites at each end (Cary et al., 1989).  
The TTAA-specificity of transposition makes integration events essentially random 
leading to two major consequences: 1) integration may disrupt gene sequences thus 
inducing insertional mutations and gene knockout (lethal mutagenesis), and 2) the 
localisation of integration has major effects on transgene expression due to the 
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presence of enhancers, silencers or presence of heterochromatic structures 
(positional effect) (Handler & O’Brochta, 2012; O’Brochta et al., 2014). As such, 
generating transgenic lines using transposition is very laborious and time consuming 
because an evaluation of all individuals carrying unique insertions is required to select 
lines with minimal or no effects on fitness and active transgene expression (Fraser, 
2012). Nevertheless, positional effect can be exploited in enhancer-trap systems 
where the presence of an enhancer nearby the site of insertion is detected by a 
reporter gene or GAL4 transcription factor under the control of a minimal promoter 
and exploited to define enhancer sequences and generate driver lines (Horn et al., 
2003; O’Brochta et al., 2011).  
Further limitations of the system include constrained carrying capacity (10-13 kb) 
(Geurts et al., 2003) and possible post-integration mobility mediated by an unintended 
transposase source which may lead to repositioning or loss of the transgene cassette. 
To overcome this, stabilisation techniques were introduced that involve the post-
integration removal or rearrangement of the sequences essential for mobility such as 
the transposon terminal repeats (Handler, 2004).  
 
1.4.4 Site-specific integration using the PhiC31/att system  
Site-specific integration approaches were introduced to circumvent issues related with 
positional effect derived from random transposon-mediated transformation.  
The PhiC31/att integration system is mediated by the bacteriophage PhiC31 integrase 
that catalyses the recombination between heterospecific attachment sites 
independently located in the genome of the bacteriophage PhiC31 (attP) and in that 
of Streptomyces bacteria (attB) (Figure 1.9). As recombination results in the formation 
of hybrid sites (attL and attR) which are no longer recognised by the integrase, 
integration is unidirectional, which overcomes the issue of post-integration 
mobilisation (Thorpe & Smith, 1998). Moreover, constructs longer than 100 kb have 
been reported to be successfully integrated in D. melanogaster overcoming carrying 
capacities constrains (Venken et al., 2006). Finally, analysis of phenotypes caused 
by different transgenes located in identical genomic locations can be performed that 
minimises the bias of positional effect (Bateman et al., 2006). 
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Figure 1.9 Schematic of PhiC31-mediated 
integration (taken from Wimmer, 2005). Plasmid 
DNA is integrated into the genome via 
recombination of the attB and attP sites resulting 
in the formation of hybrid sites attR and attL. 
 
Site-specific integration can be exploited for transgenesis in a two-phase approach: 
transposon-mediated insertion is firstly required to create a docking line carrying attP 
sites in unique transcriptionally active genomic landing sites (phase I), and site-
specific integration of an attB-flanked plasmid can then occur after its microinjection 
in the docking strain embryos (phase II) (Meredith et al., 2011). Therefore, creating 
docking lines still requires an initial random integration process followed by 
characterisation of lines with the least fitness cost and position effects. Yet, from these 
selected lines a great variety of new transgenic lines can be successively created by 
site-specific recombination.  
In insects, PhiC31-mediated integration was firstly achieved in D. melanogaster 
(Groth et al., 2004) and later applied in the mosquitoes Ae. aegypti (Nimmo et al., 
2006), Ae. albopictus (Labbé et al., 2010), An. gambiae (Meredith et al., 2011), and 
An. stephensi (Isaacs et al., 2012). 
 
1.4.4.1 Recombinase-Mediated Cassette Exchange (RMCE)  
A modification of the standard site-specific insertion systems, called recombinase-
mediated cassette exchange (RMCE), involves the replacement of a previously 
integrated DNA construct with a donor DNA rather than its integration. This is 
achieved by flanking both donor and recipient cassettes with recombinase-specific 
target sites at each end, which allows for two independent crossover events resulting 
in cassette swop.  
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RMCE was achieved using the PhiC31/att system (Figure 1.10) in D. melanogaster 
(Bateman et al., 2006) and has also been applied successfully to non-model insects 
including the mosquitoes An. gambiae (Lynd et al., unpublished; Hammond et al., 
2016), Ae. aegypti and P. xylostella (Haghighat-Khah et al., 2015), and B. mori (Long 
et al., 2015).  
RMCE has advantages that permit new experimental designs: 1) only the DNA 
flanked by attB sites integrates in the specified genomic location rather than the whole 
donor plasmid (Bateman et al., 2006; Haghighat-Khah et al., 2015); 2) unmarked 
constructs can be integrated and successful integration identified by loss of 
fluorescent marker (Bateman et al., 2006); 3) there is an immediate gain in time and 
efficiency as the assessment of multiple lines to define localisation of insertion and 
fitness is bypassed.   
 
 
Figure 1.10 Schematic of the PhiC31-RMCE (taken from Bateman et 
al., 2006). The system is based on flanking the donor plasmid with attB 
sites (B) and the recipient cassette with attP sites (P) at each end. This 
results in the donor DNA flanked by attBs replacing the DNA flaked by 
attPs in the genomic target via two separate recombination events.  
 
1.4.5 The GAL4/UAS system  
Transgenic binary systems of expression represent a valuable tool to investigate the 
biological function of genes in vivo via localization of expression of genes linked to 
fluorescent reporters, gene overexpression, and gene knockouts. 
Binary systems such as the GAL4/UAS, can be used for heterologous and 
homologous gene expression while their modular nature allows for repeated use of 
transgenic lines. The system was identified in the yeast S. cerevisiae where it is 
essential for the catabolism of galactose (Giniger et al., 1985). Here, gene expression 
is activated by the binding of 2 molecules of the transcription factor GAL4 (881 amino 
acids) to a 17 bp Upstream Activating Sequence (UAS) region localised upstream of 
the gene expressed (Laughon & Gesteland, 1982; Hong et al., 2008). GAL4/UAS was 
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exploited in insects to design a binary system consisting of two transgenic 
components independently inserted in the genome of transgenic lines, a driver or 
GAL4 and a reporter or UAS (Brand & Perrimon, 1993) (Figure 1.11). The driver line 
carries the GAL4 sequence, the expression of which is under the control of a specific 
promoter that defines the desired spatio-temporal pattern of expression; the 
responder line contains the UAS localised upstream of the sequence of the gene of 
interest. The system is active only in the progeny resulting from the cross between 
the driver and responder lines, which expresses the desired gene in the selected 
transcription pattern.  
 
 
Figure 1.11 The GAL4/UAS bi-partite system (adapted from Lynd & Lycett, 
2011). The driver construct consists of a promoter that drives the expression 
of the transcription activator factor GAL4. The responder construct contains 
the GAL4 binding site UAS (Upstream Activating Sequence) located 
upstream of the gene of interest. When the system is active GAL4 binds to 
the UAS and the genes is transcribed.  
 
Binary systems offer several advantages compared to linear transgene expression 
including amplification of gene expression, repeated use of lines for comparing gene 
expression or promoter activity, possibility of creating lines bearing toxic genes as 
their expression is inactive in the parental lines, and investigation of phenotypes 
resulting from both gene-specific loss-of-function (silencing via RNAi) and gain-of-
function (overexpression) in spatially and temporally controlled patterns. Furthermore, 
gene expression can be repressed by the GAL4 inhibitor GAL80, which binds to GAL4 
and impairs its transactivation activity. Therefore, an additional layer of spatial or 
temporal control of transgene expression can be achieved by placing GAL4 and 
GAL80 under alternative promoters which results in the creation of mosaic organisms 
(Lee et al., 1999; Lai & Lee, 2006).  
Since its first application in D. melanogaster to induce overexpression (Brand & 
Perrimon, 1993) or gene silencing (Piccin et al., 2001), the GAL4/UAS system has 
been applied to B. mori (Imamura et al., 2003), T. castaneum (Schinko et al., 2010), 
Ae. aegypti (Kokoza & Raikhel, 2011), An. stephensi (O’Brochta et al., 2012), and An. 
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gambiae, where the system was firstly developed in this laboratory in mosquito cell 
culture (Lynd & Lycett, 2011) and soon after applied to transgenic individuals to obtain 
gene overexpression (Lynd & Lycett, 2012) and silencing (Lynd et al., unpublished). 
As mentioned previously, assessment of gene function using the GAL4/UAS system 
is currently limited by the availability of a restricted number of promoters and, most 
notably, the lack of a ubiquitous promoter. Expanding these tools available for GAL4-
mediated functional analysis of resistance and other genes is one of the aims of this 
study.  
 
1.5 Aims of the study   
In view of the lack of functional analysis of resistance genes in Anopheles, this work 
aimed to identify the P450 genes that are physiologically involved in the emergence 
of metabolic resistance in An. gambiae mosquitoes and the tissues in which their 
expression is crucial for acquiring resistance.  
The hypotheses to be tested included whether the upregulation of the single candidate 
P450 genes, Cyp6m2 or Cyp6p3, is sufficient to drive the emergence of WHO-level 
of resistance in vivo, and whether resistance is dependent on expression in specific 
tissues (e.g. midgut, oenocytes or Malpighian tubules), or multiple tissues.  
To do so we aimed to induce independent overexpression of Cyp6m2 and Cyp6p3 in 
tissue-specific and ubiquitous patterns of expression in susceptible mosquitoes using 
the GAL4/UAS system and to then assay for acquired resistance using WHO standard 
methods. 
Since promoters for some of the locations we intended to investigate had not been 
characterised, this study also aimed to expand the flexible tools available for An. 
gambiae transgenesis by 1) identifying a promoter that drives widespread whole-body 
gene expression; 2) identifying a promoter that drives Malpighian tubule-specific 
expression; and 3) creating mosquito driver lines carrying newly identified promoters 
which will also serve as docking strains for PhiC31-mediated site-specific integration 
and cassette exchange.  
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2. Chapter 2 
Characterisation of resistance phenotypes resulting from 
midgut or oenocyte-specific overexpression of Cyp6m2 or 
Cyp6p3  
 
 
2.1 ABSTRACT  
The P450 monooxygenases CYP6M2 and CYP6P3, encoded by Cyp6 genes, are 
strong candidates linked to insecticide metabolic resistance as supported by 
transcriptome data and in vitro metabolism experiments. Yet, in vivo analysis is 
needed to identify which Cyp6 genes and tissues are responsible for the resistant 
phenotype to occur in the absence of other adaptations. Here, we investigated the 
ability of CYP6M2 and CYP6P3 to cause resistance when overexpressed in the 
midgut or in the oenocytes of otherwise susceptible An. gambiae mosquitoes. To do 
so, the GAL4/UAS system was used to drive overexpression of these genes in the 
targeted tissues of susceptible mosquitoes, which was successfully validated at RNA 
level for both genes and at protein level for CYP6M2. Mosquitoes overexpressing 
either Cyp6m2 or Cyp6p3 in the midgut or in the oenocytes did not show enhanced 
resistance to permethrin, deltamethrin, DDT, or bendiocarb compared to controls. The 
study provides the first in vivo evidence in elucidating the molecular basis of P450-
mediated metabolic resistance in An. gambiae suggesting a potential involvement of 
other Cyp6-overexpressing tissue/s in driving resistance. 
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2.2 INTRODUCTION 
Resistance mediated by the increased detoxification of insecticides by enzymes of 
the cytochrome P450 CYP6 family has been reported in a variety of mosquito species 
across Africa (David et al., 2013; Ranson & Lissenden, 2016). Amongst these, An. 
gambiae Cyp6m2 and Cyp6p3 are top candidate genes associated with metabolic 
resistance in this species as suggested by transcriptome analysis of resistant vs 
susceptible mosquitoes (Djouaka et al., 2008; Müller et al., 2008b; Mitchell et al., 
2012; Fossog Tene et al., 2013; Kwiatkowska et al., 2013; Djègbè et al., 2014; Edi et 
al., 2014; Antonio-Nkondjio et al., 2016; Yahouédo et al., 2016), in vitro metabolism 
data (Yunta et al., unpublished) and, more recently, in vivo functional analysis in D. 
melanogaster (Edi et al., 2014). Taken together these data showed CYP6M2 ability 
to metabolise the pyrethroids permethrin and deltamethrin in vitro and to increase 
insecticide tolerance when overexpressed in Drosophila (Stevenson et al., 2011; Edi 
et al., 2014; Yunta et al., unpublished). Additionally, overexpression of CYP6M2, for 
which inability to metabolism DDT and bendiocarb was reported (Yunta et al, 
unpublished; Edi et al., 2014), caused a significant increase in LD50 of both 
insecticides in Drosophila (Edi et al., 2014). Similar data on CYP6P3 showed activity 
against pyrethroids and bendiocarb both in vitro and in Drosophila (Müller et al., 
2008b; Edi et al., 2014). 
Despite the growing data on the role of individual genes involved in detoxification, 
their physiology is overlooked with regards to the contribution of specific tissues to 
insecticide detoxification. The first comprehensive study of tissue-specificity of An. 
gambiae detoxifying gene families was conducted by Ingham at al. (2014), who 
investigated the native transcription enrichment in specific tissues compared to whole 
body, and compared enrichment levels in each body part in resistant vs susceptible 
mosquitoes. This revealed a general abundance of detoxifying gene transcripts in the 
midgut and Malpighian tubules of resistant mosquitoes, while some top candidate 
genes displayed a more widespread distribution of expression. Among these, 
Cyp6m2 did not show tissue-specific overexpression in the locations investigated, 
while Cyp6p3 was significantly overexpressed in the midgut of resistant mosquitoes 
in relation to the whole body. Identifying tissues where these genes are 
overexpressed is essential to start untangling pathways of detoxification along the 
mosquito body, which in turn will help understanding insecticide chemistries and the 
impact of routes of insecticide administration in mosquitoes. Among the tissues 
believed to be involved in detoxification, the midgut (Stevenson et al., 2011) and the 
oenocytes (Lycett et al., 2006) have been suggested in An. gambiae respectively via 
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analysis of transcript abundance and in vivo knockout of the P450 cofactor CPR. They 
constituted the first targets for analysis as driver lines specific for these tissues had 
already been established in the laboratory, thus effects of the overexpression in these 
locations was the initial focus.  
 
2.3 AIMS AND OBJECTIVES  
The study’s aim was to investigate the ability of single Cyp6 genes to drive resistance 
when independently overexpressed in individual mosquito tissues thought to be 
involved in detoxification. To do so, we used the GAL4/UAS system to overexpress 
candidate genes Cyp6m2 and Cyp6p3 in the midgut and the oenocytes of susceptible 
An. gambiae mosquitoes and tested the resulting phenotype for acquired resistance.  
The study’s objectives were: 
• To create two transgenic responder lines for the UAS-regulated expression of 
An. gambiae genes Cyp6m2 and Cyp6p3; 
• To drive overexpression of Cyp6 candidates by crossing newly created UAS 
responder lines to previously established GAL4 driver lines specific for 
expression in the midgut and the oenocytes; 
• To validate Cyp6 gene upregulation and CYP6 protein overexpression in the 
targeted tissues; 
• To characterise the resistance phenotype obtained from midgut- and oenocyte-
specific CYP6M2 and CYP6P3 overexpression using the WHO tube bioassay.  
 
2.4 MATERIALS AND METHODS  
 
Contributions  
Dr. Amy Lynd created the driver lines for expression in the midgut and in the 
oenocytes and the responder plasmid in which Cyp6 sequences were cloned.  
Dr. Gareth Lycett performed the embryo microinjections.  
 
General methods including DNA extraction, PCR, agarose gel electrophoresis, DNA 
purification and clean-up, restriction endonuclease digestion, ligation, E. coli 
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transformation, minipreps, midipreps, ethanol precipitation, and sequencing are 
described in Appendix A.  
 
2.4.1 Plasmid preparation  
 
2.4.1.1 The UAS-Cyp6m2 plasmid (pUASm2) 
This plasmid was designed for the expression of Cyp6m2 (AGAP008212) under the 
regulation of the UAS and was marked with yellow fluorescent protein (YFP). The 
1500 bp coding sequence of Cyp6m2 from the susceptible strain Kisumu was 
amplified from plasmid PB13:CYP6M2 (Stevenson et al., 2011) using primers M2fw 
and M2rv (Appendix B, Table B.1) and Phire Hot Start II DNA Polymerase (Life 
Technologies) following manufacturer’s protocol. The Cyp6m2 sequence was then 
cloned into pJET1.2/blunt vector using CloneJET PCR Cloning Kit (Thermo Scientific) 
and transformed into MegaX DH10B™ T1R Electrocomp™ E. coli cells (Invitrogen). 
Plasmid was purified from clonal bacterial cultures using the Merlin miniprep protocol 
and sequenced using primers pJETseqFW and pJETseqRV (Appendix B, Table B.1). 
The Cyp6m2 sequence was finally digested out from the vector using EcoRV/XhoI 
and cloned into pSL*attB:Gyp:UAS14i:eYFP (Lynd et al., unpublished) to obtain the 
final plasmid pSL*attB:Gyp:UAS14i:Cyp6m2:eYFP (pUAS-m2) (Figure 2.1). This was 
harvested by miniprep and confirmed by single restriction enzyme digestions using 
SphI, BglII and SalI. Lastly, midiprep (Qiagen Plasmid Midi Kit) was performed 
following manufacturer’s recommendations to isolate larger quantities of the plasmid, 
which was then stored at -20 °C. 
 
 
Figure 2.1 Schematic map of pUASm2. attB: PhiC31 attachment sites; 3xP3: eye-specific promoter; 
YFP: yellow fluorescent protein marker; SV40: Simian virus 40 PolyA transcription terminator; Gyp1 and 
Gyp2: Gypsy insulators; UAS: Upstream Activating Sequence, binding site of GAL4; Cyp6m2: coding 
sequence of Cyp6m2. Plasmid backbone is pSLfa1180fa. 
 
2.4.1.2 The UAS-Cyp6p3 plasmid (pUASp3) 
This YFP-marked plasmid was designed for the expression of Cyp6p3 (AGAP002865) 
under the regulation of the UAS and was prepared as described above for Cyp6m2 
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except for the isolation of the coding sequence. The coding sequence of Cyp6p3 was 
not previously cloned in its entirety as the first 24 bp were substituted by the amino-
terminal sequence of the bovine steroid 17-α-hydroxilase for expression in E. coli 
(Müller et al., 2008b). Therefore, to obtain the full sequence, fusion PCR was used to 
join the 5’ terminal sequences from cDNA to the abovementioned partial clone. A 193 
bp fragment was amplified from Kisumu cDNA using primers P3fw1 and P3rv1 
(Appendix B, Table B.1) and the remaining 1362 bp fragment from plasmid pCW:17α-
Cyp6p3 (Müller et al., 2008b) using primers P3fw2 and P3rv2 (Appendix B, Table 
B.1). A third PCR was conducted to obtain the full 1555 bp sequence using primers 
P3EcoRIfw and P3rv2 (Appendix B, Table B.1). All PCRs were performed in a final 
volume of 20 µl using Phire Hot Start II DNA Polymerase (Thermo Scientific) 
according to manufacturer’s protocol. Following amplification, cloning into the 
pJET1.2/blunt vector and sequencing using primers pJETseqFW and pJETseqRV 
(Appendix B, Table B.1), the coding sequence was cloned into 
pSL*attB:Gyp:UAS14i:eYFP (Lynd et al., unpublished) as described above. The map 
of the final plasmid pSL*attB:Gyp:UAS14i:Cyp6p3:eYFP (pUAS-p3) was verified by 
single restriction enzyme digestions using HindIII and SalI. 
 
 
Figure 2.2 Schematic map of pUASp3. attB: PhiC31 attachment sites; 3xP3: eye-specific promoter; YFP: 
yellow fluorescent protein marker; SV40: Simian virus 40 PolyA transcription terminator; Gyp1 and Gyp2: 
Gypsy insulators; UAS: Upstream Activating Sequence, binding site of GAL4; Cyp6p3: coding sequence 
of Cyp6p3. Plasmid backbone is pSLfa1180fa.  
 
2.4.2 Establishment of transgenic lines  
 
2.4.2.1 Mosquito lines  
Details of mosquito maintenance are reported in Appendix A. In this study, six 
mosquito lines were used:  
- G3: wild type strain, originally isolated from The Gambia, obtained from the 
Malaria Research and Reference Reagent Resource Centre (MR4). 
- A11: transgenic homozygous docking line created by piggyBac-mediated 
integration. The transgene cassette is inserted in 2R: 33,858,877-80 (Lynd et al., 
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unpublished) and is flanked by attP sites for PhiC31-RMCE. The line is marked 
with 3xP3-driven cyan fluorescent protein (CFP). 
- GAL4mid: transgenic homozygous driver line created by piggyBac-mediated 
integration. It expresses GAL4 under the control of the An. gambiae 
carboxypeptidase promoter (Moreira et al., 2000) which directs expression in the 
adult midgut. The transgene cassette lays in an imprecisely mapped site on the 
3R chromosome (Lynd & Lycett, 2012) and the line is marked with 3xP3-driven 
Discosoma sp. red fluorescent protein (DsRed). 
- GAL4oeno: transgenic homozygous driver line created by piggyBac-mediated 
enhancer trapping. It directs expression of GAL4 in the oenocytes of all life 
stages. The transgene cassette is inserted in 2R: 48,392,077-80 (Lynd et al., 
unpublished) and line is marked with 3xP3-driven DsRed. 
- UASm2 and UASp3: transgenic responder lines created by PhiC31-RMCE 
using the A11 docking strain. They are marked with 3xP3-driven YFP and 
designed for the expression of Cyp6m2 and Cyp6p3 respectively. Details on the 
creation of these lines are reported in sections 2.4.2.3 and 2.5.1. 
 
2.4.2.2 Microinjections 
Transgenic mosquitoes were produced by site-specific germline transformation 
(Pondeville et al., 2014) using PhiC31-RMCE. 
 
2.4.2.2.1 DNA and needle preparation for microinjection  
To prepare the pUASm2 injection mix, plasmid DNAs were harvested from bacterial 
cultures using Plasmid Midi Kit (Qiagen), ethanol precipitated and resuspended to 
obtain a solution containing 350 ng/µl of the pUASm2 responder plasmid and 150 
ng/µl of the integrase helper plasmid PKC40 (Ringrose, 2009) in a total volume of 20 
µl of 1x injection buffer (5 mM KCl, 0.5 mM NaPO4, pH 7.2) (Lombardo et al., 2009). 
For pUASp3, an injection solution with a final concentration of 330 ng/µl was prepared 
instead at the same ratio of donor to helper plasmids. These mixes were used in two 
independent microinjection experiments. 
Injecting needles were pulled from quartz capillaries with filament (fire polished) 
(Sutter Instrument Co.) with a length of 7.5 cm, 1 mm outer diameter and an inner 
diameter of 0.7 mm. Needles were prepared using Sutter Instrument Co. P-2000 
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Micropipette Puller with the following setting: HEAT = 650; FIL = 4; VEL = 25; DEL = 
145; PUL = 200. 
 
2.4.2.2.2 Embryo alignment and microinjection 
Adult female mosquitoes of the A11 docking strain were allowed to lay in water for 20 
minutes in the dark and embryos left to develop for further 30 minutes in insectary 
conditions.  
Eggs were transferred in 25 mM NaCl onto a microscope slide and arranged in lines 
against the edge of Whatman filter paper grade 1 (Sigma). All embryos were aligned 
so the posterior (thinner) pole was exposed for injection and, whenever possible, so 
they laid on their dorsal side. After completing a line of ~50 embryos, Whatman paper 
was dried and removed, and eggs transferred onto a cover slip with double sticky 
tape. Here they were left to dry for 30 seconds before recovering them in a drop of 25 
mM NaCl. Alignments were conducted using Leica MZ FLIII stereoscope at room 
temperature.  
Microinjections were carried out in 25 mM NaCl at 200x magnification using Nikon 
Eclipse TE2000-U inverted microscope and Eppendorf® FemtoJet® Microinjector (Pi 
= 2000-3000 HPa) at room temperature (Lombardo et al., 2009).  After injection, eggs 
were immersed in 2-3 cm of mineral water and returned to insectary conditions. 
 
2.4.2.3 Creation of the UASm2 and UASp3 responder lines  
Emerging F0 larvae were separated by sex at pupal stage and surviving F0 adults 
were pooled into sex specific founder cages and outcrossed with 3x excess of wild 
type G3s of the opposite sex. Five days after crossing, a first blood meal was offered 
and larvae of the F1 progeny screened for YFP expression only (cassette exchange), 
CFP expression only (no exchange) or CFP/YFP expression (cassette integration) in 
the eyes and nerve cord.  
For the UASm2 line, a second blood meal was offered to the founder cages and 16 
individual female lays were set up to obtain F1 isofemale lines. To do so, universal 30 
ml plastic vials containing wet cotton wool and Whatman filter paper grade 3 (Sigma) 
were prepared and, two days after blood-meal, single females transferred inside and 
left laying overnight. Papers containing eggs were transferred into individual trays to 
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hatch. Females that did not lay were left in the vials for another night, after which they 
were discarded if did not lay eggs.   
For the UASp3 lines, 19 isofemale lines were set up as described above from F1 
transgenic females after crossing with G3s. Orientation of insertion was then 
assessed in corresponding parental females and a single isofemale line established 
as the definitive line either by crossing transformant individuals with G3s (UASm2) or 
by interbreeding them with negative adults of the same batch (UASp3). Responder 
lines were kept as a mix of homozygous and heterozygous individuals so to obtain 
GAL4/+ progeny to be used as transgenic blank controls.  
Minimum transformation efficiency was calculated as (Number of independent 
insertions / total F0 adult survivors) x 100. 
 
2.4.2.3.1 Orientation of insertion  
Cassette exchange may happen in two different orientations with respect to the 
chromosome, designated A or B (Figure 2.3). Orientation check was performed on 
the parental females and on the controls G3 and A11 by PCR. Combinations of 4 
primers designed to give a product only in one of the orientations were used in 4 
different PCRs: piggyBacR-R2 + Red-seq4R for PCR 1, M2intFW or P3intFW + 
ITRL1R for PCR 2, piggyBacR-R2 + M2intFW or P3intFW for PCR3, and Red-seq4R 
+ ITRL1R for PCR 4 (Figure 2.3). PCRs were performed using Phire Hot Start II DNA 
Polymerase (Life Technologies) and a 30-cycle thermal program consisting of 60°C 
annealing temperature and 60-second extension.  
Definitive UASm2 and UASp3 isofemale lines were created from individuals showing 
orientation of insertion A, which was chosen consistent with previous RMCE lines 
created in this laboratory.  
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Figure 2.3 Two possible orientations of insertion, A and B, after recombination of the attP sites in the 
docking mosquito genome and the attB sites in the UAS-Cyp6 plasmids.  attP, attB: PhiC31 
recombination sites; CFP: cyan fluorescent protein; YFP: yellow fluorescent protein; UAS: upstream 
activating sequence; attL, attR: hybrid sites created after recombination; →: primer annealing site, 1: 
piggyBacR-R2; 2: Red-seq4R; 3: M2intFW or P3intFW; 4: ITRL1R (Appendix B, Table B.1). 
 
2.4.3 GAL4 x UAS crosses 
Crosses were established between the homozygous drivers specific for expression in 
the midgut (GAL4mid) (Lynd & Lycett, 2012) or in the oenocytes (GAL4oeno) (Lynd 
et al., unpublished) marked with DsRed, and opposite sex individuals of the UASm2 
and UASp3 responder lines marked with YFP. A total of 4 crosses was established: 
GAL4mid x UASm2, GAL4mid x UASp3, GAL4oeno x UASm2 and GAL4oeno x 
UASp3.  
The progeny of these crosses was expected to give GAL4/UAS transgenic 
mosquitoes expressing both YFP and DsRed and GAL4/+ mosquitoes expressing 
DsRed only (controls). Progeny was sorted at pupa stage according to marker colour 
to have DsRed/YFP-positive and DsRed-positive individuals using a Leica MZ FLIII 
fluorescence stereo microscope fitted with DsRed and YFP filters (Leica 
Microsystems). 
 
2.4.4 Assessment of Cyp6 gene expression in GAL4/UAS vs GAL4/+ 
 
2.4.4.1 Sample preparation 
To quantify Cyp6 gene expression in GAL4/UAS and GAL4/+ individuals, total RNA 
was harvested from pools of whole adults, pupae, larvae and their dissected body 
parts. For the GAL4mid crosses, RNA was isolated from whole adults, dissected 
midguts and remainder tissues (carcass), while for the GAL4oeno crosses collection 
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was carried out from whole L4 larvae, pupae, adults, dissected adult abdomens 
(without internal organs), and remainder adult tissues (carcass). 
For adult dissections, 2-5-day-old GAL4/UAS and Ga4/+ mosquitoes were 
anesthetised with gaseous CO2 and dissected in PBS supplemented with EDTA-free 
protease inhibitor cocktail (Roche). Dissected body parts were immediately 
transferred in 100 µl of TRI Reagent (Sigma) on ice and homogenised using an 
electrical pestle. Whole larvae, pupae and adults were directly homogenised in 100 
µl of TRI Reagent. Finally, after grinding, 400 µl of TRI Reagent were added to each 
sample to reach a final volume of 500 µl and samples briefly spun.  
Three biological replicates consisting of 5 mosquitoes (or body parts) each were 
collected from each mosquito population. 
 
2.4.4.2 RNA extraction, DNase treatment and cDNA synthesis 
RNA extraction was performed using the TRI Reagent® protocol (Sigma) following 
manufacturer’s instructions. To remove genomic DNA contamination, samples were 
treated with DNase using a Turbo DNA-Free kit (Ambion) following manufacturer’s 
instructions. RNA was then reverse-transcribed using the SuperScript III First-Strand 
Synthesis System (Life Technologies) following the oligo(dT) reaction protocol 
described by the manufacturer. cDNA was diluted to reach a final concentration of 50 
ng/µl. 
 
2.4.4.3 RT-qPCR 
RT-qPCR reactions were set in a final volume of 20 µl using 1x Brilliant III Ultra-Fast 
SYBR® Green qPCR Master Mix (Agilent Technologies), 0.5 mM primers and 1 µl (50 
ng/µl) of cDNA template. Amplification was conducted in Mx3005P qPCR System 
(Agilent Technologies) using the following conditions: 1 cycle at 95°C for 3 minutes, 
40 cycles at 95°C for 10 seconds, and 60°C for 10 seconds followed by a dissociation 
curve protocol (95°C for 1 minute, 55°C for 30 seconds and 95°C for 30 seconds). 
cDNA was tested for the expression of the targeted Cyp6 genes using primers qM2fw 
and qM2rv for quantification of Cyp6m2, and qP3fw and qP3sub for Cyp6p3 (Edi et 
al., 2014) (Appendix B, Table B.1). The qP3sub primer bears a nucleotide substitution 
(A11G) to conform its sequence to that of the G3 template. Two housekeeping genes, 
the ribosomal protein S7 (RPS7) (AGAP010592) and Ubiquitin (AGAP007927), were 
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also quantified using primers qS7fw, qS7rv, qUBfw and qUBrv (Jones et al., 2013) 
(Appendix B, Table B.1). 
Efficiency of each primer pair was determined by creating standard curves from 5 
serial dilutions of the plasmids carrying the cDNA template. Primer efficiency was 
calculated using the MxPro Mx3005P Software for SYBR Green (Agilent). Efficiency 
values of 95-103 % with R2 ≥ 0.985 were accepted. 
 
2.4.4.4 Expression data analysis by ΔΔCt method  
Transcriptional data obtained by RT-qPCR were analysed using the ΔΔCt method 
(Livak & Schmittgen, 2001; Schmittgen & Livak, 2008). Threshold cycle (Ct) values 
were corrected for primer efficiency applying the formula Corrected Ct = Ct (Logx / 
Log2), where x = 2 if efficiency is >100% and x = 1+Efficiency if efficiency is <100%. 
Ct values obtained for target genes were normalised against those of the 
housekeeping genes RPS7 and Ubiquitin using the formula ΔCt = Ct target – Ct 
housekeeping. Mean ΔCt values of GAL4/+ mosquitoes were then compared to those of 
GAL4/UAS mosquitoes using the formula ΔΔCt = ΔCt GAL4/+ – ΔCt GAL4/UAS. Finally, fold 
change (x) expression between the two populations was calculated with the formula 
2ᶺ GAL4/UAS ΔΔCt / 2ᶺ GAL4/+ ΔΔCt. Native expression of Cyp6m2 and Cyp6p3 was evaluated 
in the control GAL4/+ mosquitoes compared to the expression levels of the 
housekeeping genes RPS7 and Ubiquitin (-ΔCt) and plotted with the difference in 
expression levels between transgenic GAL4/UAS mosquitoes and GAL4/+ controls 
(ΔΔCt). Statistical differences between expression (ΔΔCt values) in GAL4/UAS vs 
GAL4/+ were determined using Welch’s t-test (two-tails, unequal variance). Names of 
files containing all raw data and analysis are reported in Appendix B. 
 
2.4.5 Assessment of CYP6 protein expression in GAL4/UAS vs GAL4/+ 
 
2.4.5.1 Sample preparation  
To detect CYP6 protein expression in GAL4/UAS and GAL4/+ individuals, total protein 
extracts were obtained from whole 2-5-day-old female adults, L4 larvae, pupae, and 
their dissected body parts.  
For the GAL4mid crosses, protein extracts were obtained from a single whole adult, 
a single carcass (whole body minus the midgut) and two midguts.  
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For the GAL4oeno crosses, total protein content was obtained from a single larva 
(without the midgut), a female pupa, a female adult, a single pupa without the head-
thorax, a single adult dissected abdomen cuticle (without internal organs) and a single 
adult carcass (whole adult without abdomen cuticle). In all samples except pupae the 
midgut was removed to minimise the action of proteinases.  
For adult dissections, mosquitoes were anesthetised with gaseous CO2 and dissected 
in ice-cold PBS supplemented with EDTA-free protease inhibitor cocktail (Roche). 
Dissected body parts were immediately transferred in a solution of PBS and 2x 
Laemmli Sample Buffer (Bio-Rad) supplemented with 2.5% 2-Mercaptoethanol. 
Samples were then homogenised using an electrical pestle, incubated at 95°C for 10 
minutes and briefly spun before being stored at -20°C. 
 
2.4.5.2 SDS-PAGE 
10 ml of 10% resolving gel solution was prepared using 4.1 ml of double-distilled 
water, 3.3 ml Acrylamide/Bis-acrylamide (Sigma), 2.5 ml resolving buffer (1.5 M Tris-
HCl, pH 8.8), 100 µl 10% SDS, 75 µl ammonium persulphate (APS), 7 µl TEMED 
(Sigma) in a 0.75 mm cast. After 1 h of polymerisation, 2.4 ml of 3% stacking gel was 
prepared using 2.05 ml of double-distilled water, 450 µl Acryl-Bis, 850 µl of stacking 
buffer (0.5 M Tris-HCl, pH 6.8), 35 µl 10% SDS, 25 µl APS and 5 µl TEMED, poured 
on the resolving gel and left to polymerase for 30-60 minutes with a 0.75 mm comb 
inserted.  
20 µl of single mosquito preparations, equivalent to 1/3 of a mosquito or its body part, 
were analysed by SDS-PAGE. The only exception was the midgut samples, for which 
20 µl contained 2 whole midguts. The higher amount of midgut sample was required 
to visualise signal of the α-tubulin loading control.   
Electrophoresis was carried out at 80 V through the stacking gel and at 150 V through 
the resolving gel in 1x running buffer (2.5 mM Tris, 19.2 mM Glycine, 0.01% SDS, pH 
8.3). 
 
2.4.5.3 Western blot  
Gels were blotted into nitrocellulose membrane (Amersham Hybond-ECL, GE 
Healthcare) using a transfer buffer (10% 25 mM Tris, 192 mM Glycine, 0.1% SDS, 
20% methanol) at 300 mA for 1 h. All washing steps were performed 3 times for 10 
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minutes using TBST (50 mM Tris, 150 mM NaCl, 0.1% Tween 20, pH 7.6) as washing 
buffer. Membranes were blocked using 5% skimmed-milk in TBST usually overnight 
at 4°C, occasionally for 1 h at room temperature.  
For probing CYP6, membranes were firstly incubated with affinity-purified polyclonal 
peptide antibodies produced in rabbit against CYP6M2 or CYP6P3 (gifts from M. 
Paine) diluted 1:200 in TBST 5% milk for 1 h and, following washing, with horseradish 
peroxidase (HRP)-tagged goat anti-rabbit IgG antibodies (Bethyl Laboratories) diluted 
1:10,000 in TBST 3% milk for 1 h.  
After detection of the CYP6 signal, membranes were re-probed with anti-
housekeeping antibodies to account for quantity of protein loaded. For this purpose, 
membrane was incubated in Restore™ PLUS Western Blot Stripping Buffer (Life 
Technologies) for 15 minutes, washed and blocked as described above, and probed 
with anti-αtubulin antibodies (Sigma or Fisher Scientific) diluted 1:2,000 in TBST 3% 
milk for 1 h followed by washing and incubation with HRP-conjugated goat anti-mouse 
IgG antibodies (Abcam) diluted 1:20,000 in TBST 3% milk for 1 h.  
Signal detection was carried out using SuperSignal™ West Dura Extended Duration 
Substrate (Life Technologies) and Amersham Hyperfilm ECL (GE Healthcare).  
 
2.4.6 Assessment of mosquito susceptibility to insecticides by WHO 
bioassay  
Mosquito susceptibility to insecticides was assessed using the WHO tube bioassay 
(WHO, 2016b). Pools of ~20 GAL4/UAS and GAL4/+ adult female mosquitoes 2-5 
day-old were exposed to filter papers impregnated with standard discriminating doses 
of insecticide – 0.75% permethrin, 0.05% deltamethrin, 0.1% bendiocarb, 4% DDT – 
for 1 h in insectary conditions. After exposure, mosquitoes were returned to the 
holding tube and a 24 h recovery period was allowed with 10% sugar solution provided 
ad libitum in insectary conditions (Figure 2.4). At the end of the 24 h, mortality rates 
were calculated as: (Total number of dead mosquitoes / Total sample size) × 100. 
When ≥5%-<20% mortality was recorded in unexposed control tubes, the Abbott’s 
formula was used to correct the data: (% observed mortality – % control mortality) / 
(100 – % control mortality) x 100. 
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Mortality rates were interpreted as follows: 
- ≥98%: susceptibility 
- <98% – ≥90%: potential resistance 
- <90%: resistance 
Following WHO guidelines, that mitigate against variability in quality control of 
insecticide papers, only assays showing 95-100% mortality in the sensitive control 
population (GAL4/+) were included in the results.  
A modified version of the WHO bioassay was also performed reducing the exposure 
time to 20 minutes (Lycett et al., 2006). 
Each experiment included mosquitoes from independent batches deriving from 
independent crosses or from subsequent gonotrophic cycles of the same cross, 
therefore they were considered as biological replicates. 1-4 experiments were 
performed for each insecticide tested. Generally, two technical replicate tubes were 
tested for each population in each experiment. Number of bioassay experiments 
conducted are reported in Table 2.1. 
Welch's t-test (two-tails, unequal variance) was performed to determine statistical 
significant differences between mortality rates in GAL4/UAS and GAL4/+ mosquitoes 
with P values (p) interpreted as follows: 
- p > 0.05: not significant 
- p ≤ 0.05: significant (*) 
- p ≤ 0.01: significant (**) 
- p ≤ 0.001: significant (***) 
- p ≤ 0.0001: significant (****) 
File names with raw data and analysis are listed in Appendix B. 
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Figure 2.4 Set up and protocol of the WHO tube bioassay for assessing resistance to standard 
discriminating insecticide doses (taken from WHO,2016b).  
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Table 2.1 Bioassay experiments performed.  
Cross Insecticide 
1 h exposure  20 min exposure 
Experiment 
(Biol. reps) 
Tot. tech. 
reps 
Experiment 
(Biol. reps) 
Tot. tech. 
reps 
GAL4mid 
x 
UASm2 
Permethrin 0.75% 2 3 3 6 
Deltamethrin 0.05% 1 2 1 2 
DDT 4% 2 3 1 2 
Bendiocarb 0.1% 1 2 1 2 
GAL4mid 
x 
UASp3 
Permethrin 0.75% 1 2 3 6 
Deltamethrin 0.05% 1 2 1 2 
DDT 4% 1 2 1 2 
Bendiocarb 0.1% 1 2 1 2 
GAL4oeno 
x 
UASm2 
Permethrin 0.75% 1 2 4 8 
Deltamethrin 0.05% 1 2 2 4 
DDT 4% 1 (4) 2 (8) 1 2 
Bendiocarb 0.1% 1 2 1 2 
GAL4oeno 
x 
UASp3 
Permethrin 0.75% 2 3 3 6 
Deltamethrin 0.05% 1 2 1 2 
DDT 4% 1 (2) 2 (4) 2 3 
Bendiocarb 0.1% 1 2 1 2 
Numbers reported represent the experiments and replicates that were included in the analysis as 
mortality in the controls reached at least 95%, while those in brackets show the total number of 
experiments and replicates performed.  
 
2.5 RESULTS 
 
2.5.1 Mosquito lines for UAS-regulated expression of Cyp6 genes 
 
2.5.1.1 UASm2 mosquito line 
The Cyp6m2 coding sequence (1500 bp) showed 100% nucleotide identity with the 
plasmid template upon sequencing (Appendix B, Figure B.1) and was successfully 
cloned into pSL*attB:Gyp:UAS:14i:eYFP to give the pUASm2 plasmid (8999 bp) 
(Figure 2.1).  
Of the 347 A11 embryos injected with pUASm2, 81 larvae (23%) hatched. From these 
49 (60%) adults (F0) emerged, 24 females and 25 males, which were separated by 
sex in two cages. A summary of the screening and crossing strategy used to establish 
the UASm2 transgenic line is reported in Table 2.2. After offering a first blood meal to 
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F0 adults, no transformant larvae were recovered from the male cage, while progeny 
from the female cage included 13 transgenic larvae: 3 YFP-positive and 10 expressing 
both YFP and CFP likely resulting from cassette integration, which were discarded. 
Of the 3 YFP-positive larvae a single adult male survived that did not give progeny. 
After offering a second blood meal to the F0 female cage, 16 isofemale lines (A-P) 
were set up of which 11 laid eggs. Two single-laying females gave F1 transgenic 
progeny: isofemale J yielded 4 (10%) transgenic YFP-positive larvae, and isofemale 
G gave 2 (2.9%) YFP/CFP expressing larvae (discarded). From isofemale J, 2 males 
reached adulthood (J1 and J2), which displayed orientation of insertion A (specific 
fragment sizes reported in Table 2.3, Figure 2.5). To create the definitive line, these 
were crossed with wild type G3 females and a total of 80 (54%) F2 YFP transformant 
larvae was obtained. 
At least two transformation events (one cassette exchange and one integration) 
occurred independently, with a minimum overall transformation efficiency of 4% (2 
events/49 F0) and efficiency of cassette-exchange of 2% (1 event/49 F0). 
 
Table 2.2 Screening and crossing strategy to establish the UASm2 transgenic line.  
F0 pool 
F0  
No. and sex 
F1 + progeny 
1st blood meal 
F1 + progeny 
2nd blood meal 
F2 
1 24 F 
3 YFP+ 
10 YFP/CFP+ 
Isofemale J: 2M YFP+ 
Isofemale G: 2 larvae YFP/CFP+ 
From J males: 
54% (80/148) 
2 25 M 0 0 N/A 
F: female, M: male. N/A: not applicable 
 
Table 2.3 Expected fragment sizes derived from the integrated UASm2 cassette following 4 specific 
PCRs performed on parental males J1 and J2 to check for two alternative orientations of insertion. 
PCR Primers* Orientation J1 – J2 G3 A11 
PCR 1 
piggyBacRR2 
RedSeq4R 
A 
838 bp -- 902 bp 
PCR 2 
M2intFW 
ITRL1R 
2662 bp -- -- 
PCR 3 
piggyBacRR2 
M2intFW 
B 
2349 bp -- -- 
PCR 4 
RedSeq4R 
ITRL1R 
1606 bp -- -- 
* All primer sequences are reported in Appendix B, Table B.1. Primer combinations include one primer 
that binds to one of the piggyBac arms present on the original docking cassette inserted in A11, and one 
annealing within the sequence of the newly inserted cassette.  
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Figure 2.5 Orientation of insertion in UASm2 transgenic males 
obtained from isofemale J (J1 and J2). G3: wild type (control); A11: 
docking line (control); –: negative control (PCR mix without DNA). 
Ladder is GeneRuler 1 kb (Thermo Scientific). Each PCR gives a 
distinct amplification fragment that is diagnostic for the orientation of 
the insertion (Table 2.3). 
 
2.5.1.2 UASp3 mosquito line  
The Cyp6p3 sequence (1530 bp) showed 100% nucleotide identity to the respective 
annotated PEST sequence and plasmid templates upon sequencing (Appendix B, 
Figure B.2). The sequence was successfully cloned into pSL*attB:Gyp:UAS:14i:eYFP 
to give the pUASp3 plasmid (9007 bp) (Figure 2.2). 
460 embryos of the A11 docking line were injected with UASp3. Of these 204 (44%) 
larvae hatched and 124 (60.8%) individuals reached adulthood, 68 females and 56 
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males. F0 adults were separated by sex in 4 cages, 3 female cages (1-3) and 1 male 
cage (4), and outcrossed with G3s. A summary of the screening and crossing strategy 
used to establish the UASm2 transgenic line is reported in Table 2.4. F1 transgenic 
individuals were detected in the progeny of cages 1, 2 and 4, which overall produced 
74 YFP-positive and 7 YFP/CFP-positive transformant individuals (discarded). Of the 
74 YFP-positive larvae, 44 reached adulthood, 25 males and 19 females. F1 
transgenic males were discarded, while females were crossed with G3s and 19 
isofemale lines (A-S) set up. From these, 9 gave at least 1 F2 transgenic progeny of 
which 4 (B, D, H, M) showed orientation A and 5 (A, C, I, O, P) orientation B. Specific 
fragment sizes expected for both orientations are reported in Table 2.5 and Figure 
2.6. Progeny from isofemale M was kept for establishing the definitive colony by 
interbreeding transgenics with negative adults of the same batch.  
Data suggest that at least 9 separate transgenic events (3 cassette exchanges, in 
both orientation A and B, and 3 cassette integrations) occurred independently, with a 
minimum overall transformation efficiency of 7% (9 events/124 F0) and cassette-
exchange efficiency of 4.8% (6 events/124 F0). 
 
Table 2.4 Screening and crossing strategy to establish the UASp3 transgenic line. 
F0 pool F0 No. and sex 
F1 + progeny F2 + progeny 
YFP+ YFP/CFP+ Isofemale Orientation 
1 28 F 
11 
(7F, 4M) 
1 
A B 
B A 
C B 
D A 
E B 
2 27 F 
10 
(2F, 8M) 
2 
H A 
I B 
3 13 F 0 N/A 
4 56 M 
23 
(10F, 13M) 
4 
M A 
O B 
P B 
F: female, M: male. N/A: not applicable 
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Table 2.5 Expected fragment sizes derived from the integrated UASp3 cassette following 4 specific 
PCRs performed on parental females M, O and P to check for two alternative orientations of insertion. 
PCR Primers Orientation p3 (M-O-P) G3 A11 
PCR 1 
piggyBacRR2 
RedSeq4R 
A 
838 bp -- 902 bp 
PCR 2 
P3intFW 
ITRL1R 
2662 bp -- -- 
PCR 3 
piggyBacRR2 
+P3intFW 
B 
1789 bp -- -- 
PCR 4 
RedSeq4R 
ITRL1R 
1551 bp -- -- 
* All primer sequences are reported in Appendix B, Table B.1. Primer combinations include one primer 
that binds to one of the piggyBac arms present on the original docking cassette inserted in A11, and one 
annealing within the sequence of the newly inserted cassette. 
 
 
Figure 2.6 Orientation of insertion in UASp3 transgenic single-laying females 
M, O, and P. G3: wild type (control); A11: docking line (control); –: negative 
control (PCR mix without DNA). Ladder is GeneRuler 1 kb (Thermo Scientific). 
Each PCR gives a distinct amplification fragment that is diagnostic for the 
orientation of the insertion (Table 2.5).  
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2.5.2 Cyp6 transcription in midgut- and oenocyte-specific crosses  
 
2.5.2.1 Cyp6 transcription levels in GAL4mid crosses  
RT-qPCR analysis in the progeny of GAL4mid crosses revealed that Cyp6m2 was 
889x overexpressed in whole GAL4mid/UASm2 compared to native expression in 
GAL4mid/+ adult females (ΔΔCt = 9.8, p = 9.36E-07) (Figure 2.7A), with highly 
enriched (2731x) localisation of over-transcription in the dissected midgut (ΔΔCt = 
11.4, p = 2.03E-06) (Figure 2.7A). A lower 77x overexpression was detected in the 
carcass of transgenic mosquitoes of the same cross compared to controls (ΔΔCt = 
6.1, p = 0.0023) (Figure 2.7A).  
In the progeny of GAL4mid crosses, Cyp6p3 was found 135x overexpressed in whole 
GAL4mid/UASp3 adult females compared to GAL4mid/+ controls (ΔΔCt = 7.08, p = 
0.0002) (Figure 2.7B), with a 659x over-transcription specifically localised in the 
dissected midgut (ΔΔCt = 9.6, p = 0.001) (Figure 2.7B). A 7x overexpression was also 
detected in the carcass of transgenic mosquitoes of the same cross compared to 
control carcasses (ΔΔCt = 2.6, p = 0.035) (Figure 2.7B). 
 
Figure 2.7 Transcription of Cyp6 genes in GAL4mid crosses. Native expression in GAL4/+ mosquitoes 
(red circles) is expressed as -ΔCt (CtHousekeepings – CtCyp6). Expression in GAL4/UAS mosquitoes 
compared to GAL4/+ controls (blue circles) is reported as ΔΔCt (ΔCtGAL4/+ – ΔCtGAL4/UAS). Transcription 
of Cyp6m2 (A) and Cyp6p3 (B) in adult females and their dissected body parts. Carcass is whole body 
without the midgut. Numbers above show the fold change (x) expression in GAL4/UAS compared to 
GAL4/+ mosquitoes. Vertical lines represent 95% confidence intervals and middle lines the mean from 
three replicates. Statistical significance was calculated using Welch’s test. * p < 0.05, ** p ≤ 0.01, *** p ≤ 
0.001, **** p ≤ 0.0001. File names with raw data and analysis are listed in Appendix B. 
 
 Chapter 2 – Cyp6 overexpression in Midgut or Oenocytes 
62 
 
2.5.2.2 Cyp6 transcription levels in GAL4oeno crosses   
RT-qPCR analysis on different life stages of individuals from the GAL4oeno cross 
revealed that Cyp6m2 was 12x upregulated in GAL4/UAS adults compared to 
GAL4oeno/+ controls (ΔΔCt = 3.8, p = 0.007) (Figure 2.8A). Upregulation was higher 
(66x) in transgenic dissected abdomens compared to blank abdomens (ΔΔCt = 6.1, 
p = 0.0006) (Figure 2.8B). A 26x upregulation was also found in the carcass of 
GAL4/UAS adults (ΔΔCt = 4.7, p = 0.0012) (Figure 2.8B).  
In individuals of the GAL4oeno/UASp3 cross, Cyp6p3 was 18x upregulated in whole 
adults (ΔΔCt = 4.2, p = 0.0004) (Figure 2.8C) and 153x in dissected abdomens (ΔΔCt 
= 7.5, p = 0.007) (Figure 2.8D). A 2x upregulation was also detected in the carcass of 
GAL4/UAS compared to control carcass (ΔΔCt = 0.99, p = 0.0002) (Figure 2.8D). 
Pupae showed the highest levels of upregulation of both Cyp6m2 (102x, ΔΔCt = 6.6, 
p = 0.0002) (Figure 2.8A) and Cyp6p3 (836x, ΔΔCt = 9.7, p = 0.0001) (Figure 2.8C). 
While no significant upregulation was detected at larval stage for either Cyp6m2 
(Figure 2.8A) or Cyp6p3 (Figure 2.8C). 
Cyp6m2 and Cyp6p3 displayed a similar pattern of native expression (Figure 2.8A,C). 
They shared a higher native transcription at the larval stage, a trough of expression 
levels at pupal stage, and an increase in adults, although not reaching larval values.  
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Figure 2.8 Transcription of Cyp6 genes in GAL4oeno crosses. Native expression in GAL4/+ mosquitoes 
(red circles) is expressed as -ΔCt (CtHousekeepings – CtCyp6). Expression in GAL4/UAS mosquitoes 
compared to GAL4/+ controls (blue circles) is reported as ΔΔCt (ΔCtGAL4/+ – ΔCtGAL4/UAS). A) Transcription 
of Cyp6m2 in adults, pupae and larvae. B) Transcription of Cyp6m2 in dissected body parts of adult 
females. C) Transcription of Cyp6p3 in larvae, pupae and adults. D) Transcription of Cyp6p3 in dissected 
body parts of adult females. Carcass is whole body without the abdomen cuticle. Numbers above show 
the fold change (x) expression in GAL4/UAS compared to GAL4/+ mosquitoes. Vertical lines represent 
95% confidence intervals and middle lines the mean from three replicates. Statistical significance was 
calculated using Welch’s test. * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. File names with raw 
data and analysis are listed in Appendix B. 
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2.5.3 CYP6 protein expression in GAL4mid and GAL4oeno crosses  
In western blot analysis of GAL4mid crosses (Figure 2.9), CYP6M2 was detected at 
~58 KDa in whole GAL4/UAS adult female extracts and in dissected midgut, but was 
not detectable in the carcass. Native CYP6M2 expression was also not at a detectable 
level in whole or dissected body part extracts of GAL4mid/+ samples. 
Signal from the α-tubulin loading control was detected at ~55 KDa in all samples 
(Figure 2.9). While, CYP6M2 signal was robust when loading 1/3 of a midgut, to detect 
α-tubulin in midgut extracts the amount loaded was increased to 2 whole midguts. 
Due to protein size similarity, detection of the α-tubulin signal in GAL4/UAS midguts 
appeared to be partially masked by that of CYP6M2 due to blot stripping limiting 
detection of proteins of similar size on subsequent exposures. 
 
 
Figure 2.9 Western blots on 2-5-day-old adult females from the GAL4mid x UASm2 
cross to determine expression of CYP6M2 (top) and α-tubulin (bottom). Wh: whole 
adult; Car: carcass (whole body without midgut); Mid: midgut. +: GAL4mid/UASm2; 
–: GAL4mid/+ controls. Whole and carcass lanes contain the protein extract from 1/3 
of a single whole mosquito, while midgut lanes contain protein extract from 2 midguts. 
CYP6M2 signal was obtained after 30-second (whole) and 3-second (carcass and 
midgut) exposure; α-tubulin was detected after 1-minute (whole) and 30-second 
(carcass and midgut) exposure. 
 
In GAL4oeno crosses, CYP6M2 signal was detected in whole GAL4oeno/UASm2 
adult female extracts and in dissected abdomens, but not in the remaining carcass 
extracts (Figure 2.10). A similar pattern of expression was observed at the pupal 
stage, with CYP6M2 only detectable in whole GAL4oeno/UASm2 female pupae and 
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their dissected abdomens, but not in the carcass (Figure 2.10). Again, no native signal 
was detected in GAL4mid/+ whole body or dissected extracts.  
CYP6M2 was also detected GAL4oeno/UASm2 larvae at ~58 KDa along with a 
second band of smaller size (<55 KDa) and variable intensity among samples, while 
in GAL4/+ larvae controls just the variable <55 KDa band appeared (Figure 2.10).  
Furthermore, a minor band at ~100 KDa is also detected in pupa and adults, and as 
a major band in occasional late 4th instar larvae (Figure 2.10). 
Signal from α-tubulin was detected at ~55 KDa for all the examined samples (Figure 
2.10) suggesting an equal loading of crude protein extract in GAL4/UAS and GAL4/+ 
samples. 
Although attempts were made to detect CYP6P3 with previously untested antiserum, 
these were unsuccessful in both GAL4mid or GAL4oeno crosses. Antibody titration 
failed to detect specific signals in any tissues in transgenic lines or controls (not 
shown).  
  
 
6
6
 
 
 
 
 
Figure 2.10 Western blot on 2-5-day-old adults, pupae and L4 larvae from the GAL4oeno x UASm2 cross to determine expression of CYP6M2 (top) and α-tubulin 
(bottom). Wh: whole adult female; Car: carcass (whole body without abdomen cuticle); Abd: abdomen cuticle. P: female pupa; L: L4 larva. +: GAL4oeno/UASm2; –
: GAL4oeno/+ controls. Each lane contains the protein extract from 1/3 of a single mosquito or 1/3 of its body part. CYP6M2 signal was obtained after 3-minute 
(adults), 30-second (pupae), and 2-minute (larvae) exposure; α-tubulin was detected after a 30-second exposure in all films.  
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2.5.4 WHO tube bioassays 
 
2.5.4.1 Resistance phenotypes in mosquitoes overexpressing Cyp6m2 or 
Cyp6p3 in the midgut  
Analysis of WHO-defined sensitivity to permethrin 0.75%, deltamethrin 0.05%, DDT 
4%, or bendiocarb 0.1% in adult females showed that GAL4/UAS and GAL4/+ 
populations were ~100% susceptible to all insecticides tested after 1 h exposure, with 
no significant difference between mortality rates in mosquitoes overexpressing 
Cyp6m2 or Cyp6p3 in the midgut and controls (Figure 2.11A). 
In order to identify subtle differences in susceptibility between GAL4/UAS and GAL4/+ 
mosquitoes, the assays were repeated reducing the exposure time. Again no 
significant differences were found in the mortality rates of mosquitoes overexpressing 
Cyp6m2 or Cyp6p3 in the midgut and their respective controls when exposed for 20 
minutes to the same diagnostic doses of the four insecticides (Figure 2.11B). 
 
2.5.4.2 Resistance phenotypes in mosquitoes overexpressing Cyp6m2 or 
Cyp6p3 in the oenocytes 
WHO-tube bioassay analysis showed that female mosquitoes overexpressing 
Cyp6m2 or Cyp6p3 in the oenocytes were susceptible to 0.75% permethrin, 0.05% 
deltamethrin, 4% DDT, and 0.1% bendiocarb according to WHO definitions and no 
difference was detected in the mortality rates of GAL4/UAS mosquitoes compared to 
GAL4/+ controls (Figure 2.12A). 
When the same assay was performed with a 20-minute exposure to the same 
diagnostic doses of the four insecticides, again no significant differences were found 
between GAL4/UAS mosquitoes overexpressing Cyp6m2 or Cyp6p3 in the oenocytes 
and their respective controls (Figure 2.12B). 
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Figure 2.11 Sensitivity to insecticides of 2-5-day-old adult females overexpressing Cyp6m2 or Cyp6p3 
in the midgut compared to GAL4/+ controls. Perm: 0.75% permethrin; Delta: 0.05% deltamethrin; DDT: 
4% DDT; Bendio: 0.1% bendiocarb. A) Standard WHO tube bioassay representing mortality rates after 
1 h of exposure and 24 h recovery. Dotted line represents 98% mortality which is the threshold for 
resistance indicated by the WHO. B) Modified WHO tube bioassay representing mortality rates after 20 
minutes of exposure and 24 h recovery. m2+: GAL4mid/UASm2; m2-: GAL4mid/+ controls from m2 
cross; p3+: GAL4mid/UASp3; p3-: GAL4mid/+ controls from p3 cross. When <4 replicates are examined, 
no box is drawn, whiskers represent minimum and maximum values, and line in the middle represents 
the median (mean).  When >4 replicates are examined, a box is drawn the bottom and the top of which 
represent the first and third quartile respectively. Line inside the box is the second quartile (median). 
Whiskers represent minimum and maximum values. ns: not significant. Number of technical replicates 
(x) for each population is indicated. File names with raw data and analysis are listed in Appendix B. 
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Figure 2.12 Sensitivity to insecticides of 2-5-day-old adult females overexpressing Cyp6m2 or Cyp6p3 
in the oenocytes compared to GAL4/+ controls. Perm: 0.75% permethrin; Delta: 0.05% deltamethrin; 
DDT: 4% DDT; Bendio: 0.1% bendiocarb. A) Standard WHO tube bioassay representing mortality rates 
after 1 h of exposure and 24 h recovery. Dotted line represents 98% mortality which is the threshold for 
resistance indicated by the WHO. B) Modified WHO tube bioassay representing mortality rates after 20 
minutes of exposure and 24 h recovery. m2+: GAL4mid/UASm2; m2-: GAL4mid/+ controls from m2 
cross; p3+: GAL4mid/UASp3; p3-: GAL4mid/+ controls from p3 cross. When <4 replicates are examined, 
no box is drawn, whiskers represent minimum and maximum values, and line in the middle represents 
the median (mean).  When >4 replicates are examined, a box is drawn the bottom and the top of which 
represent the first and third quartile respectively. Line inside the box is the second quartile (median). 
Whiskers represent minimum and maximum values. ns: not significant. Number of technical replicates 
(x) for each population is indicated. File names with raw data and analysis are listed in Appendix B.  
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2.6 DISCUSSION  
 
2.6.1 Efficiency of PhiC31-RMCE  
PhiC31-RMCE was successfully used to create transgenic An. gambiae responder 
lines for the UAS-mediated overexpression of candidate resistance genes Cyp6m2 
(UASm2) and Cyp6p3 (UASp3). In doing so, good hatching rates were achieved (23-
44%) which are either comparable or higher than that reported elsewhere using 
PhiC31 (~9-58%) (Meredith et al., 2013; Pondeville et al., 2014; Haghighat-Khah et 
al., 2015; Hammond et al., 2016). Furthermore, PhiC31-RMCE demonstrated to be a 
reliable method for site-specific transformation. Minimum transformation efficiencies 
of 2-5% were obtained, which are consistent with other recent reports of PhiC31-
RMCE in Ae. aegypti (~4.5%) (Haghighat-Khah et al., 2015) and An. gambiae (2-7%) 
(Hammond et al., 2016). 
 
2.6.2 Cyp6 gene and CYP6 protein overexpression  
Overexpression of Cyp6m2 and Cyp6p3 was achieved by crossing An. gambiae 
responder lines UASm2 and UASp3 with previously established GAL4mid and 
GAL4oeno drivers. In doing so, Cyp6m2 and Cyp6p3 transcript upregulation was 
achieved in the midgut and abdomen respectively, and we were also able to detect 
CYP6M2, but not CYP6P3, protein overexpression in the targeted body parts.  
Although the data from western and qRT-PCR analysis are mostly in agreement for 
overexpression of the Cyp6 genes in the target tissues, there is some conflict in the 
extent of off-target expression. Western analysis of CYP6M2 expression indicates 
very strong signals in extracts from the expected tissues or body sections, and an 
absence of signal from the remaining carcasses. The antibody could not detect native 
expression of the protein in control samples with the quantity of extracts used in these 
assays. In fact, to readily detect native CYP6M2, microsomal extracts need to be 
purified from several hundred mosquitoes (M. Paine pers. comm.). The protein data 
thus support the tissue distribution pattern from fluorescence analysis of live and 
dissected mosquitoes using the GAL4oeno and GAL4mid driver lines (Lynd & Lycett, 
2012, Lynd et al., unpublished), validating their ability to drive CYP6M2 expression in 
the targeted locations. Without a suitable antiserum for CYP6P3 it was not possible 
to verify CYP6P3 overexpression. 
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At the RNA level, the expected tissue-specific upregulation of both genes was also 
clear. However, Cyp6 transcript upregulation in GAL4/UAS mosquitoes was also 
observed in the carcass left after removal of the targeted tissue or body section in all 
crosses. As mentioned above, tissue-specificity of the midgut driver (GALmid) had 
been previously investigated by Lynd & Lycett (2012) in adults after crossing with a 
dual responder line expressing UAS:nuclearYFP and luciferase. This revealed that in 
GAL4/UAS individuals YFP fluorescence was specific to the midgut, in which 
luciferase expression was ~50,000x higher than in GAL4 controls. Nevertheless, the 
luciferase assay showed low levels (2x) of relative activity above background in the 
carcass. This may be due to contamination from overexpressing body parts as a 
consequence of imperfect imperfections or off-target leakiness in the expression of 
the GAL4. Expression induced by the GAL4oeno driver was found to be specific to 
the abdomen of 4th instar larvae via fluorescent assessment and luciferase assay. The 
latter analysis also showed luciferase expression in adult head and thorax (Lynd et 
al., unpublished), which might explain the significant transcript differences found 
between the carcasses. Taken altogether, it would appear that the transcript 
upregulation found in the carcasses of all crosses is mostly due to the higher 
sensitivity of the RT-qPCR technique which is dependent on the exponential 
amplification of signal against a background of relatively low levels of native 
expression and thus the presence of even small amounts of contamination from other 
sources, including target tissues or leaky expression, is amplified. Such contamination 
could not be picked up in the Western analysis. Potential leakiness from the UAS 
construct was not assessed. This was due primarily to time constraints and workload. 
Indeed, the tissue-specific driver lines used were homozygous, so no UAS/+ 
individuals could be obtained after crossing with UAS lines. Therefore, the rearing of 
additional mosquitoes would have been required, which was not manageable. 
Additionally, assessing mosquitoes deriving from the same cross and separated at 
pupal stage assures identical condition of rearing, which is essential to accurately 
assess gene expression. Finally, the focus of the study was on levels of 
overexpression compared to individuals equivalent to wild types in terms of P450 
expression (i.e. GAL4/+ carrying a single copy of the P450 gene examined). 
Whilst optimising western blot analysis of CYP6M2 abundance several issues were 
overcome. In initial experiments, when protein extracts from a 1/3 of a mosquito were 
analysed, CYP6M2 appeared more abundant in the whole adult compared to the 
midgut sample, which was unexpected for the midgut-specific driver and was not in 
agreement with the qRT-PCR data. In addition, the α-tubulin signal was not detectable 
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in midgut extracts from any of the mosquitoes analysed. This was likely due to protein 
degradation caused by the high content of midgut proteases, and indeed was largely 
circumvented by performing faster dissections on ice. In the final confirmation 
experiments to improve the α-tubulin signal, 2 midgut equivalents were loaded for 
comparison, which still showed a degree of degradation of CYP6M2 as indicated by 
a number of smaller bands detected on the western. 
In GAL4oeno crosses, the expected relative difference in CYP6M2 abundance 
between adult body sections was detected and was in line with qPCR data. 
Additionally, since the GAL4oeno driver is active throughout the mosquito life cycle, 
CYP6M2 protein overexpression was detected at all life stages, while significant 
transcript upregulation was detected in adults and pupae, but not larvae. Here, 
although a 2-fold upregulation of Cyp6m2 and Cyp6p3 was found in GAL4/UAS 
individuals, it was not significantly higher than in controls. Transcripts levels are not 
always directly comparable to protein abundance due to reasons including post-
transcriptional modifications, variability in in vivo protein half-lives, mRNA stability, 
and assay sensitivity (Greenbaum et al., 2003), but the western analysis does cast 
doubt on the accuracy of the larval RT-qPCR data.  
It should be emphasised that the differences observed in the level of upregulation of 
the two transgenes expressed using the same driver should not be misinterpreted. 
Such differences are not strictly comparable because the magnitude of expression is 
relative to native expression of the individual Cyp6 rather than absolute transcription. 
The idea that native levels of Cyp6 transcription are generally low was confirmed by 
RT-qPCR data. Analysis of the relative native transcription of Cyp6m2 and Cyp6p3 
throughout the mosquito life cycle in GAL4oeno crosses could be achieved by 
comparison with expression of housekeeping genes (ΔCt). This revealed that both 
genes share a high native expression at larval stage which drops at pupal stage and 
raises again at adult stage. In the light of a detoxification role, we could speculate that 
high amounts of xenobiotic-metabolising enzymes are needed in the early aquatic 
stages when larvae actively feed and are therefore potentially more exposed to 
external challenges. In the pupal stage, which does not ingest food, this may be less 
needed, while expression in adults may again increase to face their active feeding 
behaviour and different environmental exposures. However, this remains a 
speculation as detoxification is not the only potential role of these P450s and also this 
analysis does not take into consideration tissue-specific expression enrichment in 
different life stage (Scott, 2008). 
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In relation to the larval expression of CYP6M2 it is also interesting to note that in the 
western analysis of the GAL4oeno x UASm2 cross, as well as the ~58 KDa band seen 
in all stages and expected body sections of the overexpressing progeny, an additional 
band of <55 KDa was also detected in most larvae. The origin of this signal is 
unknown, but most likely it is the result of a larval-specific (or microbial contaminant) 
protein that binds the polyclonal peptide antibodies used for detecting CYP6M2. It is 
also possible, but unlikely, that the band detected at <55 KDa is the native CYP6M2 
and the band detected at ~58 KDa and in all the other western analysis corresponds 
to the transgenically expressed CYP6M2 that has undergone modification. P450s can 
undergo modifications such as phosphorylation, glycosylation, nitration and 
ubiquitination at transcriptional, translational and post-translational levels as a means 
to modulate enzymatic activity and to tag the protein for transport to specific cellular 
compartments or for degradation (Aguiar et al., 2005). Such modifications may result 
in protein size increase. Nevertheless, the variability in the abundance of this 
additional band in different larval samples strongly suggests its non-specific nature. 
This is further supported by the presence of an additional unspecific band of variable 
intensity at ~100 KDa.  
 
2.6.2.1 GAL4/UAS-driven vs natural overexpression levels  
Levels of Cyp6 overexpression found in resistant An. gambiae populations are 
generally lower than those generated in this study through the GAL4/UAS system and 
quantified by RT-qPCR. Here the midgut driver induced 889x and 135x 
overexpression of Cyp6m2 and Cyp6p3 respectively in the whole mosquitoes and 
2731x and 659x in the midgut; while the oenocyte-specific driver induced 12x and 18x 
overexpression of Cyp6m2 and Cyp6p3 respectively in whole mosquitoes and 66x 
and 153x in dissected abdomens.  
In An. gambiae across Africa, Cyp6m2 is found 1-10x upregulated in resistant 
mosquitoes (Djouaka et al., 2008; Mitchell et al., 2012; Fossog Tene et al., 2013; 
Djègbè et al., 2014; Edi et al., 2014), with a notable exception of 44x upregulation 
found in deltamethrin-resistant mosquitoes from Benin (Yahouédo et al., 2016); while 
Cyp6p3 is reported to be 1-12x overexpressed (Djouaka et al., 2008; Kwiatkowska et 
al., 2013; Djègbè et al., 2014; Edi et al., 2014; Yahouédo et al., 2016). 
However, our data on overexpression levels found in the midgut and in the abdomen 
cannot be easily related to field data as very little is known about levels of Cyp6 
upregulation in specific tissues and their contribution to resistance in the whole 
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mosquito. This is because data on gene upregulation in resistant populations has 
been generated from whole mosquitoes with a consequent overall dilution of the 
specific overexpression in single tissues. This means that relatively lower levels of 
upregulation found in natural population when comparing whole mosquitoes may hide 
much higher levels of upregulation when comparing single tissue transcriptomes 
(Ingham et al., 2014). This topic is discussed in greater details in Chapter 5. 
 
2.6.3 Effects on resistance of tissue-specific overexpression of single 
P450s 
Despite the high levels of overexpression of Cyp6m2 or Cyp6p3 restricted to the 
midgut or the oenocytes, this did not affect resistance according to WHO definitions 
(i.e. at least 98% mortality 24 h after 1 h exposure) (WHO, 2016b). Of note is that, 
despite working with susceptible populations, we often recorded mortality rates below 
the WHO threshold when exposing mosquitoes to 0.75% permethrin and 4% DDT. 
Several factors related to the mosquitoes or the papers used may have contributed to 
this reduced mortality which will be discussed in more details in Chapter 4. 
The use of WHO standard discriminating doses, set to assess resistance in field 
populations, limits the detection of subtler phenotypic differences. Therefore, to detect 
possible fine differences in mortality between GAL4/UAS and GAL4/+ mosquitoes, 
the exposure time was reduced to 20 minutes. This did not result in significant 
differences in mortality rates between the two transgenic populations and produced 
greater variability among biological and technical replicates. Further work may define 
any differences by examining LC50 curves following exposure to a gradation of doses 
either through CDC bottle assays (Brogdon & McAllister, 1998) or custom 
impregnated papers.  
Although UAS/+ mosquitoes were not included in the analysis, the lack of resistance 
in GAL4/UAS individuals would suggest that, even if leaky expression may occur, this 
would not be sufficient to visibly affect WHO resistance.  
While the transgene sequences used are known to encode functional proteins able to 
actively metabolise insecticides in vitro (Müller et al., 2008a, Stevenson et al., 2011; 
Edi et al., 2014; Yunta et al., unpublished), it may be that there are limiting amounts 
of CPR co-factor present in the targeted tissues that are unable to functionally sustain 
CYP6 activity relative to its overexpression. However, co-upregulation of CPR not has 
been reported in resistant An. gambiae (Ingham, 2016) or in An. funestus (J. Riveron 
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pers. comm.). Immune-fluorescence experiments also showed that CPR is natively 
highly expressed in both oenocytes and midgut (Lycett et al., 2006), furthermore, in 
vivo evidence from D. melanogaster supports the production of a resistant phenotype 
in the absence of CPR overexpression (Edi et al., 2014; Riveron et al., 2013, 2014a/b, 
2017). Taken together, these findings suggest that the amount of CPR would not be 
limiting in these tissues. 
Overall, our data suggest that tissue-specific location of overexpression is a limiting 
factor for the occurrence of resistance as phenotype is not affected when 
overexpression of Cyp6m2 or Cyp6p3 is confined to the midgut or the oenocytes. 
Nevertheless, overexpression of these genes in other single tissues may confer 
resistance. In Drosophila, most detoxifying genes show tissue-specific distribution 
which may imply the importance of local vs global defence mechanisms against 
xenobiotics. For example, Yang et al. (2007) demonstrated that D. melanogaster 
susceptibility to DDT was decreased by the overexpression of Cyp6g1 specifically 
localised in the Malpighian tubules, but not in the brain or fat body. More recently, 
brain-specific overexpression of T. castaneum Cyp6bq9 was demonstrated to be 
sufficient to confer resistance to deltamethrin in transgenic beetles (Zhu et al., 2010). 
Alternatively, a multi-tissue pattern of overexpression may be essential to affect the 
phenotype. Indeed, Riveron et al. (2013) reported that the overexpression of An. 
funestus Cyp6p9a/b in transgenic D. melanogaster affects resistance to pyrethroids 
when it is driven by the ubiquitous driver Actin5-GAL4 but not by 6g1HR-GAL4 
targeting midgut, Malpighian tubules and fat body (Chung et al., 2007).  
 
2.6.4 Conclusions  
The GAL4/UAS system developed in this laboratory for An. gambiae was successfully 
employed to independently drive overexpression of Cyp6m2 and Cyp6p3 in the 
midgut of adult mosquitoes and in the abdominal oenocytes of all mosquito life stages. 
While upregulation of Cyp6m2 and Cyp6p3 was validated at the RNA level and 
CYP6M2 overexpression at protein level, relative mosquito susceptibility to 
insecticides was not affected in transgenic compared to control mosquitoes after 1-
hour or 20-minute exposure to single WHO discriminating doses of permethrin, 
deltamethrin, DDT, and bendiocarb. This suggests that overexpression of Cyp6m2 
and Cyp6p3 confined in the midgut or in the oenocytes is not sufficient to alter the 
resistance phenotype according to WHO definitions, and other specific tissues or a 
combination of them may be physiologically important in driving resistance. To 
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explore these scenarios, the next chapter describes work aimed at the identification 
of a Malpighian tubule-specific promoter and a ubiquitous promoter and the creation 
of corresponding driver lines for assessing mosquito phenotypes following expression 
in different tissues. 
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3. Chapter 3 
Driver lines for ubiquitous and Malpighian tubule-specific 
expression 
 
3.1 ABSTRACT 
Location of overexpression of P450 genes appears critical to generate resistance, as 
transgenic mosquitoes overexpressing Cyp6m2 or Cyp6p3 in the midgut and in the 
oenocytes fail to alter resistance phenotypes. Thus, other locations of overexpression, 
namely the Malpighian tubules and multi-tissue expression were investigated. As 
promoters that regulate expression in these locations were yet to be identified in An. 
gambiae, this work aimed initially to isolate regulatory regions of candidate genes 
displaying the tissue-specific expression of interest, and then to create corresponding 
driver lines for transgenic analysis. To do so, the An. gambiae expression database 
MozAtlas was queried and regulatory regions from ubiquitous expressed candidates 
cloned and analysed by mosquito cell transfection, before creating transgenic driver 
lines using the piggyBac transposon. For Malpighian tubule-candidates, driver lines 
were directly established using PhiC31-RMCE. Patterns of expression driven by these 
new GAL4 lines were assessed by fluorescence analysis after crossing with a UAS-
mCherry line. We found multiple promoters that were active in the An. gambiae cell 
line. Moreover, the polyubiquitin-c gene promoter had the highest activity in cells and 
drives widespread expression in all life stages of transgenic mosquitoes. The two 
driver lines created, A8 and A10, express at different levels in a similar multiple tissue 
pattern. Furthermore, these lines may act as PhiC31-RMCE docking lines as they 
carry attP recombination sites at single, unique chromosomal integration loci. A 
second ubiquitous candidate, the phosphoglucose isomerase promoter, did not drive 
detectable reporter gene expression in transgenic mosquitoes despite being active in 
cells. Finally, we did not identify regulatory regions capable of driving observable 
GAL4-driven expression in the Malpighian tubules. Overall, this work greatly 
advances the tools available for An. gambiae functional analysis allowing for the 
investigation of phenotypes resulting from widespread multi-tissue expression. 
 
  
 Chapter 3 – Driver lines for ubiquitous and Malpighian expression  
78 
 
3.2 INTRODUCTION  
In light of results described in the previous chapter, here we aim to create GAL4 driver 
lines directing expression in the Malpighian tubules and ubiquitously. This would allow 
us to test whether overexpression of Cyp6m2 or Cyp6p3 in the Malpighian tubules is 
sufficient to drive resistance, or whether simultaneous expression in more than one 
tissue is necessary for the resistant phenotype to manifest.  
An endogenous promoter able to express ubiquitously in An. gambiae has not been 
identified, which greatly limits our understanding of phenotypes resulting from genes 
expressed in a multi-tissue manner. In an effort to obtain multi-tissue expression, 
promoters of ubiquitin genes have been investigated in different insects. These 
encode proteins involved in a wide range of biological processes mediated by protein 
conjugation and are evolutionary remarkably conserved thus representing promising 
candidates. Amongst these, the D. melanogaster polyubiquitin (PUB) promoter was 
reported to drive widespread expression in transgenic D. melanogaster (Handler & 
Harrell, 1999), Anastrepha suspensa (Handler & Harrell, 2001), L. cuprina (Heinrich 
et al., 2002), and An. albimanus (Perera et al., 2002). A similar phenotype was also 
described for the regulatory region of the PUB gene of T. castaneum in transgenic 
beetles (Lorenzen et al., 2002). Finally, the promoter of the Aedes aegypti PUB gene 
was shown to drive widespread expression across all developmental stages of 
transgenic Ae. aegypti (Anderson et al., 2010).  
When expression targeting certain specific tissues is required, tools are more 
numerous (these are described in section 1.5.1). Nevertheless, we lack promoters 
acting in most tissues, including ovaries and Malpighian tubules, which makes it 
difficult to investigate phenotypes emerging from modulation of expression in these 
tissues.  
The role of Malpighian tubules in xenobiotic detoxification has been shown in D. 
melanogaster through transcriptomic (Wang et al., 2004; Yang et al., 2007) and in 
vivo functional analysis in transgenic flies (Yang et al., 2007). In An. gambiae, a similar 
role is suggested by the enrichment of several P450 families in this tissue in 
susceptible (Baker et al., 2011; Ingham et al., 2014; Stevenson et al., 2011) and 
resistant mosquitoes (Ingham et al., 2014). Thus, Malpighian tubules are thought to 
be a main site for insecticide clearance and the characterisation of a promoter specific 
for this tissue would allow us to functionally define its contribution to resistance in An. 
gambiae.  
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Identification of tissue-specific transcription factor binding sites is challenging due to 
their short length (6-12 bp) and their typical location within intergenic genomic regions 
(Dissanayake et al., 2006; Sieglaff et al., 2009). One method to identify sequences 
that will produce specific expression patterns is to investigate the 5’ regions of genes 
that display the required pattern of expression. This promoter identification is 
facilitated by the availability of online databases integrating collections of An. gambiae 
gene expression data, which allows analysis of gene transcript enrichment in specific 
tissues, life stages or conditions of interest (Sieglaff et al., 2009; Koutsos et al., 2007). 
Resources such as VectorBase (Giraldo-Calderón et al., 2015) 
(www.vectorbase.org/) and angaGEDUCI (Dissanayake et al., 2006) 
(www.angaged.bio.uci.edu) incorporate gene expression data, mostly generated by 
microarray analysis (Marinotti et al., 2006; Baker et al., 2011) with more recent 
RNAseq data, as well as gene expression maps (MacCallum et al., 2011). Amongst 
others, the MozAtlas database (Baker et al., 2011) 
(http://mozatlas.gen.cam.ac.uk/mozatlas/) hosts a collection of the transcriptional 
profiles of An. gambiae genes across somatic (head, salivary glands, midgut, 
Malpighian tubules, ovaries, carcass) and reproductive tissues (ovaries and testis) of 
adult male and female mosquitoes. For building the database, microarray analysis 
was conducted in a population of mosquitoes originated from a single strain reared in 
standardised conditions. As such, it provides a promising tool to retrieve comparative 
gene expression data from several female adult tissues. Candidate promoter 
sequences can then be used to drive expression of reporter genes in transgenic lines 
to observe the subsequent patter of expression (Lycett et al., 2012). 
Achieving the desired expression pattern of transgenes, however, does not solely 
depend on identifying the promoter region that will produce the intrinsic spatio-
temporal pattern required, but is affected by the precise genomic environment into 
which it is inserted. Positional effect is a consequence of the essentially random 
integration mediated by transposons and results in the laborious process of creation 
of multiple lines and their assessment for gene expression and fitness (Handler & 
O’Brochta, 2012; O’Brochta et al., 2014). To overcome the repeated creation of 
transgenic lines using transposons, docking lines can be established that bear a 
reusable transcriptionally active docking site. In general, defining a universally 
permissive expression site is challenging as the properties of any DNA sequence are 
likely to be affected by its relocation in the genome. Nevertheless, the isolation of 
active sites that permit multi-tissue expression is desirable as they would represent 
an established context for future comparative experiments. From docking lines 
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bearing insertions in permissive areas of the genome it is then possible to create a 
great variety of other lines by integrating the target DNA alongside the existing 
construct or by replacing the existing cassette with a donor cargo via RMCE (Bateman 
et al., 2006). PhiC31-RMCE has been applied to An. gambiae (Lynd et al., 
unpublished; Hammond et al., 2016) but a very limited number of docking strains has 
been created so far.  
 
3.3 AIMS AND OBJECTIVES  
This work aimed to identify candidate promoters for ubiquitous and Malpighian tubule-
specific expression and to investigate their ability to drive expression in vivo using the 
GAL4/UAS system in cell line and transgenic mosquitoes. In doing so, we also aimed 
to create GAL4 driver lines bearing docking sites for PhiC31 site-specific integration 
or RMCE in single, unique transcriptionally active regions of the genome. 
Specific objectives of the study were: 
• To retrieve data on gene expression in adult female tissues from the MozAtlas 
database, isolate 5’ regulatory regions of candidate ubiquitous and Malpighian 
tubule-specific genes and clone them into GAL4 driver plasmids.  
• To assess relative promoter strength of candidate ubiquitous promoters in An. 
gambiae SUA5.1 cell line after co-transfection with a UAS plasmid driving 
luciferase expression.  
• To create docking driver lines carrying single copies of the ubiquitous candidate 
promoters PUBc (AGAP001971) and PGI (AGAP012167), and the Malpighian 
tubule candidate promoter VATG (AGAP001823).  
• To characterise the fluorescent pattern of expression driven by GAL4 lines 
bearing a single copy of the transgenic cassette after crossing with a UAS-
mCherry line. 
• To identify and isolate transcriptionally active genomic locations sustaining 
ubiquitous expression to be exploited for site-specific integration or cassette 
exchange using the PhiC31 attP sites present in the integrated construct. 
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3.4 MATERIALS AND METHODS  
 
Contributions  
Dr. Gareth Lycett performed the embryo microinjections of the PUBc_GAL4 plasmid. 
Amalia Anthousi dissected and prepared mosquito tissues for fluorescence analysis. 
 
General methods including DNA extraction, PCR, agarose gel electrophoresis, DNA 
purification and clean-up, restriction endonuclease digestion, ligation, E. coli 
transformation, minipreps, midipreps, ethanol precipitation, and sequencing are 
described in Appendix A.  
 
3.4.1 Selection of promoter candidates 
To find candidate promoters, the MozAtlas database (Baker et al., 2011) was used to 
search for genes showing either widespread expression across An. gambiae adult 
female tissues or expression confined to the Malpighian tubules. To do so, raw gene 
expression data (log2 fluorescence values derived from microarray analysis) from the 
carcass, head, Malpighian tubules, midgut, ovaries and salivary glands were 
extracted to Excel for analysis.  
For ubiquitous candidates, data for all tissues were classified into three expression 
level categories: “low” (100 – 1000 log2 fluorescence), “medium” (1000 – 4000 log2 
fluorescence), and “high” (2000 – > 10 000 log2 fluorescence). This was to test 
different promoter strengths and to account for potential toxicity that different levels of 
GAL4 expression may have in vivo. Gene IDs showing the highest and most 
consistent expression within each category were searched in VectorBase (Giraldo-
Calderón et al., 2015) to assess the quality of gene maps from associated 
transcriptome (RNAseq) data. The top two or three candidates from each category 
were taken forward for cloning based on quality of transcript distribution along the 
genome (i.e. transcripts that map to annotated exonic regions of the genome). The 
promoter of the polyubiquitin-c gene (AGAP001971) was added to the list of 
candidates as its orthologue was reported to drive ubiquitous expression Ae. aegypti 
(AAEL003877) (Anderson et al., 2010). 
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For Malpighian tubule-specific candidates, gene IDs were sorted in descending order 
according to raw fluorescence values in the Malpighian tubules. Transcript enrichment 
in the tubules was calculated as fold change (x) from the average expression in other 
tissues (carcass, head, midgut, ovaries and salivary glands). Three expression 
categories were defined: “low” (2 – 50 x), “medium” (51 – 400 x), and “high” (401 – 
1500 x). Two top candidates from each category were taken forward for cloning.  
 
3.4.2 Plasmid preparation  
 
3.4.2.1 pPUBc_GAL4 
The plasmid was designed to carry: piggyBac inverted repeats for random insertion, 
attP sites for site-specific integration through RMCE, a CFP marker under the control 
of the 3xP3 eye-specific promoter, Gypsy insulators, and the GAL4 sequence under 
the control of the 5’ and 3’ regulatory regions of the An. gambiae polyubiquitin-c 
(PUBc) gene (AGAP001971). As annotated in the PEST genome, the cloned 5’ 
sequence consisted of 2005 bp upstream of the ATG translation start site in the 
second exon and included the first exon, the intron, and the intergenic space that 
separates PUBc from the preceding gene (PUBb, AGAP001970) (Figure 3.1). The 
selected 3’ sequence included 407 bp downstream of the second exon covering the 
intergenic space between the gene stop codon and the succeeding gene (TSR4 
protein, AGAP001972) (Figure 3.1). The GAL4 coding sequence was used to replace 
that of the coding exon.  
 
 
Figure 3.1 Schematic of the An. gambiae polyubiquitin-c gene and its regulatory sequences 
(not to scale). Orange fragments represent the cloned 5’ (PUB5) and the 3’ regulatory region 
(PUB3). PUB5 includes 2005 bp upstream of the predicted start codon of exon 2 (E2) until the 
preceding gene. PUB3 comprises 407 bp downstream of the predicted stop codon of E2 up to 
the following gene. In the transgenic construct, the GAL4 coding sequence seamlessly replaces 
that of E2.  
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The cloning strategy consisted of using a CFP-marked piggyBac plasmid carrying an 
attP-left site (attPl) as backbone to create the final plasmid PUBc_GAL4 by adding 
the six following components in order: Gypsy1 (Gyp1), PUBc 5’ region (PUB5), GAL4, 
PUBc 3’ region (PUB3), Gypsy2 (Gyp2), and attP-right site (attPr). To do so, the 
cloning strategy combined Gibson Assembly (Gibson et al., 2009, 2010) and 
restriction enzyme-based cloning and included the following steps: 
 
1) Using Gibson assembly to create two intermediate plasmids each containing three 
fragments: pSL*Gyp1:PUB5:GAL4 and pSL*PUB3:Gyp2:attPr (Figure 3.2A).   
Single fragments were amplified using primers carrying overlapping regions using 
Phusion High-Fidelity DNA Polymerase (Thermo Scientific) as detailed in Table 
3.1, and the backbone plasmid pSLfa1180fa digested with BamHI/NsiI. Gibson 
assembly reactions were set up in a total volume of 20 µL using 100 ng of digested 
backbone plasmid pSLfa1180fa, 0.02-0.1 pmol/µL of each fragment and 10µL of 
2x Gibson Assembly® Master Mix (New England Biolabs) and incubated at 50°C 
for 1 h. Diagnostic restriction digestions were carried out using BglII/NheI and 
HindIII/NcoI before sequencing. pSL*Gyp1:PUB5:GAL4 sequence was verified 
using primers attB3-seqR, seq5’UTR-RV, seqINTRON-FW, pUB5-GAL4-FW, 
1971-int-fw, GAL4-seq-2F, GAL4-pSL-RV, and PSL1180-1; while 
pSL*PUB3:Gyp2:attPr was sequenced using attB3-seqR and PSL1180-1 
(Appendix C, Table C.1). 
 
Table 3.1 Amplification of single components for creating two intermediate plasmids, 
pSL*Gyp1:PUB5:GAL4 and pSL*PUB3:Gyp2:attPr (Figure 3.2A), by Gibson cloning. 
Fragment Template Primers* 
RES 
Tag 
Size 
(bp) 
Tm  
(̊C) 
Ext. 
time 
No. 
cycles 
Gyp1 
attB:UAS:
Cyp6m2 
pSL-Gypsy1-FW 
Gypsy1-pUB5-RV 
-- 
NheI 
126 65 5 sec 35  
PUB5 
Kisumu 
gDNA 
Gypsy1-pUB5-FW 
pUB5-GAL4-RV 
NheI 
-- 
2005 62 30 sec 35  
GAL4 
attB:GAL4:
DsRed 
pUB5-GAL4-FW 
GAL4-pSL-RV 
-- 
BglII 
2646 70 30 sec 35  
PUB3 
Kisumu 
gDNA 
pSL-pUB3-FW 
pUB3-Gypsy2-RV 
BglII 
NdeI 
407 65 5 sec 35  
Gyp2 
attB:UAS:
Cyp6m2 
pUB3-Gypsy2-FW 
Gypsy2-attP-RV 
NdeI 
SacI 
126 70 5 sec 35  
attPr 
pBACl:attP
:CFP 
Gypsy2-attP-FW 
attP-pSL-RV 
SacI 
-- 
204 72 5 sec 35  
*All primer sequences are reported in Appendix C, Table C.1.  
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2) Restriction enzyme-based cloning was used to perform the final cloning steps. 
The PUB3:Gyp2:attPr fragment was cut out from pSL*PUB3:Gyp2:attPr and 
inserted into the BglII/NotI sites of pSL*Gyp1:PUB5:GAL4 to generate 
pSL*Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr (Figure 3.2B). 
Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr was then excised from the shuttle plasmid 
and cloned into the AscI sites of pBACl:attPl:CFP:pBACr to obtain the final 
plasmid pBACl:attPl:CFP:Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr:pBACr (Figure 
3.2C). Plasmid map was verified by SphI/NheI and BglII/EcoRI double enzymatic 
restriction. 
 
 
                     
Figure 3.2 Schematic of cloning steps used to create the PUBc_GAL4 plasmid (13 839 bp) (not to 
scale). A) Two intermediate plasmids, pSL*Gyp1:PUB5:GAL4 and pSL*PUB3:Gyp2:attPr, were 
created by Gibson assembly. B) pSL*Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr was obtained by cloning 
PUB3:Gyp2:attPr into the BglII/NotI sites of  pSL*Gyp1:PUB5:GAL4. C) Final plasmid PUBc_GAL4 
was obtained using AscI to clone the Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr fragment into a 
pBACl:attPl:CFP:pBACr plasmid. This construct was used for both cell transfection and G3 embryo 
injection. Gyp1 and Gyp2: Gypsy insulators; PUB5: 5’ regulatory region upstream of PUBc; PUB3: 3’ 
regulatory region downstream of PUBc; attPl and attPr: PhiC31 attachment sites left and right 
respectively; pBACl and pBACr: piggyBac arms left and right respectively; CFP: cyan fluorescent 
protein used as 3xP3-driven eye maker. 
 
3.4.2.2 GAL4 plasmids carrying MozAtlas ubiquitous promoter candidates   
The 5’ regions of eight putative ubiquitous genes selected from MozAtlas - 
AGAP006459, AGAP006782, AGAP003864, AGAP004654, AGAP012167, 
AGAP010572, AGAP011050 - were cloned upstream of the GAL4 sequence in a 
plasmid marked with 3xP3-driven DsRed (Figure 3.3). Putative promoters were 
amplified from Kisumu genomic DNA using Phusion High-Fidelity DNA Polymerase 
or Phire Hot Start II DNA Polymerase (Thermo Scientific) and primers tagged with 
SpeI and EcoRV as reported in Table 3.2. After SpeI/EcoRV double digestion and 
purification, PCR products were independently cloned into 
pSL*attB:HSP:GAL4:DsRed:attB replacing the HSP promoter originally contained in 
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the plasmid. Plasmid maps were verified by restriction digestion with NheI/EcoRV or 
HindIII and sequencing of the newly cloned fragments. Primers used for sequencing 
were: M13fw, RT-GAL4-2R and SpeI-6459-EcoRV-fw for AGAP006459; M13fw, RT-
GAL4-2R and SpeI-6782-EcoRV-fw for AGAP006782; M13fw and RT-GAL4-2R for 
AGAP003864; M13fw, RT-GAL4-2R and SpeI-4654-EcoRV-fw for AGAP004654; 
M13fw, RT-GAL4-2R and SpeI-12167-EcoRV-fw for AGAP012167; M13fw, RT-
GAL4-2R and SpeI-10572-EcoRV-fw for AGAP010572; and M13fw, RT-GAL4-2R 
and SpeI-11050-EcoRV-fw for AGAP011050 (Appendix C, Table C.1). 
 
 
Figure 3.3 Schematic map of pSL*attB:Promoter:GAL4:DsRed:attB 
(not to scale). Eight independent reactions using SpeI and EcoRV 
were performed to replace the original promoter with each of the 5’ 
regulatory regions of putative ubiquitous genes. This construct was 
used for both cell transfection and docking line embryo injection. attB: 
PhiC31 attachment sites; SV40: transcription terminator; DsRed: red 
fluorescent protein used as 3xP3-driven eye maker. 
 
Table 3.2 Amplification of 5’ regions upstream of ubiquitous gene candidates.  
Gene ID Primers* 
RES 
Tag 
Region 
amplified 
Tm  
(̊C) 
Ext. 
time 
No. 
cycles 
AGAP006459 
SpeI-6459-EcoRV-fw 
SpeI-6459-EcoRV-rv 
SpeI 
EcoRV 
2000 bp 56 50 sec 35  
AGAP002182 
SpeI-2182-EcoRV-fw 
SpeI-2182-EcoRV-rv 
SpeI 
EcoRV 
1331 bp 58 30 sec 35  
AGAP006782 
SpeI-6782-EcoRV-fw 
SpeI-6782-EcoRV-rv 
SpeI 
EcoRV 
1842 bp 60 50 sec 35  
AGAP003864 
SpeI-3864-EcoRV-fw 
SpeI-3864-EcoRV-rv 
SpeI 
EcoRV 
605 bp 60 20 sec 35  
AGAP004654 
SpeI-4654-EcoRV-fw 
SpeI-4654-EcoRV-rv 
SpeI 
EcoRV 
996 bp 60 35 sec 35  
AGAP012167 
SpeI-12167-EcoRV-fw 
SpeI-12167-EcoRV-rv 
SpeI 
EcoRV 
2000 bp 60 35 sec 35  
AGAP010572 
SpeI-10572-EcoRV-fw 
SpeI-10572-EcoRV-rv 
SpeI 
EcoRV 
1172 bp 53 35 sec 35  
AGAP011050 
SpeI-11050-EcoRV-fw 
SpeI-11050-EcoRV-rv 
SpeI 
EcoRV 
1757 bp 60 35 sec 35  
*All primer sequences are reported in Appendix C, Table C.1. 
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3.4.2.3 pPGI_GAL4 
The driver plasmid PGI_GAL4 was designed to carry the following components: 
piggyBac sites, attP sites, CFP marker under the control of the 3xP3 eye-specific 
promoter, Gypsy insulators, and the 2 kb 5’ regulatory region of the phosphoglucose 
isomerase gene (PGI) (AGAP012167) upstream of the GAL4 sequence (Figure 3.4B).  
The cloning strategy adopted consisted of replacing the PUB5:GAL4:PUB3 
component of the pSL*Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr plasmid (Figure 3.2B) 
with PGI:GAL4:SV40 and then to clone the resulting 
Gyp1:PGI:GAL4:SV40:Gyp2:attPr fragment into the AscI sites of the 
pBACl:attPl:CFP:pBACr plasmid. To do so, the cloning strategy combined Gibson 
Assembly (Gibson et al., 2009, 2010) and restriction enzyme-based cloning including 
the following steps: 
 
1) Gibson assembly was used to clone PGI, GAL4 and SV40 into 
pSL*Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr to give 
pSL*Gyp1:PGI:GAL4:SV40:Gyp2:attPr (Figure 3.4A). The 2 Kb 5’ region upstream 
the PGI gene was amplified from pSL*attB:PGI:GAL4:DsRed:attB (Figure 3.3), and 
GAL4 and SV40 sequences from plasmid templates using Phusion High-Fidelity DNA 
Polymerase (Thermo Scientific) and primers carrying overlapping regions as reported 
in Table 3.3. Plasmid pSL*Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr was digested with 
NheI/NdeI. After gel purification, Gibson Assembly reactions were set up in a total 
volume of 25.4 µL using 90 ng of digested backbone plasmid 
pSL*Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr, 0.099 pmols of each fragment and 12.7 µL 
of 2x Gibson Assembly® Master Mix and were incubated at 50°C for 1 h. Plasmid 
pSL*Gyp1:PGI:GAL4:SV40:Gyp2:attPr sequence was verified by EcoRV/HindIII 
digestion and sequenced using primers AttB3-seqR, p9_pSL_fw, p9_GAL4_rv, 
GAL4_p9_fw, GAL4_sequ_2F, GAL4_SV40_rv, SV40_GAL4_fw, SV40_pSL_rv and 
pSL1180-1 (Appendix C, Table C.1). 
 
Table 3.3 Amplification of PGI_GAL4 components for Gibson cloning.  
Fragment Template Primers* 
RES 
Tag 
Region 
amplified 
Tm  
(̊C) 
Ext. 
time 
No. 
cycles 
PGI 
attB:PGI:GA
L4:DsRed 
p9_pSL fw 
p9_GAL4 rv 
NheI 
EcoRV 
2000 bp 60 50 sec 35 X 
GAL4 
attB:GAL4:D
sRed 
GAL4_p9 fw 
GAL4_SV40 rv 
EcoRV 
-- 
2646 bp 60 50 sec 35 X 
SV40 
attB:GAL4:D
sRed 
SV40_GAL4 fw 
SV40_pSL rv 
-- 
NdeI 
693 bp 60 50 sec 35 X 
*All primer sequences are reported in Appendix C, Table C.1. 
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2) Restriction enzyme-based cloning was used to obtain the final plasmid PGI_GAL4.  
The Gyp1:PUB5:GAL4:PUB3:Gyp2:attPr fragment was excised from 
pSL*Gyp1:PGI:GAL4:SV40:Gyp2:attPr and cloned into the AscI sites of  
pBACl:attPl:CFP:pBACr to obtain the final plasmid 
pBACl:attPl:CFP:Gyp1:PGI:GAL4:SV40:Gyp2:attPr:pBACr (Figure 3.4B). Plasmid 
map was verified by enzymatic restriction using NcoI/NotI and HindIII. 
 
 
Figure 3.4 Schematic of cloning steps used to create the PGI_GAL4 plasmid (14 039 bp) (not to scale). 
A) Creation of pSL*Gyp1:PGI:GAL4:SV40:Gyp2:attPr by Gibson assembly. B) Final plasmid PGI_GAL4 
was obtained using AscI to clone the Gyp1:PGI:GAL4:SV40:Gyp2:attPr fragment into a 
pBACl:attPl:CFP:pBACr plasmid. This construct was used for G3 embryo injection only; experiments on 
cells were conducted using pSL*attB:PGI:GAL4:DsRed:attB. Gyp1 and Gyp2: Gypsy insulators; PGI: 5’ 
regulatory region upstream of the PGI gene; SV40: transcription terminator; attPl and attPr: PhiC31 
attachment sites left and right respectively; pBACl and pBACr: piggyBac arms left and right respectively; 
CFP: cyan fluorescent protein used as 3xP3-driven eye maker. 
 
3.4.2.4 GAL4 plasmids carrying MozAtlas Malpighian-specific promoter 
candidates  
The 5’ regions of six genes selected from MozAtlas showing enriched expression in 
the Malpighian tubules - AGAP002587, AGAP001823, AGAP011426, AGAP002629, 
AGAP010364, AGAP010975 - were cloned upstream of the GAL4 sequence in 
pSL*attB:Promoter:GAL4:DsRed:attB (Figure 3.3). Putative promoters were amplified 
from Kisumu genomic DNA using Phusion High-Fidelity DNA Polymerase or Phire Hot 
Start II DNA Polymerase (Thermo Scientific) and primers tagged with AflII/EcoRV or 
SpeI/EcoRV as reported in Table 3.4. After AflII/EcoRV or SpeI/EcoRV double 
digestion and purification, PCR products were independently cloned into 
pSL*attB:Promoter:GAL4:DsRed:attB replacing the original HSP promoter. 
Restriction digestion with NheI/EcoRV and HindIII and sequencing with M13F and 
RT-GAL4-2R (Appendix C, Table C.1) were performed to confirm plasmid maps.  
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Table 3.4 Amplification of 5’ regions upstream of six Malpighian tubule-specific gene candidates.  
Gene ID Primers* 
RES 
Tag 
Region 
amplified 
Tm  
(̊C) 
Ext. 
time 
No. 
cycles 
AGAP002587 
AflII-2587-EcoRV-fw 
AflII-2587-EcoRV-rv 
AflII 
EcoRV 
2000 bp 60 50 sec 35  
AGAP001823 
NheI-1823-EcoRV-fw 
AflII-1823-EcoRV-rv 
NheI 
EcoRV 
2000 bp 60 50 sec 35  
AGAP011426 
AflII-11426-EcoRV-fw 
AflII-11426-EcoRV-rv 
AflII 
EcoRV 
1140 bp 60 25 sec 35  
AGAP002629 
SpeI-2629-EcoRV-fw 
SpeI-2629-EcoRV-rv 
SpeI 
EcoRV 
2000 bp 60 35 sec 35  
AGAP010364 
SpeI-10364-EcoRV-fw 
SpeI-10364-EcoRV-rv 
SpeI 
EcoRV 
2000 bp 58 35 sec 35  
AGAP010975 
SpeI-10975-EcoRV-fw 
SpeI-10975-EcoRV-rv 
SpeI 
EcoRV 
2000 bp 58 35 sec 35  
*All primer sequences are reported in Appendix C, Table C.1. 
 
3.4.3 An. gambiae mosquito cell transfection and luciferase assay  
 
3.4.3.1 An. gambiae cell line 
The haemocyte-like An. gambiae cell line Sua5.1 (Müller et al., 1995) was maintained 
at 28˚C in Schneider’s medium (Invitrogen) supplemented with 7-10% foetal bovine 
serum (PAA) and 100 U/ml Ampicillin + 100 U/ml Streptomycin (Invitrogen). Cells 
were kept in 25 cm2 15 ml flasks and sub-cultured every 7-10 days. 
 
3.4.3.2 Cell transfection and luciferase assay 
Cells were split 24 h before transfection in 16-well plates and then transfected using 
EffecteneTransfection Reagent (Qiagen) following manufacturer’s instructions. 
Briefly, 202 ng of total DNA, 1.6 μl enhancer, 5 μl Effectene, 60 μl Buffer EC and 350 
μl medium were applied dropwise to each well. DNA samples contained 100 ng of 
GAL4 driver plasmid, 100 ng of a responder plasmid driving the expression of firefly 
luciferase (UAS-Luc) (Lynd & Lycett, 2011), and 2 ng of Actin Renilla plasmid to 
normalise for efficiency of transfection (Table 3.5). The pPUBc-GFP plasmid (Lycett, 
unpublished), which expresses cytoplasmic GFP under the control of a similar PUBc 
promoter sequence than the one used in this study, was used to visually assay 
transfection efficiency and measure background activity (blank) in the absence of a 
GAL4 driver. The activity of each GAL4/UAS combination was tested in 3-6 technical 
replicates. After 48 h incubation, cell extracts were tested for luciferase expression 
using a Dual-Luciferase® Reporter Assay System (Promega). Cells were lysed in 100 
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μl/well of Passive Lysis Buffer, 8 μl of cell extract was added to 100 μl of LAR II and 
Firefly activity measured. Renilla luciferase activity was then measured after adding 
100 μl of Stop&Glo®. All measurements were carried out using a Lumat LB 9507 tube 
luminometer (EG&G Berthold) programmed to perform a 2-second premeasurement 
delay followed by a 10-second measurement. Relative light units (RLU) 
measurements obtained for each well were normalised by Renilla activity (RLULuc / 
RLURen) and adjusted for the activity of the blank (RLUsample – RLUblank).  
One-way ANOVA with multiple comparison analysis was performed to determine 
statistical significant differences (p < 0.05) between each GAL4/UAS combination. 
The Dunnett’s test was used to perform pairwise comparisons between each 
GAL4/UAS combination and the control, while the Tukey’s test was used for pairwise 
comparisons between GAL4/UAS combinations. 
 
Table 3.5 Experimental set up of luciferase reporter assay in SUA5.1 cells to 
test relative promoter-GAL4 activity. 
Promoter-GAL4 
plasmid 
UAS-Luciferase 
plasmid 
Renilla 
plasmid 
No. 
replicates 
pBPnucl pUAS-Luc Actin Renilla 6 
pPGI pUAS-Luc Actin Renilla 6 
pLTV1 pUAS-Luc Actin Renilla 6 
pALDred pUAS-Luc Actin Renilla 6 
pAGAP003864 pUAS-Luc Actin Renilla 3 
pSUI1 pUAS-Luc Actin Renilla 3 
pATPcar pUAS-Luc Actin Renilla 3 
pPUBc pUAS-Luc Actin Renilla 5 
-- pUAS-Luc Actin Renilla 6 
pPUBc-GFP -- Actin Renilla 6 
 
 
3.4.4 Creation and characterisation of An. gambiae transgenic lines  
 
3.4.4.1 Mosquito lines  
Details of mosquito maintenance are reported in Appendix A.  
Three mosquito lines were used in this study including the wild type colony G3, the 
docking line A11 (described in Chapter 2), and the UAS-mCherry line. This is a 
transgenic homozygous responder line for UAS-mediated expression of mCherry 
fluorescent protein targeted to cell membranes. Line carries 3xP3-driven CFP and 
YFP eye-specific markers created by PhiC31-mediated modification of line E 
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(Meredith et al., 2011) with a attB:UAS-mCherry expression cassette (gift of E. 
Pondeville). 
 
3.4.4.2 Embryo microinjections 
Transgenic mosquitoes for ubiquitous expression were produced by piggyBac-
mediated germline transformation as previously described (Lycett et al., 2012; Lynd 
& Lycett, 2012). The line for Malpighian tubule-specific expression was created by 
site-specific germline transformation (Pondeville et al., 2014). 
Plasmid DNA was purified using Plasmid Midi Kit (Qiagen) and ethanol precipitation 
was carried out to obtain a solution containing 350 ng/µL of GAL4 driver plasmid and 
150 ng/µL of the helper plasmid (transposase plasmid phsp-pBac (Handler & Harrell, 
1999) for piggyBac and integrase plasmid PKC40 (Ringrose, 2009) for RMCE) in a 
total volume of 25 µL of 1X injection buffer (5 mM KCl, 0.5 mM NaPO4, pH 7.2) to give 
a final concentration of 500 ng/µL (Lombardo et al., 2009).  
Microinjections were carried out as described in Chapter 2.  
 
3.4.4.3 Establishment of transgenic lines  
 
3.4.4.3.1 Lines created by piggyBac-mediated germline transformation  
 
3.4.4.3.1.1 Screening and husbandry  
F0 L1 larvae were screened for transient (episomal) CFP expression in the anal 
papillae to have an indication of successful DNA uptake, and positive larvae were 
reared separately. Adults emerged in sex-specific cages and backcrossed with 3-5-
fold excess of opposite sex wild type G3. F1 L2-L3 larvae were assessed for stable 
expression of the eye marker and negative larvae discarded. F1 transformant adult 
females were backcrossed with wild type G3 individuals. Isofemale lines were 
obtained from single laying females and scored for inheritance of the CFP marker. In 
most cases, lines yielding a percentage of transformants not compatible with a single 
insertion (i.e. >50% fluorescent progeny) were discarded. Individuals from isofemale 
lines showing ~50% of transgenic progeny were interbred to create stable lines.  
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3.4.4.3.1.2 Inverse-PCR  
Inverse PCR was conducted as described by Lycett et al., 2012. Genomic DNA was 
extracted from pools of 20 F2 transgenic adults from selected isofemale lines that 
showed ~50% of transgenic progeny using Qiagen Genomic tips (Qiagen). 1 μg of 
gDNA was then digested with BfuCI (NEB), self-ligated using T4 ligase (NEB) at a 
final concentration of 5 ng/μl for 14-18 h at 16 ˚C, and PCR was performed to amplify 
DNA regions flanking the piggyBac arms at the site of insertion (primers ITRL1F and 
ITRL1R for left arm, ITRR1F and ITRR1R for right arm, Appendix C, Table C.1). 
Amplification reactions were performed using 2.5 μl of ligation product in a total 
volume of 50 μl using Phire Hot Start II DNA Polymerase (Thermo Scientific) and 
annealing temperatures of 65 ˚C for the piggyBac left arm, 58 ˚C for the right arm. 
PCR products were sequenced and genomic location of insertions identified using the 
BLAST tool integrated in VectorBase (Giraldo-Calderón et al., 2015). In case of 
ambiguity in the location of integration due to short sequence or lack of PCR product 
from one of the piggyBac arms, genomic DNA was digested at 65 ˚C using TaqαI 
(NEB) and the protocol repeated. 
For the A8 and A10 lines, location of insertion was additionally confirmed by 
amplification of the regions flanking each piggyBac arm using ITRL1F and 
A10_insert_rv for A10 left arm, ITRR1F and A10_R_check_rv for A10 right arm, 
ITRL1F and A8_L_check_rv for A8 left arm, and A8_R_check_fw2 and ITRR1F for 
A8 right arm (Appendix C, Table C.1). PCRs were performed using DreamTaq DNA 
polymerase (Thermo Scientific), 55°C annealing temperature, a 30-second extension 
and 35 cycles.  
 
3.4.4.3.2 Lines created by PhiC31 site-specific germline transformation  
 
3.4.4.3.2.1 Screening and husbandry  
F0 L1 larvae were screened for transient (episomal) expression of DsRed in the anal 
papillae to have an indication of DNA uptake and to confirm the presence of the CFP 
marker of the A11 docking strain. Adults emerged in sex-specific cages and were 
backcrossed with 3-5-fold excess of opposite sex wild type G3. F1 L2-L3 larvae were 
assessed for stable expression of the red eye marker and positive adults backcrossed 
with wild type individuals. Six single-laying female lines were set up and, after laying 
eggs, their DNA was extracted to check the orientation of insertion.   
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3.4.4.3.2.2 Orientation of insertion  
Orientation check was performed on the parental females and on the controls G3 and 
A11 by PCR. Four combinations of 4 primers designed to give a product just in one 
of the orientations were used in 4 different PCRs: piggyBacR-R2 + Red-seq4R for 
PCR 1, P6_int_rv + ITRL1R for PCR 2, piggyBacR-R2 + P6_int_rv for PCR3, and 
Red-seq4R + ITRL1R for PCR 4 (Appendix C, Table C.1). PCRs were performed 
using DreamTaq DNA polymerase (Thermo Scientific) and thermal program involving 
54°C annealing temperature, a 3-minute extension and 30 cycles.  
F2 progeny from a single female that showed orientation of insertion A was kept and 
a definitive line created by interbreeding.  
 
3.4.4.3.3 Transformation efficiency calculations  
Minimum transformation efficiency was calculated as (Number of independent 
founder families yielding transgenics / total F0 adult survivors) x 100. When molecular 
characterisation of insertion location was conducted, transformation efficiency was 
calculated as (Number of independent single insertions / total F0 adult survivors) x 
100. 
 
3.4.4.4 GAL4 x UAS crosses for assessing promoter activity  
Crosses were established between GAL4 driver lines marked with CFP (A10, A8 and 
PGI) or DsRed (VATG), and opposite sex individuals of the UAS-mCherry line, which 
is marked with CFP and YFP. Progeny of these crosses was sorted at pupa stage 
according to marker colour: 
- A10, A8, PGI: CFP and YFP for GAL4/UAS and CFP only for GAL4/+ 
mosquitoes (controls);  
- VATG: DsRed, CFP and YFP for GAL4/UAS and DsRed only for GAL4/+ 
controls. 
 
3.4.4.5 Dissections 
2-5-day-old GAL4/UAS and GAL4/+ mosquitoes were anesthetised with gaseous CO2 
and dissected in PBS supplemented with EDTA-free protease inhibitor cocktail 
(Roche). Body parts were incubated in fixing solution (4% paraformaldehyde, 1x PBS 
pH 7.4, 2 mM MgSO4, 1 mM EGTA) for 30-45 minutes at room temperature, washed 
in PBS, mounted on a microscope slide using Vectashield mounting medium (Vector 
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Laboratories), and stored in the dark at 4 ˚C. For preparation of abdomens, after 
removing internal organs, they were cut and flatten open to reveal the fat body 
attached to the cuticle and incubated for 2 minutes in methanol before fixing using the 
same conditions described above.   
 
3.4.4.6 Imaging 
All mosquitoes were observed with Leica MZ FLIII fluorescence stereo microscope 
fitted with CFP, DsRed and YFP filters (Leica Microsystems). 
Fluorescence photos were taken using the LAS X Microscope Software integrated 
within a Leica M165 FC fluorescent stereo microscope (Leica Microsystems). 
 
3.5 RESULTS  
 
3.5.1 Candidate ubiquitous genes and cloning of their 5’ regulatory 
regions 
Nine candidate genes showing widespread expression across all tissues were 
selected from MozAtlas: AGAP004654, AGAP012167, AGAP010572 for low 
expression; AGAP002182, AGAP003864, AGAP011050 for medium expression; and 
AGAP006459, AGAP006782, AGAP001971 for high expression. Details on selected 
genes and their cloning are listed in Table 3.6 and raw gene expression levels 
reported in Appendix C, Figure C.1A.  
Cloning of the 5’ regions located upstream of the predicted start codon into the 
pSL*attB:Promoter:GAL4:DsRed:attB RMCE plasmid (Figure 3.5A) was successful 
for all candidates except AGAP002182 which did not amplify from genomic DNA. 
PUBc was cloned directly into a piggyBAC vector and carried its native 3’ region 
downstream of the GAL4 (Figure 3.5B), while the RMCE-based plasmids carried the 
SV40 terminator (Figure 3.5A). 
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Table 3.6 List of selected ubiquitous candidate genes.  
Gene ID Protein 
Promoter 
name 
Chr. 
Cloned 5’ 
region (bp) 
Plasmid 
size (bp) 
AGAP004654 3'(2'), 5'-bisphosphate nucleotidase BPnucl 2R 990 9763 
AGAP012167 glucose-6-phosphate isomerase PGI 3L 2003 10776 
AGAP010572 protein LTV1 LTV1 3L 1168 9941 
AGAP002182 ATP-binding cassette transporter ATPtra 2R N/A N/A 
AGAP011050 aldehyde reductase ALDred 3L 1752 10525 
AGAP003864 unknown UKW 2R 606 9379 
AGAP006459 protein translation factor SUI1 SUI1 2L 2473 11246 
AGAP006782 ADP,ATP carrier protein 1 ATPcar 2L 1772 10545 
AGAP001971 Polyubiquitin-c PUBc 2R 2005 13839 
N/A: not applicable  
 
 
A)    
B)   
Figure 3.5 Schematic maps of driver plasmids carrying ubiquitous candidate promoters (not to scale). 
A) pSL*attB:Promoter:GAL4:DsRed:attB. Seven 5’ regulatory regions were independently cloned 
upstream of the GAL4. attB: PhiC31 attachment sites; SV40: transcription terminator; DsRed: red 
fluorescent protein used as 3xP3-driven eye maker. B) PUBc_GAL4. Gyp1 and Gyp2: Gypsy insulators; 
PUB5: 5’ regulatory region upstream of PUBc start codon; PUB3: 3’ regulatory region downstream of 
PUBc stop codon; attPl and attPr: PhiC31 left and right attachment sites; pBACl and pBACr: piggyBac 
left and right arms; CFP: cyan fluorescent protein used as 3xP3-driven eye maker. 
 
3.5.2 Candidate Malpighian tubule-specific genes and cloning of their 5’ 
regulatory regions 
Malpighian tubule-specific candidates selected from MozAtlas were AGAP001823 
and AGAP002629 for low expression, AGAP010364 and AGAP010975 for medium 
expressions, AGAP002587 and AGAP011426 for high expression. Details on 
selected genes and their cloning are listed in Table 3.7 and raw gene expression 
levels reported in Appendix C, Figure C.1B. 
All candidate 5’ region cloning into pSL*attB:Promoter:GAL4:DsRed:attB was 
successful except AGAP011426 and AGAP010364. Plasmids carrying AGAP001823, 
AGAP002629, AGAP010975 contained two attB sites (Figure 3.6A), while that 
carrying AGAP002587 had only one attB site (Figure 3.6B). This was due to the 
unavailability of a suitable restriction site to digest out the original promoter without 
altering the attB site located upstream of it, which resulted in its loss. 
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Table 3.7 List of Malpighian tubule-specific candidate genes  
Gene ID Protein encoded 
Promoter 
name 
Chr. 
Cloned 5’ 
region (bp) 
Plasmid 
size (bp) 
AGAP002587 unknown  P5 2R 2000 10438 
AGAP001823 V-type ATPase subunit G VATG (P6) 2R 1937 10710 
AGAP011426 Solute carrier family 17 P7 3L N/A N/A 
AGAP002629 unknown  P14 2R 2001 10774 
AGAP010364 unknown  P15 3L N/A N/A 
AGAP010975 unknown  P16 3L 1998 10771 
N/A: no amplification product  
 
 
 
Figure 3.6 Schematic maps of driver plasmids carrying Malpighian tubule-specific 
candidate promoters (not to scale). A) pSL*attB:Promoter:GAL4:DsRed:attB. Three 
promoters were independently cloned upstream of the GAL4. B) 
pSL*Promoter:GAL4:DsRed:attB. One promoter was cloned upstream of the GAL4. 
attB: PhiC31 attachment sites; SV40: transcription terminator; DsRed: red 
fluorescent protein used as 3xP3-driven eye maker. 
 
 
3.5.3 In vivo assessment of putative ubiquitous promoters in An. 
gambiae cells  
The GAL4-mediated activity of the putative ubiquitous promoters BPnucl, PGI, LTV1, 
AGAP003864, ALDred, SUI1, ATPcar and PUBc was investigated by luciferase assay 
after co-transfection with the responder plasmid pUAS-Luc in An. gambiae SUA5.1 
cells.  
pPUBc and pPGI were active in cells showing significantly higher activity than control 
transfections with the responder plasmid only (~4220x, p = < 0.0001; ~950x, p = 
0.0417 respectively) (Figure 3.7). In addition, background activity from a GAL4-less 
(blank) plasmid was not significantly different to the pUAS-Luc control (P = 0.16) (not 
shown), indicating limited leakiness in UAS regulated expression. The other six 
promoters tested had observable activity in these cells (Figure 3.7), but did not show 
a statistically significant difference from control transfections using one-way ANOVA 
with multiple comparison analysis (Appendix C, Table C.2).  
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Figure 3.7 Relative GAL4-mediated activity of putative promoters in An. gambiae SUA5.1 cells. 
Promoter activity is shown as luciferase expression after co-transfection of driver plasmids 
containing putative promoters with the pUAS-Luc responder. Luciferase expression (Relative Lights 
Units – RLU) is standardised for Renilla expression and shown as average from three (pSUI1, 
pATPcar, pAGAP003864), five (pPUBc), or six (pBPnucl, pPGI, pLTV1, pALDred, pUAS-Luc) 
technical replicates. Top bars represent standard error from mean. Significant differences were 
calculated using One-way ANOVA with multiple comparison analysis. * p < 0.05, **** p ≤ 0.0001. 
 
3.5.4 Generation of mosquito driver lines and assessment of promoter 
activity 
 
3.5.4.1 PUBc_GAL4 driver lines for ubiquitous expression  
 
3.5.4.1.1 Establishment of transgenic lines  
To assess the ability of PUBc-GAL4 to express in vivo in transgenic mosquitoes, we 
used the piggyBac transposon to create a series of driver lines carrying the cassette 
in single, unique genomic locations.  
 Chapter 3 – Driver lines for ubiquitous and Malpighian expression  
97 
 
A total of 180 An. gambiae G3 strain embryos were injected with pPUBc_GAL4 
(Figure 3.5B); of these 113 (63%) larvae hatched and 77 (68%) showed CFP transient 
expression in the anal papillae. The mating and screening strategy used to isolate 
transgenic isofemale lines is summarised in Table 3.8. 97 adults (54% of eggs 
injected) were obtained and pooled into 6 sex-specific F0 founder cages (A-F). 
Transgenic F1 progeny (45) were recovered from each of the 4 F0 cages established 
from founders showing transient expression (A-D), while no transformants were 
recovered from negative F0 founders (cages E,F). F1 transgenic females derived from 
A, C and D founder cages and males from B (no transgenic F1 females recovered) 
were backcrossed with wild-type individuals and F2 progeny from individual females 
assessed for inheritance of the eye-marker to estimate transgene copy number. We 
identified 14 isofemale lines showing 47-53% transgene inheritance (A2, A3, A6, A7, 
A8, A10, A11, A12, A15, B3, B8, C1, C2, D2), consistent with single copy insertions. 
4 lines yielding ≥58% transgenic progeny (A5, B1, B2, B7), which may be caused by 
multiple integrations some of which may be in close linkage, were discarded. 
 
Table 3.8 Selection strategy to isolate stable transgenic driver lines carrying a single insertion of the 
PUBc_GAL4 cassette. 
F0 pool 
F0 adults 
No. and sex 
Transient CFP 
expression 
No. +F1 
(sex) 
% +F2 larvae 
(No. +larvae/total) 
A 13 F + 
34 
(17 F, 17 M) 
A 2 – 49% (84/173) 
A 3 – 48% (74/154) 
A 5 – 62% (5/8) 
A 6 – 42% (80/190) 
A 7 – 50% (52/103) 
A 8 – 49% (67/136) 
A 10 – 47% (65/139) 
A 11 – 52% (63/121) 
A 12 – 53% (102/193) 
A 15 – 51% (93/181) 
B 14 M + 
3 
(3 M) 
B 1 – 73% (8/11) 
B 2 – 58% (18/31) 
B 3 – 44% (31/71) 
B 7 – 59% (69/116) 
B 8 – 53% (62/116) 
C 18 F + 
5 
(2 F, 3 M) 
C 1 – 47% (28/59) 
C 2 – 47% (73/155) 
D 20 M + 
3 
(2 F, 1 M) 
D 2 – 46% (53/115) 
E 23 M – 0 N/A 
F 9 F – 0 N/A 
F: female, M: male. NS: not screened. N/A: not applicable.  
Other isofemales: A1: dead (mosquito died without laying eggs). A4, B9: not mated (eggs did not hatch). 
A9, A13, A14, B4, B5, B6, B10, D1: sterile (mosquito did not lay eggs). 
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Isofemale lines A2, A3, A6, A7, A8, A10, A11, A12, A15, B3, C1, D2 were 
characterised to verify number and location of integration sites by inverse-PCR and 
sequencing. In several instances, identical integration sites were found in distinct 
isofemale lines from the same founder cage (A8=A15, A10=A12, A3=A6=A7=A11) 
(Figure 3.8). Replicate lines were discarded thus overall the final analysis was 
consistent with the isolation of 7 isofemale lines carrying separate single integration 
sites (Table 3.9). Four lines (A8, A10, B3, C1), carried intergenic insertions, one line 
(A3) carried an insertion within the open reading frame of Cyp6m4 (AGAP008214), 
and two (A2, D2) carried insertions within highly repetitive regions that precluded their 
exact localisation in the genome (Table 3.9). Inverse-PCR failed to amplify the region 
flanking the piggyBac right arm of lines A8 and A10 so, using the information derived 
from the left arm, location in these lines was confirmed with primers designed on the 
genomic DNA flanking the insertion (Appendix C, Figure C.2). All sites of integration 
characterised occurred at TTAA genomic sequences that are canonical for piggyBac-
mediated insertion (Table 3.9).  
Overall, we achieved a minimum transformation efficiency of 7% (% of independent 
insertions). All 7 lines were interbred and underwent preliminary assessment of in vivo 
promoter activity in larvae.  
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Figure 3.8 Agarose gel electrophoresis showing results for inverse-PCR on regions flanking the 
piggyBac arms after BfuCI digestion and self-ligation of genomic DNA isolated from isofemale lines. 
Among the isofemales derived from cage A, those sharing the same PCR product size derive from the 
same F0 founder individual and thus bear an insertion in the same genomic location. Six different single 
insertions are shown: 1) A2; 2) A3 = A6 = A7 = A11; 3) A8 = A15; 4) A10 = A12, 5) B3; 6) C1. Results 
for Taq1α digestions of A2, A8, A10, C1 and D2 are shown in Appendix C, Figure C.3. Ladder is 
GeneRuler 1 kb Plus (Thermo Scientific). 
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Table 3.9 Molecular characterisation of transgenic lines carrying single insertions by inverse-PCR. 
Line 
pBAC 
arm 
Enzyme Sequence 
Query 
length  
Alignment 
length 
Identity 
% 
PEST 
Chromosome  
Position 
A2 
Left TaqαI TTAAATGGATAGCGGTAGCT 795 653-6 95-96 
Multiple hits N/A 
Right BfuCI CCGGTGAGTGCGTAGCTTAA 79 79 100 
A3 
Left BfuCI TTAAACTGTTTGCCGGCCGC 75 75 96 
3 R 
6,934,418 
6,934,415 
Intragenic 
AGAP008214 Right BfuCI GTCCTCCAGGTAGTCTTTAA 33 31 100 
A8 
Left 
Right* 
TaqαI 
-- 
TTAATCTCGGTTCTCGGTAT 
ATATTTACGCAGATTCTTAA 
323 
53 
323 
42 
100 
90.5 
2 R 
32,162,290 
32,162,293 
Intergenic 
A10 
Left 
Right* 
TaqαI 
-- 
TTAAAGAACTGATCAATACA 
CAAACGCACAGTACCATTAA 
404 
368 
329** 
353 
99.1 
98.9 
2 R 
5,816,202 
5,816,199 
Intergenic 
B3 
Left BfuCI TTAAAGCTCGTTCATACTCT 221 221 98.2 
3 R 
32,092,431 
32,092,428 
Intergenic 
Right BfuCI GAAGCTGTAAAAAGCTTTAA 192 191 95.8 
C1 
Left TaqαI TTAAAAGAGATCCCGCGAGG 652 648 99.2 
X 
21,936,498 
21,936,501 
Intergenic 
Right BfuCI TAGGTCGATGAACTCCTTAA 102 102 100 
D2 Left TaqαI TTAAAGTGCTTTCAACGTTA 700 700 98.6-99.4 Multiple hits N/A 
 
*the genomic position flanking this arm was obtained by amplification of genomic DNA using primer sequences deducted by the position of the left arm. 
**there is an insertion in the PEST sequence that is not present in A10, Pimperena, or An. coluzzii. 
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3.5.4.1.2 In vivo assessment of PUBc promoter activity in transgenic mosquitoes 
 
To investigate the patterns of expression driven by PUBc and identify multiple 
insertion sites able to sustain ubiquitous expression, profiles generated by selected 
transgenic PUBc_GAL4 isofemales lines (A2, A3, A8, A10, B3, C1 and D2) and male 
pools were assessed and compared after crossing with a responder line carrying 
UAS-regulated mCherry. 
The expression profiles driven by individual isofemale lines differed in terms of signal 
intensity and distribution with the following phenotypes detected in larvae (Appendix 
C, Figure C.4): intensely bright and widespread mCherry signal detected throughout 
the whole body (A10 and D2), symmetrically patterned mCherry signal distributed 
along the abdomen with intense signal in the head and mouthparts (A8), asymmetrical 
mCherry signal along the abdomen, in the head and mouthparts (A3 and C1), 
asymmetrical mCherry signal limited to the terminal part of the abdomen (A2), and 
intense signal in the brain and mouthparts (B3).  
No fluorescent phenotypes from male pool progeny (Appendix C, Figure C.4) were 
observed that differed from those derived from the single isofemales lines, suggesting 
that the male pool members examined originated from the same F0 individuals as their 
female counterparts, or that they carried insertions in similarly permissive sites. 
Therefore, progeny from males was discarded. Due to the large number of lines 
produced, we restricted our in-depth analysis to the isofemale lines A10 and A8 which 
showed the most widespread signal and were representative of two distinct levels of 
expression, higher and lower respectively.  
From the dorsal side of both A10/ch and A8/ch larvae, mCherry fluorescence was 
evident in the mouthparts, brain, fat body, and muscles surrounding the aorta and the 
heart (Figure 3.9 A,C). On the ventral side, strong mCherry expression was detectable 
in the developing thoracic imaginal discs and the central nerve cord (Figure 3.9 E,G). 
Fluorescent signal in A10/ch larvae was more intense compared to A8/ch larvae, with 
the only exception of the mouthparts (Figure 3.9 A,C,E,G). Furthermore, in A8/ch 
larvae a distinct symmetrical expression pattern was detected dorsally and ventrally 
in each abdominal segment (Figure 3.9 C,G), while A10/ch individuals displayed a 
very bright and dispersed signal throughout the larval body (Figure 3.9 A,E).  
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In pupae, the difference in signal intensity and the distinct abdominal pattern of 
expression was maintained, and strong fluorescence was detected in the developing 
appendages in both A10/ch and A18/ch female pupae (Figure 3.10).  
At adult stage, mCherry expression was widespread in females and males of both 
A10 and A8 crosses with A10/ch displaying a brighter signal than A8/ch mosquitoes. 
In both crosses, fluorescence was detected in all the appendages including legs, veins 
of the wings, antennae, palps, and proboscis/labium (Figure 3.11). Here, fluorescence 
appeared strongly at the tip of palps and proboscis as well as at the junction of leg 
segments, which can be explained by the lack of cuticle sclerotization in these areas 
(Figure 3.11). Expression was also robust at the base of the antennae in the pedicel, 
which hosts the Johnston's organ, and in the brain (Figure 3.11). A10/ch mosquitoes 
showed bright mCherry expression in a variable proportion of the ommatidia, while in 
A8/ch individuals this generally occurred in fewer ommatidia (Figure 3.11). Finally, 
fluorescence was widely detected in the thorax and along the abdomen both dorsally 
and ventrally with bright signal visible through the non-sclerotized areas of the cuticle 
(Figure 3.11).  
To identify internal organs and tissues where the PUBc promoter is active, we 
performed dissections on A10/ch and A8/ch adult female mosquitoes. In dissected 
abdomens expression was readily detectable in the cuticle, fat body, lateral muscles 
and nerve cord (Figure 3.12 A,C). Besides displaying a lower signal intensity, A8/ch 
abdomens showed a mosaic pattern of expression in muscular tissues (Figure 3.12 
C). The PUBc promoter was active in the salivary glands of A10/ch, with mCherry 
fluorescence detected in all lobes, while the signal was weak in A8/ch salivary glands 
(Figure 3.12 M,O). Along the digestive tract, a comparable level of fluorescence was 
detected in A10/ch and A8/ch mosquitoes in the trachea surrounding the foregut, 
midgut, hindgut and Malpighian tubules of unfed females; no expression was 
detectable in the midgut epithelium (Figure 3.12 I,K). 24-48 h after blood meal the 
stretched muscles and nerves surrounding the midgut were clearly visible (not 
shown). Ovaries of sugar-fed A10/ch females showed bright oviducts and follicles 
(Figure 3.12 E,G), and fluorescence was also strongly detected 24-48 h after blood 
meal in the developing oocytes (not shown); while fluorescence in these tissues in 
A8/ch mosquitoes was weaker (Figure 3.12 E,G). In the males from A10 or A8 lines 
mCherry signal was barely discernible in the testes (not shown). In the haemolymph 
of mosquitoes from both lines, different classes of haemocytes were found expressing 
mCherry (not shown). The fat body of both lines also appeared diffusely fluorescent 
(not shown).    
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Overall, fluorescence driven by A10 and A8 lines was widespread and maintained 
from new-born larvae to adults of both sexes and was detected in a variety of tissues 
and body parts with levels of fluorescence generally lower in A8/ch compared to 
A10/ch individuals.
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Figure 3.9 Expression profiles driven by the PUBc promoter in A10/ch (left) and A8/ch (right) L3-L4 larvae. A-D are dorsal views, E-H ventral views. A,C,E,G represent 
mCherry signal at 650 nm; numbers show seconds (s) of exposure. B,D,F,H are the corresponding bright fields. Bar = 0.5 mm.  
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Figure 3.10 Expression profiles driven by the PUBc promoter in A10/ch (left) and A8/ch female pupae (centre and right). A and B represent mCherry signal at 650 nm; 
numbers show seconds (s) of exposure. C is the bright field image of B. Bar = 0.5 mm.  
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Figure 3.11 Expression profile driven by the PUBc promoter in A10/ch (left) and A8/ch (right) adult mosquitoes. All 
images are ventral views. A,C,E,G,I,K,M,O represent mCherry signal at 650 nm; numbers show seconds (s) of exposure. 
B,D,F,H,J,L,N,P are the corresponding bright fields. Bar = 0.5 mm.  
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Figure 3.12 Expression profile driven by the PUBc promoter in A10/ch (left) and A8/ch (right) adult dissected and fixed 
tissues. A,C,E,G,I,K,M,O represent mCherry signal at 650 nm; numbers show milliseconds (ms) or seconds (s) of exposure. 
B,D,F,H,J,L,N,P are the corresponding bright fields. Bar = 0.5 mm.  
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3.5.4.2 PGI_GAL4 driver lines for ubiquitous expression 
PGI_GAL4 driver lines were created using piggyBac-mediated germline 
transformation. 193 embryos of the G3 strain were injected with pPGI_GAL4 (Figure 
3.4B) and 24 (14.5%) larvae hatched, of which 10 (42%) showed transient CFP 
expression. Eighteen (9.3%) F0 adults, 8 positives and 10 negatives, survived and 
were pooled into 4 F0 founder sex-specific families (G-J) (Table 3.10). After backcross 
with G3s, 17 F1 transgenic larvae were recovered from family G only, which included 
mosquitoes showing transient expression of CFP at early larval stage (Table 3.10). 
Mosquitoes that did not show CFP transient expression (I, J) did not produce 
transgenic progeny (Table 3.10). F1 transgenic females from cage G were crossed 
with G3s and 7 isofemale lines set up (G 1-7) to determine the percentage of 
transgenics obtained in the F2. All lines yielded 100% inheritance of the eye-marker, 
suggesting a large number of insertions of the transposon or another unusual 
transformation event had occurred in one or multiple founders. Therefore, these lines 
were not molecularly characterised for integration site. 
Overall, we report a minimum transformation efficiency, i.e. % of F0 survivors 
producing fluorescent offspring, of 5.5%.  
 
Table 3.10 Selection strategy to isolate stable transgenic GAL4 lines carrying a single insertion of the 
PGI promoter. 
F0 pool 
F0 adults 
No. and sex 
Transient CFP 
expression 
No. +F1 
(sex) 
% +F2 larvae 
(No. +larvae/total) 
G 4 F + 
17 
(8 F, 9 M) 
G1 – 100% (74/74) 
G2 – 100% (10/10) 
G3 – 100% (183/183) 
G4 – 100% (85/85) 
G5 – 100% (144/144) 
G6 – 100% (2/2) 
G7 – 100% (59/59) 
H 4 M + 0 N/A 
I 4 F – 0 N/A 
J 6 M – 0 N/A 
F: female, M: male. N/A: not applicable 
 
Despite the likely presence of multiple integrated copies, the ability of the PGI 
promoter to drive expression was tested by crossing individuals of the G5 line with 
UAS-mCherry mosquitoes. No mCherry signal was detected in the progeny of this 
cross at any life stage. 
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The G5 line was outcrossed with wild types for two generations attempting to reduce 
the number of integrated copies, but 100% fluorescent progeny was recovered each 
time and colony eventually discarded. 
 
3.5.4.3 VATG_GAL4 driver lines for Malpighian tubule-specific expression 
Owing to their predicted tissue specific activity, Malpighian-specific putative 
promoters were not tested by transfection in the haemocyte-like mosquito cell cultures 
available. Instead, we used RMCE to integrate the VATG_GAL4 cassette site-
specifically and created a driver line to test the ability of the 5’ sequence upstream of 
V-type ATPase subunit G gene (AGAP001823) to drive Malpighian tubule-specific 
expression in transgenic mosquitoes.  
349 eggs of the A11 docking line were injected with VATG_GAL4 (Figure 3.6A), 86 
larvae (25%) hatched of which 39 (45%) showed transient expression of the DsRed 
marker in the anal papillae. 57 (66%) F0 adults emerged, 31 females and 26 males, 
which were separated into 6 sex-specific cages (A-F) and backcrossed with G3 
individuals (Table 3.11). Transgenic F1 progeny was recovered from founder cage F 
only, which produced 68 DsRed-positive (cassette exchange events) and 8 
DsRed/CFP-positive (integration events) larvae. Isofemale lines were set up from 6 
randomly-chosen cassette-exchange females, 5 of which displayed orientation A (FA-
FE) and 1 (FF) orientation B (Table 3.11). The FA line was kept for in vivo analysis 
while other lines were discarded. The minimum transformation efficiency achieved 
was 3.5% (2 events/57 F0). 
To test the ability of the VATG promoter to drive expression, individuals of the FA line 
were crossed with UAS-mCherry mosquitoes. Progeny of this cross did not display 
mCherry signal in the Malpighian tubules or in any other tissue in any life stage. 
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Table 3.11 Selection strategy to isolate a stable transgenic GAL4 lines carrying the VATG_GAL4 
cassette 
F0 pool 
F0 adults 
No. and sex 
Transient DsRed 
expression 
No. +F1 adults 
(sex) 
F2 isofemale lines 
A 7 M – 0 N/A 
B 15 F – 0 N/A 
C 6 M – 0 N/A 
D 4 F – 0 N/A 
E 13 M + 0 N/A 
F 12 F + 
60 
(27 F, 33 M) 
FA – orientation A 
FB – orientation A 
FC – orientation A 
FD – orientation A 
FE – orientation A 
FF – orientation B 
F: female, M: male. N/A: not applicable 
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3.6 DISCUSSION  
 
3.6.1 Candidate promoter selection for in vivo analysis  
The availability of publicly accessible gene expression catalogues, such as the 
MozAtlas database (Baker et al., 2011), should facilitate promoter search allowing for 
direct comparison of relative gene expression in a diverse range of mosquito tissues. 
Further transcriptome studies, particularly with RNAseq technology will also improve 
the depth of coverage available (Padrón et al., 2014; Matthews et al., 2016). 
In this study one in eight of the putative ubiquitous regulatory regions selected in silico, 
PGI, showed statistically significant promoter activity in cell transfections compared 
to controls. This may be explained by the lack of critical regulatory elements that may 
be located further upstream of the region cloned in some cases. However, it is clear 
that the analysis was not done in sufficient depth to obtain rigorous statistical power. 
Further biological and technical repeats would be required to provide more confidence 
in the relative activity of the different promoters in this haemocyte-like cell line.  
Although promoter activity in a single mosquito cell line does not provide much 
information on the in vivo specificity or on the location of expression in transgenic 
organisms, cell screening was a preliminary tool to check plasmid constructs before 
embarking in transgenic experiments. One could hypothesise that a truly ubiquitous 
promoter would have activity in all cell lineages.  
In interpreting relative driver strength, is of note that the activity observed in the 
SUA5.1 cell line may be haemocyte-specific and gives no indication on the extension 
or strength of expression in transgenic individuals. For example, the An. gambiae 
LRIM promoter is active in this cell line (Lynd & Lycett, 2011; Lombardo et al., 2013) 
but its activity in transgenic mosquitoes is confined to the haemocytes (Volohonsky et 
al., 2017).  
The other promoter active in SUA5.1 cells was PUBc, which was chosen via 
comparative analysis with Ae. aegypti and was not identified by MozAtlas search. Of 
note is that the PUBc regulatory region used included the 3’ sequence downstream 
of the gene instead of the SV40 terminator present in all the other plasmids. This may 
have had a role in enhancing the intrinsic characteristic of the promoter.   
Malpighian tubule-specific candidate promoters were excluded from analysis by cell 
transfection due to their predicted tissue specificity. To screen the selected 
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candidates, it was initially intended to perform transient expression experiments by 
injecting putative Malpighian drivers into the embryos of a UAS-YFP line (Lynd & 
Lycett, 2012) and screening for larval Malpighian-specific fluorescence. However, due 
to time limits, a single promoter was selected for direct transgenic analysis based on 
previous experiments conducted in our laboratory that had shown transient activity 
driven by an alternative version of this promoter in larvae derived from UAS-YFP 
injected embryos (Lynd et al., unpublished).  
The other cloned candidate promoters could be examined by transgenic analysis, 
however the search for Malpighian-specific candidates would benefited from cross 
analysis with the more recent MozTubules database (Overend et al., 2015) 
(www.moztubules.org/search2016.cgi), which contains data on the An. gambiae 
Malpighian tubule transcriptome in males and females at different life stages and diet 
conditions. Furthermore, screening for common Malpighian tubule transcription factor 
binding domains would narrow our analysis to fewer specific candidates sharing 
common features in their upstream regions.  
The MozAtlas database was built using microarray data obtained with a variable 
number of probes per gene with some non-consistent results identified amongst 
probes used to quantify expression of the same gene. In this respect, more stringent 
criteria and search parameters should have been used to perform the selection 
including gene IDs showing consistent results across multiple probes and excluding 
those with high variability amongst probes. 
Overall, with the availability of the sequences of all major species of mosquito vectors, 
genome-wide in silico comparative approaches can be used to identify cis-regulatory 
elements (CREs) and transcription factor binding sites within them (Sieglaff et al., 
2009). Recently, a methodology for high-throughput discovery of CREs based on the 
sequencing of nucleosome-free strands of chromatin (FAIRE – formaldehyde-
assisted isolation of regulatory elements) was proven useful to identify CREs in Ae. 
aegypti (Behura et al., 2016) and may be used to support CRE identification in An. 
gambiae.  
 
3.6.2 Embryo microinjections  
Microinjection of An. gambiae embryos is a challenging technique that requires 
practice.  
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In initial experiments, very low hatching rates were recorded (Appendix C, Tables C.3 
and C.4). Factors affecting post-injection egg survival include: purity, concentration 
and toxicity of injected DNA solution, quality of eggs and pre-injection handling, and 
needle-induced mechanical damage. Also, the size and number of plasmids injected 
negatively affect the transformation efficiency with single small plasmids transforming 
more successfully than multiple larger ones (Venken et al., 2006; Volohonsky et al., 
2015).  
To investigate the cause of high post-injection mortality, controls were introduced 
including un-injected egg lines to monitor egg quality and pre-injection handling 
procedures, and injections with buffer to control for DNA toxicity. In doing so, high 
hatching rates in un-injected controls and high mortality were observed when injecting 
buffer only, suggesting that neither the quality of eggs nor the toxicity of the DNA 
injected was the cause of low post-injection survival.  
In order to exclude technical issues other than the practical challenge of performing 
microinjections, all buffers and solutions were freshly prepared which, along with 
technical skills improved by practice, determined an increase in survival. Despite that, 
low transient expression rates and no transformants were obtained (Appendix C, 
Tables C.3 and C.4). For inheritable transgenesis, injections must precisely target the 
egg posterior pole so to modify the germ cells (Lobo et al., 2006). Therefore, while 
transient expression of the fluorescent marker gives an indication of DNA uptake, it 
does not assure stable transformation which is successful in a small proportion of 
individuals. 
The concentration of the DNA injected plays a crucial role in transformation 
experiments. In general, concentration affects the viscosity of a solution decreasing 
the ease of injection and thus increasing the likelihood of egg damage (Lobo et al., 
2006), but it also increases the amount of DNA delivered into the embryo and, in turn, 
the likelihood of transformation. Therefore, while in intermediate experiments the 
concentration of the solution injected was decreased to 250-300 ng/μl to aid survival, 
in latter experiments it was increased to 500 ng/μl, which is the recommended 
concentration (Lombardo et al., 2009). Accordingly, in these last experiments survival 
declined but higher transient expression rates were obtained and transgenic 
individuals recovered. 
Overall, the combination of improved technical skills, which were practised over a 
seven-month period, freshly prepared buffers, and the increased concentration of 
DNA injected combined to achieve higher hatching rates and successful germline 
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transformation. In these experiments, hatching rates of 14.5% (PGI) and 40% (PUBc) 
were achieved which are comparable or higher compared to survival rates reported 
in An. gambiae elsewhere for piggyBac 11-23% (Grossman et al., 2001; Kim et al., 
2004; Lombardo et al., 2009; Meredith et al., 2013). Minimum transformation 
efficiencies were 4% (PGI) and 5.5% (PUBc), which are similar to the most efficient 
rates reported elsewhere using piggyBac (0.6-5%) (Grossman et al., 2001; Kim et al., 
2004; Lobo et al., 2006; Lombardo et al., 2009; Lycett et al., 2012; Meredith et al., 
2013). 
Interestingly, transgenic progeny was yielded only from F0 mosquitoes showing 
transient episomal expression of the transformation marker in the anal papillae at 
early larval stage. This has been previously reported by Pondeville et al., (2014) 
indicating that, when high survival rates are achieved, screening workload could be 
reduced by breeding only from subsets of F0 mosquitoes that show marker gene 
fluorescence.  
 
3.6.3 Strategy for phenotypical and molecular assessment of driver 
docking lines for ubiquitous expression 
PiggyBac-mediated integration occurs in an essentially random manner in TTAA 
genomic sites and can therefore lead to the insertion of multiple copies of the 
transgenic cassette. The selection strategy used here aimed at maximising the 
identification of single reusable intergenic genomic sites, desirable for docking lines, 
and looking for variation in expression profiles, whilst also maintaining a manageable 
workload. To do so, of all the lines carrying the PUBc cassette, we molecularly and 
phenotypically characterised those derived from F1 transgenic females only as they 
are easier to breed from. F1 males were crossed in pools to UAS-mCherry to assess 
phenotypes generated as a backup in case other interesting phenotypes (and thus 
likely to be alternative insertions) were observed solely through the male lines. Lines 
derived from males were eventually discarded as corresponding mCherry phenotypes 
were recovered in female lines too.  
Phenotypic assessment by crossing all drivers carrying single insertions with the 
mCherry responder line revealed a variety of phenotypes that reflected positional 
effect both in terms of intensity and localisation of expression of the mCherry signal. 
Although differences in the expression of the 3xP3-CFP marker were detected in 
different lines, these were minor and did not correlate with the variegation observed 
in the mCherry signal. This may suggest that genomic sites from which good levels of 
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neuronal expression are obtained are not all capable to sustain ubiquitous expression. 
This is supported by findings in Ae. aegypti, where 3xP3 was an unreliable marker for 
inferring efficiency of transgene expression at specific genomic locations (Franz et al., 
2011). 
The variety of position variegation in the expression of mCherry also suggests that 
the presence of gypsy insulators flanking the GAL4 cassette was not effective in 
mitigating the influence of nearby effectors and/or chromatin status on transgene 
expression. Gypsy insulators (Roseman et al., 1993) have been previously reported 
to determine an increase of gene expression by repressing the action of nearby 
suppressors when flanking a 3xP3-eye marker cassette in D. melanogaster and An. 
stephensi (Sarkar et al., 2006; Carballar-Lejarazú et al., 2013). Yet, no quantitative 
study has been conducted in Anopheles spp. using the GAL4/UAS system. When 
insulating a UAS-Luciferase cassette in D. melanogaster, gypsy insulators were 
proven useful to equalise expression in various attP landing sites, with efficiency of 
insulation depending on genomic locus (Markstein et al., 2008). In An. gambiae, when 
gypsy sequences flanked a UAS-Luciferase cassette, the carboxypeptidase-GAL4 
cassette drove midgut-specific expression in all transgenic lines generated using 
piggyBac regardless of position of insertion (Lynd & Lycett 2012). Nevertheless, 
consistent tissue-specific detection across lines may also be attributed to the GAL4-
induced signal amplification which may lead to saturation. Indeed, when the Ae. 
aegypti carboxypeptidase promoter was inserted in a non-insulated GFP-fusion 
reporter cassette, tissue-specific expression was detected only in 2/9 lines (Franz et 
al., 2011). In addition, there may be differences in the insulation capacity of the gypsy 
sequences when flanking UAS compared to GAL4 constructs.  
 
3.6.4 Polyubiquitin-c (PUBc) promoter  
Here, we isolated and characterised for the first time the regulatory regions of the An. 
gambiae PUBc gene (AGAP001971) and demonstrated their ability to drive 
widespread multi-tissue expression in vivo.  
As described previously, regulatory regions of polyubiquitin genes were identified in 
D. melanogaster (Handler & Harrell, 1999) and Ae. aegypti (Anderson et al., 2010) 
and their ability to drive ubiquitous expression reported in several dipteran species 
including mosquitoes (Handler & Harrell, 2001; Heinrich et al., 2002; Perera et al., 
2002; Anderson et al., 2010). In An. gambiae three PUB genes (AGAP001969, 
AGAP001970, and AGAP001971) cluster in chromosome 2R:12 and share the same 
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structure consisting of two exons, one of which is non-coding. Transcriptome studies 
indicate that An. gambiae PUBc (3368 bp) is strongly expressed in larvae, pupae and 
adults (Marinotti et al., 2006) and it shares 100% protein identity with the Ae. aegypti 
PUB gene AAEL003877, the promoter of which was shown to drive multi-tissue 
expression in transgenic Ae. aegypti (Anderson et al., 2010). 
In this study, An. gambiae PUBc was demonstrated to drive luciferase expression via 
the GAL4 transactivator in haemocyte-like cells, in which it showed the highest activity 
compared to other 7 candidate promoters examined. Furthermore, visual assessment 
of progeny derived from selected PUBc driver lines (A10 and A8) crosses with UAS-
mCherry individuals, revealed that the regulatory regions identified for PUBc are 
active in a variety of tissues and organs in all mosquito life stages examined and 
presumably in embryonic stages too, as neonate larvae are intensely fluorescent. In 
adults, these tissues include: eyes, brain, and ventral nerve cord; muscles of the aorta 
and heart; trachea, nerves and muscles surrounding the digestive tract and the 
Malpighian tubules; salivary glands; sugar-fed and blood-fed ovaries and developing 
oocytes; fat body; appendages (legs, palps, antennae, proboscis); and haemocytes. 
Tissues where expression was not readily detectable include the epithelium of the 
digestive tract and Malpighian tubules. We cannot exclude that expression occurs in 
these tissues at a level that is not detectable by fluorescence. It is also possible that 
the expression of mCherry as a membrane protein is not as efficient in these tissues 
as it is in others, although progeny from the cross with the midgut-specific driver line 
show observable gut epithelium fluorescence (not shown).  
The expression pattern reported here largely overlaps those described for promoter 
fragments derived from other insect PUB genes (Handler & Harrell, 2001; Heinrich et 
al., 2002; Perera et al., 2002) and, more specifically, with that of the Ae. aegypti PUB 
promoter (Anderson et al., 2010). In Ae. aegypti a combination of fluorescence and 
transcription data was used to show that PUB-driven expression was robust and 
widespread throughout the mosquito body from larvae to adults (Anderson et al., 
2010). Two major differences were noted between expression pattern described in 
Ae. aegypti. We found that the A10 line drives strong fluorescence in the salivary 
glands, while in Ae. aegypti these tissues displayed little fluorescence and lacked 
mRNA signal. Conversely, strong fluorescence was seen in Ae. aegypti midguts, 
whilst it was observed only in the trachea and nerves surrounding the gut but not the 
midgut epithelium in An. gambiae. These differences may be due to innate variation 
in promoter activity from the region selected in the two species or they may be the 
result of positional effect. 
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To date, the profile described here represents the most widespread expression driven 
by an endogenous promoter in An. gambiae. Of note, however, is that expression also 
appears very low or absent in the Malpighian tubules.  
 
3.6.5 Phosphoglucose isomerase (PGI) promoter 
The An. gambiae PGI promoter was the most active in cells after PUBc. Yet, when 
corresponding driver lines were created, no activity was detected in transgenic 
mosquitoes after crossing with the UAS-mCherry line. 
All the isofemale lines obtained for this cassette when outcrossed to wild type showed 
100% inheritance of the transformation marker suggesting the presence of multiple 
integrated copies. Although the molecular basis of this finding was not explored to 
discover how many transposon copies were integrated or their genomic locations, it 
can be argued that the likely presence of multiple copies is involved in the lack of 
functionality of the driver construct and, in turn, the absence of the UAS-driven 
mCherry signal.  
It is of note that low transformation efficiency was achieved for this construct with 
transgenic progeny likely to have originated from a single founder individual, which 
may suggest toxicity. If multiple cassette integration is lethal, then the transgenic 
individuals isolated represent an exception in which the expression of the GAL4 was 
silenced while that of the fluorescent marker remained functional allowing the 
identification of transegnics. The presence of high copy number can trigger 
transposon silencing mechanisms put in place as a defensive mechanism by the host 
genome. In Drosophila, these silencing mechanisms are usually based on small 
RNAs interfering with the expression of mobile genetic elements via DNA methylation 
or degradation of their transcripts (Rozhkov et al., 2010). It is possible that such 
silencing involved only a portion of the cassette, leaving the fluorescent marker 
unaffected.  
In a different scenario, it is possible that the high number of copies was caused by the 
integration of the transposase gene, supplied via the helper plasmid at the time of 
injection, as well as the transposon resulting in persistent repositioning of the PGI 
cassette as a self-driving element. This would be supported by the observation that 
multiple successive outcrosses failed to reduce the percentage of fluorescent 
progeny. 
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3.6.6 VATG promoter for Malpighian tubule-specific expression  
VATG genes code for the subunit G of the vacuolar-type H+-transporting ATPase (V-
ATPase). Insect V-ATPases are large proton pumps found in epithelia (Dow et al., 
1997) where they energise transport across membranes (Pullikuth et al., 2003). 
These enzymes are found enriched in the highly active epithelium of the Malpighian 
tubules of D. melanogaster (Wang et al., 2004) and An. gambiae (Overend et al., 
2015) as demonstrated by tissue-specific microarray-based transcriptome analysis. 
Nevertheless, despite the past evidence of transient expression, the promoter 
analysis conducted here using a stable VATG_GAL4 driver line showed no 
expression in the Malpighian tubules or elsewhere. The promoter sequence used here 
was ~700 bp shorter than that used in past transient experiments, thus it possibly 
lacked crucial regulatory elements. Another explanation may be linked to the fact that 
V-ATPases consist of at least 13 subunits, which in D. melanogaster are encoded by 
31 genes (Dow et al., 1999); the expression of each subunit might be subjected to 
tight stoichiometric regulation by cis-acting elements working in concert and located 
elsewhere in the genome.   
 
3.6.7 Conclusions  
This work greatly contributes to the expansion of the toolkit for An. gambiae 
transgenesis and in vivo functional analysis through the characterisation of a 
ubiquitous endogenous promoter and two driver docking lines.  
We found that PUBc_GAL4 drives robust luciferase expression in SUA5.1 cells and 
widespread multi-tissue expression in all life stages in transgenic mosquitoes. This 
widespread expression pattern is unprecedented for an An. gambiae driver line 
carrying an endogenous promoter. As part of the promoter analysis, we characterised 
two novel driver lines, A10 and A8, bearing a single copy of the PUBc_GAL4 cassette 
in genomic locations that sustain widespread gene expression at high or low levels 
respectively and are designed for PhiC31-RMCE. Since these genomic sites allow for 
robust widespread expression, they are likely to be suitable locations for the 
expression of other transgenic cassettes.  
Future work should include demonstrating docking with these lines and performing an 
assessment of fitness cost inflicted by GAL4 expression in homozygous individuals 
compared with other transgenes inserted in these sites.  
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For the purpose of this thesis, the ability to express transgenes in a whole-body 
manner enabled the examination of resistance phenotypes generated by the 
ubiquitous overexpression of the CYP6 P450s, which is the aim of the following 
chapter. 
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4. Chapter 4 
Characterisation of resistance phenotypes resulting from 
multi-tissue overexpression of Cyp6m2 or Cyp6p3  
 
4.1 ABSTRACT  
Characterisation of genes and their physiological patterns of overexpression that 
confer insecticide resistance is crucial for effective vector control. As previously 
demonstrated, the overexpression of An. gambiae candidate genes Cyp6m2 and 
Cyp6p3 confined in the midgut or in the oenocytes is not sufficient to induce 
resistance, therefore here we investigated whether more widespread expression can 
drive resistance, exploiting the newly-established driver lines. To do so, crosses were 
performed to generate mosquitoes overexpressing Cyp6m2 and Cyp6p3 under the 
control of the ubiquitous An. gambiae polyubiquitin promoter.  Our results show that, 
under these conditions, Cyp6m2 confers resistance to WHO-defined diagnostic doses 
of the pyrethroids permethrin and deltamethrin, whilst Cyp6p3 also confers diagnostic 
resistance to bendiocarb. Resistance to DDT was not conferred by overexpressing 
either gene. Additionally, increased susceptibility to malathion was recorded when 
either Cyp6m2 or Cyp6p3 were overexpressed. The study provides the first evidence 
of the ability of Cyp6m2 and Cyp6p3 overexpression and resulting insecticide 
metabolism to drive WHO-levels of insecticide resistance to a diverse range of 
insecticides. 
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4.2 INTRODUCTION 
The physiological spatio-temporal pattern of P450 overexpression has crucial 
implications in insecticide management, yet it has been somewhat neglected. Results 
presented as part of this thesis showed that the midgut and oenocytes do not play a 
crucial role in driving resistance when Cyp6m2 and Cyp6p3 are overexpressed. 
Therefore, two driver lines for multi-tissue overexpression were established that 
exploit the ubiquitous properties of the An. gambiae polyubiquitin promoter and 
express at two different levels, higher (A10) and lower (A8) (Chapter 3). These lines 
allow for testing the effects of widespread expression of Cyp6m2 and Cyp6p3 on 
insecticide resistance.   
To date, the involvement of Anopheles resistance genes (Cyp6p9a/b (Riveron et al., 
2013), Cyp6m7 (Riveron et al., 2014a) and Cyp9j11 (Riveron et al., 2017) from An. 
funestus, and Cyp6m2, Cyp6p3 (Edi et al., 2014) and Gste2 (Daborn et al., 2012; 
Mitchell et al., 2014) from An. gambiae) in determining resistance in vivo has been 
only investigated in transgenic D. melanogaster. This was achieved using either the 
ubiquitous promoters Actin5 and TubulinP or the 6g1HR promoter which expresses 
in midgut, Malpighian tubules and fat body. In these studies, methods to determine 
resistance varied from assessing mortality after 24h exposure to a range of insecticide 
doses (Daborn et al., 2012; Edi et al., 2014) to measuring mortality at different time 
points during the 24 h exposure to a single insecticide dose chosen after dose-
response curve analysis (Riveron et al., 2013, 2014a/b). These methodologies and 
the insecticide concentrations used in D. melanogaster are not equivalent to the 
standard procedures used for testing mosquitoes, such as the WHO tube bioassay or 
the CDC bottle assay, therefore results are not directly comparable to those obtained 
in mosquitoes and thus not operationally relevant.  
P450-mediated metabolism of pyrethroids and carbamates derives from the oxidation 
of these insecticides into non-neurotoxic metabolites that are then cleared from the 
system (Guengerich, 2001). In contrast, metabolites resulting from the oxidation of 
organophosphate insecticides, such as the malathion metabolite malaoxon, are more 
toxic than their precursors (Cohen, 1984; Berkman et al., 1993). Therefore, 
overexpression of specific P450s may be expected to increase susceptibility to 
organophosphate pro-insecticides, making them suitable to specifically target 
mosquitoes that are resistant to pyrethroids through enhanced expression of the 
same P450. As such, organophosphate-based synergistic formulations are promising 
tools for vector control and synergistic combinations of pyrethroids and 
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organophosphates have been successfully used for controlling agricultural pests 
(Martin et al., 2003).  
 
4.3 AIMS AND OBJECTIVES 
The aim of the work described in this chapter was to investigate the ability of single 
Cyp6 genes to drive resistance when overexpressed in multiple tissues. To do so, the 
GAL4/UAS system was employed to induce overexpression of candidate genes 
Cyp6m2 and Cyp6p3 ubiquitously in susceptible An. gambiae mosquitoes and the 
resulting phenotype was tested for acquired resistance by WHO tube bioassay.  
The study’s objectives were: 
• To drive overexpression of Cyp6 candidates by crossing UASm2 and UASp3 
responder lines to GAL4 driver lines A10 and A8, which carry a PUBc_GAL4 
construct in single, unique genomic locations; 
• To validate gene and protein overexpression in progeny of these crosses; 
• To characterise resistance to the insecticides permethrin, deltamethrin, DDT and 
bendiocarb using the WHO tube bioassay;  
• To characterise susceptibility to the pro-insecticide malathion resulting from the 
overexpression of Cyp6m2 and Cyp6p3 in the midgut, oenocytes or ubiquitously.  
 
4.4 MATERIALS AND METHODS 
 
4.4.1 Mosquito lines and GAL4 x UAS crosses  
Details of mosquito maintenance are reported in Appendix A. Mosquito lines used in 
this study were: 
- A10 and A8: driver lines for ubiquitous expression carrying the PUBc_GAL4 at 
single unique integration sites. Lines consist of a mixture of heterozygous and 
homozygous individuals and are marked with 3xP3-driven CFP. Details on the 
creation of these lines are described in Chapter 3. 
- UASm2 and UASp3: responder lines for the UAS-regulated expression of 
Cyp6m2 and Cyp6p3. Lines consist of a mixture of heterozygous and 
homozygous individuals and are marked with 3xP3-driven YFP. The creation of 
these lines is described in Chapter 2. 
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- GAL4mid and GAL4oeno: driver lines for expression in the midgut and in the 
oenocytes respectively. Lines are homozygous and are marked with 3xP3-driven 
DsRed. Details on these lines are reported in Chapter 2. 
 
To obtain ubiquitous expression crosses were established between CFP-marked A10 
and A8 drivers and opposite sex individuals of the UASm2 and UASp3 responder 
lines marked with YFP. A total of 4 crosses was established: A10 x UASm2, A10 x 
UASp3, A8 x UASm2 and A8 x UASp3. For tissue-specific expression crosses were 
established between DsRed-marked driver lines GAL4mid and GAL4oeno and YFP-
marked responder lines UASm2 and UASp3.  
Progeny was sorted at pupa stage based on eye marker colour using a Leica MZ FLIII 
fluorescence stereo microscope fitted with CFP, DsRed and YFP filters (Leica 
Microsystems). CFP/YFP-positive and CFP-positive individuals were isolated for the 
ubiquitous crosses, and DsRed/YFP-positive and DsRed-positive for tissue-specific 
crosses.  
 
4.4.2 Assessment of Cyp6 gene expression in GAL4/UAS vs GAL4/+ 
To quantify Cyp6 gene expression in GAL4/UAS and GAL4/+ individuals, total RNA 
was harvested from pools of 2-5-day-old adult females. RNA extraction, DNase 
treatment, cDNA synthesis, RT-qPCR were performed as described in Chapter 2. 
Three biological replicates consisting of 5 adult mosquitoes each were collected from 
each mosquito population. 
Data analysis was performed as described in Chapter 2 with the exception that, to 
compare Cyp6 expression driven by A10 and A8, mean ΔCt values were obtained by 
pooling data from A10/+ and A8/+ mosquitoes. Statistical differences between 
expression (ΔΔCt values) in GAL4/UAS vs GAL4/+ were determined using Welch’s t-
test (two-tails, unequal variance). File names reporting raw data are reported in 
Appendix D. 
 
4.4.3 Assessment of CYP6 protein expression in GAL4/UAS vs GAL4/+ 
To detect CYP6 protein expression in GAL4/UAS and GAL4/+ individuals, total protein 
extracts were obtained from single 2-5-day-old adult females. Extracts were prepared 
in a total volume of 60 µL (30 µl PBS supplemented with EDTA-free protease inhibitor 
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cocktail (Roche) and 30 µl 2x Laemmli Sample Buffer (Bio-Rad) supplemented with 
2.5% 2-Mercaptoethanol as described in Chapter 2.  
SDS-PAGE and Western blot were conducted as described in Chapter 2, except in 
this case, because of interference between the similarly sized abundant CYP6M2 and 
α-tubulin proteins, two gels were run simultaneously, one for detection of CYP6M2 
and one for assessing α-tubulin. 6 µL of each extract (equivalent of 1/10 of a single 
female mosquito) were loaded onto each gel. Detection of the CYP6M2 signal was 
performed using 1:500 anti-CYP6M2 or anti-CYP6P3 peptide antibodies produced in 
rabbit (gifts from M. Paine) and 1:10,000 anti-rabbit-HRP IgG antibodies (Bethyl 
Laboratories); while detection of the α-tubulin control was carried out using 1:2,000 
anti-αtubulin (Sigma) and 1: 20,000 anti-mouse-HRP IgG antibodies (Abcam).  
 
4.4.4 Assessment of mosquito susceptibility to insecticides by WHO 
bioassay  
Mosquito susceptibility to insecticides was assessed using the WHO tube bioassay 
(WHO, 2016b) as described in Chapter 2. 2-5 day-old females were exposed to 0.75% 
permethrin, 0.05% deltamethrin, 0.1% bendiocarb, 4% DDT, for 1 h. A modified 
version of the WHO bioassay was performed for testing 5% malathion by reducing 
the exposure time to 25 minutes. 
1-3 experiments (biological replicates) were performed for each insecticide tested. 4-
6 technical replicate tubes were tested for each population. Number of bioassay 
experiments conducted are reported in Table 4.1. Following WHO guidelines, that 
mitigate against variability in quality control of insecticide papers, only assays showing 
95-100% mortality in the sensitive control population (GAL4/+) were included in the 
results. File names with raw data and analysis is reported in Appendix D. 
 
  
 Chapter 4 – Multi-tissue Cyp6 overexpression  
125 
 
Table 4.1 Bioassay experiments performed. 
Cross Insecticide 
Experiments 
(biol reps) 
Tot tech  
reps 
A10 
x 
UASm2 
Permethrin 0.75% 2 (3) 5 (7) 
Deltamethrin 0.05% 2 4 
Bendiocarb 0.1% 1 (2) 4 (5) 
DDT 4% 1 (2) 4 (5) 
Malathion 5% 2 4 
A10  
x  
UASp3 
Permethrin 0.75% 3 (5) 5 (9) 
Deltamethrin 0.05% 1 4 
Bendiocarb 0.1% 2 6 
DDT 4% 2 (4) 6 (9) 
Malathion 5% 2 4 
A8  
x  
UASm2 
Permethrin 0.75% 2 (3) 5 (7) 
Deltamethrin 0.05% 2 4 
Bendiocarb 0.1% 3 4 
DDT 4% 2 4 
Malathion 5% 2 5 
A8  
x  
UASp3 
Permethrin 0.75% 3 (5) 5 (9) 
Deltamethrin 0.05% 2 4 
Bendiocarb 0.1% 2 (4) 4 (8) 
DDT 4% 3 6 
Malathion 5% 3 4 
GAL4mid 
x 
UASm2 
Malathion 5% 2 4 
GAL4mid 
x 
UASp3 
Malathion 5% 3 5 
GAL4oeno 
x 
UASm2 
Malathion 5% 3 6 
GAL4oeno 
x 
UASp3 
Malathion 5% 3 5 
Numbers represent the experiments and replicates that were included in the 
analysis as mortality in the controls reached at least 95%, while those in brackets 
show the total number of experiments and replicates performed.  
 
4.5 RESULTS 
 
4.5.1 Cyp6 transcription levels obtained by the A10 and A8 drivers 
RT-qPCR analysis in the progeny of A10 crosses revealed that Cyp6m2 was 2447x 
overexpressed in A10/m2 compared to native expression in adult female A10/+ 
controls (ΔΔCt = 11.2, p = 0.0007) (Figure 4.1A). Cyp6p3 was also found significantly 
overexpressed (513x), in A10/p3 (ΔΔCt = 8.99, p = 0.0002), yet to a lesser extent 
(Figure 4.1B).  
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The relative Cyp6 transcription levels in progeny of the A8 crosses were significantly 
lower than the respective A10 crosses. Cyp6m2 was 420x overexpressed in A8/m2 
compared to native expression in adult females (ΔΔCt = 8.7, p = 0.0004) (Figure 
4.1A). Whereas Cyp6p3 was 73x overexpressed in A8/p3 mosquitoes (ΔΔCt = 6.12, 
p = 0.002) (Figure 4.1B). 
When comparing driver strength, A10 drove 5.5x (p = 0.0038) (Figure 4.1A) and 7.5x 
(p = 0.0042) (Figure 4.1B) higher transcription compared to the A8 driver when 
quantifying Cyp6m2 and Cyp6p3 respectively.  
 
Figure 4.1 Quantification of Cyp6 gene expression driven by A10 and A8. Expression in GAL4/UAS 
mosquitoes compared to GAL4/+ controls is reported as ΔΔCt (ΔCtGAL4/+ – ΔCtGAL4/UAS) on a log2 scale. 
A) Transcription of Cyp6m2 in adult females of the A10 x UASm2 and A8 x UASm2 crosses. B) 
Transcription of Cyp6p3 in adult females of the A10 x UASp3 and A8 x UASp3 crosses. Mean values 
with 95% confidence intervals are shown. Numbers on the top represent the fold change (x) expression. 
Statistical differences between ΔΔCt values from three biological replicates were calculated using 
Welch’s test. * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. File names reporting raw data are in 
Appendix D. 
 
4.5.2 CYP6 protein expression driven by the A10 and A8 lines  
Western blot was carried out to monitor CYP6M2 expression in protein extracts from 
adult female mosquitoes overexpressing Cyp6m2 under the control of the A10 and 
A8 drivers and respective GAL4/+ and +/ UASm2 individuals.  
A single clear band of the correct size (~58 kDa) for CYP6M2 was detected in extracts 
from A10/m2 and A8/m2 mosquitoes, but not in GAL4/+ or +/UASm2 controls (Figure 
4.2), providing clear evidence for overexpression of CYP6M2 in the A10/m2 and 
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A8/m2 mosquitoes. The signal from CYP6M2 appeared more abundant in A10/m2 
compared to A8/m2 adults (Figure 4.2) when also taking into account the α-tubulin 
loading controls, which were of similar abundance in all samples (Figure 4.2), 
suggesting that similar loading of crude protein extracts was achieved.  
 
Figure 4.2 Two parallel western blots on 2-5-day-old adult 
females from the A10 x UASm2 and A8 x UASm2 crosses 
to determine expression of CYP6M2 (top) and α-tubulin 
(bottom). Protein extract from the equivalent of 1/10 of a 
whole mosquito was loaded in each lane. 2-minute 
exposure.  
 
The CYP6P3 antiserum again failed to detect specific signals in Western analysis 
(data not shown) of A10xP3 and A8xP3 crosses and controls. 
 
4.5.3 WHO tube bioassays 
 
4.5.3.1 Resistance phenotypes resulting from A10-driven overexpression of 
Cyp6m2 or Cyp6p3  
WHO bioassay analysis revealed that the A10-driven multi-tissue overexpression of 
Cyp6m2 or Cyp6p3 is sufficient to cause WHO-defined resistance to standard doses 
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of the pyrethroid insecticides permethrin and deltamethrin. Significantly different 
mortality rates were found between GAL4/UAS and GAL4/+ mosquitoes when tested 
against 0.75% permethrin (p = 0.0007 for Cyp6m2; p = 1.811E-05 for Cyp6p3) and 
0.05% deltamethrin (p = 0.04 for Cyp6m2; p = 0.003 for Cyp6p3) (Figure 4.3). The 
magnitude of reduction in mortality was comparable in Cyp6m2- and Cyp6p3-
overexpressing mosquitoes after exposure to permethrin, while individuals 
overexpressing Cyp6p3 showed a greater decrease in mortality when exposed to 
deltamethrin compared to mosquitoes overexpressing Cyp6m2 (p = 0.003) (Figure 
4.3).  
Mosquitoes overexpressing Cyp6m2 under the control of the A10 driver did not show 
resistance to 4% DDT or 0.1% bendiocarb as 100% mortality was recorded in both 
GAL4/UAS and GAL4/+ mosquitoes (Figure 4.3A).  Similarly, individuals 
overexpressing Cyp6p3 did not show resistance to 4% DDT (Figure 4.3B). Instead, a 
significant decrease in mortality was recorded in A10/p3 mosquitoes compared to 
controls after exposure to 0.1% bendiocarb (p = 0.00015) (Figure 4.3B). 
 
4.5.3.2 Resistance phenotypes resulting from A8-driven overexpression of 
Cyp6m2 or Cyp6p3   
WHO bioassay analysis on females overexpressing Cyp6m2 under the control of the 
A8 driver revealed that the lower Cyp6m2 overexpression is sufficient to drive 
resistance to 0.75% permethrin as a significant difference in mortality was recorded 
in A8/m2 mosquitoes compared to A8/+ controls (p = 0.027) (Figure 4.4A). No 
significant differences in mortality rates were recorded in A8/m2 mosquitoes 
compared to controls after exposure to WHO diagnostic doses of 0.05% deltamethrin, 
4% DDT, or 0.1% bendiocarb (Figure 4.4A).  
Mosquitoes overexpressing Cyp6p3 under the control of the A8 driver line showed no 
significant resistance to all the insecticides tested (Figure 4.4B). Nevertheless, trends 
of reduced mortality were found in A8/p3 compared to A8/+ after exposure to 
permethrin and bendiocarb (Figure 4.4B).  
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Figure 4.3 Sensitivity to insecticides of 2-5-day-old adult females overexpressing Cyp6m2 or Cyp6p3 
ubiquitously under the control of the A10 driver. A) Sensitivity of the progeny from A10 x UASm2 crosses. 
B) Sensitivity of the progeny from A10 x UASp3 crosses. Mortality rates were obtained by WHO tube 
bioassay after 1 h exposure to insecticides and 24 h recovery. Dotted line represents 98% mortality which 
is the threshold for resistance indicated by the WHO. Perm: 0.75% permethrin; Delta: 0.05% 
deltamethrin; DDT: 4% DDT; Bendio: 0.1% bendiocarb. m2+: A10/UASm2 females; m2-: A10/+ controls 
from m2 cross; p3+: A10/UASp3 females; p3-: A10/+ controls from p3 cross. Statistical significance was 
calculated using Welch’s test. ns: not significant, * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. 
The bottom and the top of each box represent the first and third quartile respectively, line inside the box 
is the second quartile (median), and whiskers represent minimum and maximum values. Number of 
technical replicates (x) for each population is indicated. File names with raw data and analysis is reported 
in Appendix D. 
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Figure 4.4 Sensitivity to insecticides of 2-5-day-old adult females overexpressing Cyp6m2 or Cyp6p3 
ubiquitously under the control of the A8 driver. A) Sensitivity of the progeny from A8 x UASm2 crosses. 
B) Sensitivity of the progeny from A8 x UASp3 crosses. Mortality rates were obtained by WHO tube 
bioassay after 1 h exposure to insecticides and 24 h recovery. Dotted line represents 98% mortality which 
is the threshold for resistance indicated by the WHO. Perm: 0.75% permethrin; Delta: 0.05% 
deltamethrin; DDT: 4% DDT; Bendio: 0.1% bendiocarb. m2+: A8/UASm2 females; m2-: A8/+ controls 
from m2 cross; p3+: A8/UASp3 females; p3-: A8/+ controls from p3 cross. Statistical significance was 
calculated using Welch’s test. ns: not significant, * p < 0.05. The bottom and the top of each box represent 
the first and third quartile respectively, line inside the box is the second quartile (median), and whiskers 
represent minimum and maximum values. Number of technical replicates (x) for each population is 
indicated. File names with raw data and analysis are reported in Appendix D. 
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4.5.3.3 Susceptibility to Malathion in mosquitoes overexpressing Cyp6m2 or 
Cyp6p3 tissue-specifically or ubiquitously 
Susceptibility to the pro-insecticide malathion was assessed by a modified WHO 
bioassay exposing mosquitoes overexpressing Cyp6m2 or Cyp6p3 either tissue-
specifically (midgut or oenocytes) or ubiquitously (A10 or A8 drivers) for 25 minutes 
rather than 1 hour.  
Mosquitoes overexpressing Cyp6m2 under the control of the A10 driver showed 
significantly higher mortality rates compared to controls (p = 8.06345E-05) (Figure 
4.5A). Similarly, but to a significantly lesser extent compared to A10/m2 (p = 0.002), 
A10/p3 mosquitoes also showed a significant increase in mortality compared to A10/+ 
controls (p = 0.048) (Figure 4.5B). 
The A8-driven multi-tissue overexpression of Cyp6m2 or Cyp6p3 resulted in a 
significant increase in mortality rates in GAL4/UAS mosquitoes compared to controls 
(p = 0.0015 for Cyp6m2; p = 0.0009 for Cyp6p3) (Figure 4.5). No significant 
differences were found between the two genes (p = 0.19). 
Both A10- and A8-driven expression was correlated with 80-100% mortality in 
mosquitoes overexpressing Cyp6m2. A significantly greater degree of mortality (p = 
0.008) was found in A10/p3 compared to A8/p3 mosquitoes.  
No significant difference was found in the susceptibility of mosquitoes overexpressing 
Cyp6m2 or Cyp6p3 in the midgut or in the oenocytes compared to controls, although 
a trend of increased mortality in GAL4/UAS mosquitoes is seen (Figure 4.5). 
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Figure 4.5 Sensitivity to 5% malathion of 2-5-day-old adult females overexpressing Cyp6m2 or Cyp6p3 
ubiquitously or tissue-specifically under the control of the A10 (UbiA10), A8 (UbiA8), GAL4mid (Midgut) 
or GAL4oeno (Oenocytes) drivers. A) Sensitivity of the progeny deriving from the overexpression of 
Cyp6m2. m2+: mosquitoes overexpressing Cyp6m2; m2-: blank controls from the UASm2 cross. B) 
Sensitivity of the progeny deriving from the overexpression of Cyp6p3. p3+: mosquitoes overexpressing 
Cyp6p3; p3-: blank controls from the UASp3 cross. Mortality rates were obtained by modified WHO tube 
bioassay after 25-minute exposure and 24 h recovery. Whiskers represent minimum and maximum 
values, line in the middle is the median. Statistical significance was calculated using Welch’s test. ns: not 
significant, * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. The bottom and the top of each box 
represent the first and third quartile respectively, line inside the box is the second quartile (median), and 
whiskers represent minimum and maximum values. Number of technical replicates (x) for each 
population is indicated. File names with raw data and analysis are reported in Appendix D. 
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4.6 DISCUSSION  
 
4.6.1 Cyp6 gene and CYP6 protein overexpression 
We achieved the overexpression of Cyp6 candidate genes by independently crossing 
responder lines created for Cyp6m2 (UASm2) and Cyp6p3 (UASp3) overexpression 
with driver lines promoting multi-tissue overexpression at higher (A10) and lower (A8) 
levels. Widespread pattern of transcription driven by A10 and A8 was previously 
demonstrated assessing the expression of the fluorescent reporter mCherry and 
assumed to be representative for that of P450s.  
To compare data on relative driver strength, RT-qPCR results obtained from A10/+ 
and A8/+ controls on the native expression levels of each gene were pooled and 
compared to overexpressing mosquitoes. This revealed that the A10 driver induces 
higher levels of transgene transcription compared to the A8 driver. This finding is in 
line with the relative intensities observed during fluorescence analysis in progenies 
from crosses to the UAS-mCherry line (Chapter 3) and by the western analysis of 
relative CYP6M2 abundance.  
Although quantification of protein levels was not performed, Western blot analysis 
indicated abundant CYP6M2 protein when driven both by A10 and A8 lines. It is 
impossible to absolutely compare with native expression from this data, since 
CYP6M2 was never detected in GAL4/+ controls when extracts from 1/3 or 1/10 of a 
single mosquito were analysed to get a reasonable signal from the overexpressing 
lines. In previous experiments assessing tissue-specific expression, 1/3 of an adult 
mosquito or its body parts was sufficient for CYP6M2 and α-tubulin detection, with the 
exception of midgut samples. However, when the same amount was used to assess 
expression driven by ubiquitous drivers, the intense signal obtained from CYP6M2 
impeded the detection of α-tubulin due to size similarity. We encountered a similar 
issue with size and intensity of CYP6M2 signal covering that of α-tubulin when loading 
protein content from 2 whole midguts. Nevertheless, even when the amount of protein 
extract loaded was reduced to the equivalent of 1/10 of a single mosquito expressing 
ubiquitously, α-tubulin was still not detectable due to CYP6M2 abundance. Thus, in 
the latter experiments, two identically loaded parallel gels were run and detection of 
the two proteins performed independently.  
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4.6.2 GAL4/UAS-driven vs natural overexpression levels 
Our current knowledge on magnitude of P450 overexpression in natural mosquito 
populations mostly derives from comparative microarray followed by validation of top 
candidate hits by RT-qPCR. In this study, GAL4/UAS induction with the A10 driver 
generates 2447x and 513x overexpression of Cyp6m2 and Cyp6p3 respectively, 
while the A8 line drives 430x and 73x respectively. In An. gambiae natural populations 
levels of transcription of Cyp6 genes, including the ones investigated here, are 
generally lower. For example, in DDT-resistant An. gambiae populations collected in 
Ghana and Cameroon Cyp6m2 transcript abundance was respectively 4x and 3-10x 
higher than in susceptible populations from Cameroon and Benin (Mitchell et al., 
2012; Fossog Tene et al., 2013); while in DDT-resistant mosquitoes from Benin 
Cyp6m2 was found 1.2-4.6x upregulated and Cyp6p3 3.8-2.5x (Djègbè et al., 2014). 
Increased levels of expression of both Cyp6m2 (~2.6x) and Cyp6p3 (2.8-12.4x) were 
also recorded in permethrin-resistant An. gambiae from Benin and Nigeria compared 
to a susceptible Nigerian strain (Djouaka et al., 2008); while Cyp6p3 was 1.6x 
upregulated in permethrin-resistant samples from Ghana (Müller et al., 2008b). 
Cyp6m2 was recently reported to be 44x upregulated in deltamethrin-resistant An. 
gambiae populations from Benin, while an upregulation of 4.8x was found for Cyp6p3 
(Yahouédo et al., 2016). Finally, in pan-resistant An. gambiae Tiassalé mosquitoes 
from Côte d’Ivoire fold changes of ~8x and ~6x were recorded for Cyp6m2 and 
Cyp6p3 respectively compared to susceptible laboratory and field populations (Edi et 
al., 2014). Similar levels of Cyp6p3 upregulation (7-10x) were found in pan-resistant 
samples from Burkina Faso (Kwiatkowska et al., 2013). 
However, in respect of the magnitude of transcription a few observations must be 
made. In most of these studies, mosquitoes used as susceptible controls are not, in 
sympatry with the resistant population tested or are laboratory established 
populations. As such, relative quantifications are made irrespective of the native 
transcription levels of those genes, which may naturally vary in geographically 
separated populations without affecting the phenotype.  
Furthermore, multiple mechanisms of resistance occur simultaneously in the field. 
Therefore, most data are collected from mosquitoes bearing target-site mutations 
(kdrR or ace-1R) alongside P450 upregulation. It is not clear how multiple mechanisms 
of resistance affect the levels of P450 overexpression but we can speculate that the 
presence of target-site resistance could lower the level of P450 upregulation needed.  
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This is supported by the levels of Cyp6 upregulation found in natural An. funestus 
mosquitoes in which target-site resistance has not been described (Menze et al., 
2016). Mosquitoes of this species from Mozambique and Malawi were found to 
upregulate Cyp6p9a and Cyp6p9b ~40-75x and ~27-88x respectively compared to 
the FANG susceptible strain (Riveron et al., 2013, 2014a, 2015). Cyp6m7 was also 
found ~38x overexpressed in An. funestus mosquitoes from Zambia (Riveron et al., 
2014a). Similarly, multiple resistance candidates are usually overexpressed in natural 
populations which may reduce upregulation levels of single genes. This was for 
example suggested in Zambian An. funestus populations where Cyp6p9a and 
Cyp6p9b were found 2-7x less upregulated compared to Malawian and Mozambican 
samples which was partly attributed to the concomitant ~38x overexpression of 
Cyp6m7 in mosquitoes from this area (Riveron et al., 2014a).  
As mentioned, our data on magnitude of overexpression are, to some extent, 
comparable to those found in the field for An. funestus mosquitoes, where Cyp6 genes 
are found upregulated up to 88 times compared to susceptible strains (Riveron et al., 
2013, 2014a, 2015). This is similar to the 75x upregulation of Cyp6p3 obtained with 
the A8 driver which did not affect resistance. This may suggest that levels of 
upregulation required for the resistant phenotype to manifest are gene specific and 
dependant on levels of basal expression and actual amount of active protein 
produced. In addition, differently from mosquitoes generated here, the overexpression 
seen in An. funestus may occur only in key detoxifying tissues that affect the 
phenotype.  
 
4.6.3 Effects on resistance to insecticides of ubiquitous overexpression 
of Cyp6m2 and Cyp6p3 
In vivo overexpression of Cyp6m2 or Cyp6p3 in the multi-tissue pattern promoted by 
the A10 driver was correlated with WHO-defined levels of resistance to diagnostic 
doses of the pyrethroids insecticides permethrin and deltamethrin. This data build on 
the evidence of these single genes to alter LD50 to pyrethroids in transgenic D. 
melanogaster (Edi et al., 2014). It also supports in vitro data on the ability of CYP6M2 
and CYP6P3 recombinant proteins to metabolise pyrethroids in vitro (Müller et al., 
2008b; Stevenson et al., 2011). A10-driven Cyp6m2 and Cyp6p3 overexpression 
caused a comparable decrease in mortality after exposure to permethrin, while 
resistance to deltamethrin was significantly more evident in A10/p3 compared to 
A10/m2 mosquitoes. This is in line with data showing ~98% of deltamethrin depletion 
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when incubated with recombinant CYP6P3 compared to ~55% seen with CYP6M2 
(Yunta et al., unpublished). In general, CYP6P3 is found to have a more promiscuous 
substrate specificity compared to CYP6M2 during in vitro depletion experiments 
(Yunta et al., unpublished). 
Resistance to DDT was not affected by the ubiquitous overexpression of Cyp6m2 or 
Cyp6p3 driven by either A10 or A8. This result is in accordance with in vitro data 
showing lack of substrate depletion when recombinant CYP6M2 or CYP6P3 are 
incubated with DDT (Yunta et al., unpublished). DDT is not depleted in the presence 
of several other candidates of the Anopheles CYP6 and CYP9 families (Yunta et al., 
unpublished). Although the expression of Cyp6 genes in tissues not targeted with A10 
and A8 may confer resistance to DDT, the results would support the idea that DDT 
resistance could mainly rely on the presence of kdrR and upregulation of GSTs 
(Mitchell et al., 2014). Indeed, An. gambiae recombinant GSTE2 metabolises DDT in 
vitro (Ortelli et al.,2003; Mitchell et al., 2014) and its overexpression in transgenic D. 
melanogaster determines acquisition of resistance to DDT (Daborn et al., 2012; 
Mitchell et al., 2014). However, further in vivo evidence in D. melanogaster showed a 
significant difference in the DDT LD50 in flies overexpressing CYP6M2 ubiquitously 
(Edi et al., 2014). Such discrepancies between results obtained in Anopheles and 
Drosophila transgenics will be discussed in Chapter 5.  
Resistance to bendiocarb is affected only in mosquitoes overexpressing Cyp6p3 
under the control of the A10 driver. Once again, this is in accordance with in vitro 
metabolism data showing the ability of recombinant CYP6P3, but not CYP6M2, to 
metabolise bendiocarb (Edi et al., 2014). Remarkably, CYP6P3 was the only enzyme 
able to deplete bendiocarb in vitro among nine CYP6 (including CYP6M2) and CYP9 
enzymes tested elsewhere (Yunta et al., unpublished). In comparison, in vivo D. 
melanogaster data showed that both CYP6M2 and CYP6P3 confer resistance to 0.1 
µg bendiocarb when ubiquitously overexpressed (Edi et al., 2014).  
Overall, despite the high level of overexpression driven by A10, the resultant enzyme 
activity is able to be sustained sufficiently by the native levels of CPR in relevant 
tissues to impart resistance. Although it would be interesting to assess whether there 
is an upregulation of CPR in these crosses in response to transgenic P450 
expression.  
When Cyp6 overexpression is induced by the A8 driver, WHO levels of resistance to 
insecticides are not observed, with the exception of A8/m2 mosquitoes showing low, 
but significant, resistance to permethrin. In these mosquitoes, reduction in mortality is 
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less marked than in A10/m2. Also, a trend of decrease in mortality, although not 
significant, is found in A8/p3 mosquitoes exposed to permethrin or bendiocarb. In 
these instances, since resistance is suspected, additional replicate experiments are 
required to define resistance status according to WHO guidelines (WHO, 2016b); 
increasing the number of repeats increases the power of statistical analysis and may 
show defined significant differences. The levels of resistance observed from the A8 
crosses thus support the data on driver strength obtained by fluorescence (Chapter 
3) and analysis of transcript and protein abundance. It would suggest that the amount 
of CYP6 produced in A8 lines is not saturating relative to A10, and that higher enzyme 
quantities in A10 provide greater resistance even at these levels of ubiquitous 
overexpression. Clearly, it may be that expression is required in only a few key 
detoxifying tissues to confer resistance, and in these tissues the A10 lines produce 
more enzyme than the A8 lines.  
Overall the data suggest that, besides location of overexpression, levels of 
overexpression are crucial for the resistance phenotype to manifest.  
 
4.6.4 Effects on resistance to the pro-insecticide malathion of 
ubiquitous vs tissue-specific overexpression of Cyp6m2 and 
Cyp6p3 
This work reports on the first in vivo evidence of the involvement of Cyp6m2 and 
Cyp6p3 in the sensitivity to malathion in An. gambiae mosquitoes. When exposed to 
the WHO diagnostic dose of malathion for 25 minutes, both Cyp6m2 and Cyp6p3 
determined an increase in susceptibility when overexpressed ubiquitously but not 
tissue-specifically in the midgut or in the oenocytes. This negative cross resistance 
can be explained by the bioactivation of malathion in its toxic metabolite malaoxon via 
P450-mediated oxidation (Cohen et al, 1984; Berkman et al., 1993). The ability of both 
the P450s tested to deplete malathion in vitro has been recently demonstrated (Yunta 
et al., unpublished), which correlates with the increased toxicity seen in P450-
overexpressing mosquitoes compared to controls.   
Although all mosquitoes were susceptible to malathion after 1 h of exposure, during 
this exposure time GAL4/UAS mosquitoes were knocked-down much faster than 
controls suggesting involvement of P450 metabolism (not shown). This observation 
led us to reduce the exposure time to 25 minutes to observe differences between 
GAL4/UAS and GAL4/+ mosquitoes.   
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Cyp6m2 caused a range of 80-100% mortality when it was driven by either the A10 
or A8 drivers, suggesting the toxic oxidation of malathion into malaoxon is sustained 
even by lower levels of P450 overexpression. Conversely, differences in mortality 
induced by the overexpression of Cyp6p3 were found between the A10 and A8 
drivers. Here, levels of overexpression driven by the weaker driver A8 induced 
significantly higher mortality compared to that induced by the stronger driver A10. This 
may be explained considering that P450-induced metabolism of malathion is likely to 
be a two-step process involving 1) oxidation-mediated activation of malathion into its 
highly toxic metabolite malaoxon (Matolcsy, 1988), and 2) oxidative degradation of 
malaoxon.  It can be speculated that in A8/p3 mosquitoes the lower level of CYP6P3 
favours oxidation of malathion into malaoxon with resultant high toxicity, while in 
A10/p3 mosquitoes, where higher quantity of enzyme is present, oxidation of 
malathion is accompanied by detoxification of malaoxon. Nevertheless, the kinetics 
of this two-step oxidation is unclear. Overall, mortality rates induced by A10-driven 
Cyp6m2 overexpression were higher than those found in Cyp6p3-overexpressing 
mosquitoes suggesting that CYP6M2 may show higher catalytic activity for malathion 
compared to malaoxon and therefore the bioactivation step is favoured. 
In mosquitoes overexpressing Cyp6 in the midgut or in the oenocytes, despite a trend 
of increased mortality being observed, this was not significantly different from 
mortality in control mosquitoes. This suggests that tissue location of malathion turn-
over is critical and is not sufficient to significantly affect the susceptibility when it is 
confined to the midgut or the oenocytes. 
While resistance to pyrethroids is widespread in Africa (Ranson & Lissenden, 2016), 
resistance to organophosphates is much less so due to the decreased use of this 
class of insecticides as adulticides since the advent of pyrethroids. Therefore, the 
enhanced susceptibility to malathion after 25 minutes of exposure and the faster 
knock-down observed after 1 h of exposure in mosquitoes overexpressing P450s 
ubiquitously is promising for control strategies based on exploiting the combined 
effect of insecticides with different modes of action. One such strategy involves 
combining the use of pyrethroid-based LLINs with malathion-based IRS. This would 
combine the additive effect of the two classes of insecticides on susceptible 
mosquitoes, while specifically targeting pyrethroid-resistant mosquitoes 
overexpressing P450 enzymes. In these mosquitoes, malathion could also synergise 
the toxicity of pyrethroids by acting as a competitive substrate for P450s (Martin et al., 
2003). The binding of malathion to P450s would result in the production of the toxic 
malaoxon form while rendering the P450 active site unavailable for pyrethroid binding, 
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thus preventing detoxification. Furthermore, the use of two different classes of 
insecticides would reduce the currently high selective pressure imposed by 
pyrethroids on the mosquito population (WHO, 2012b). The synergetic action of 
organophosphates on the efficacy of pyrethroids was demonstrated in the cotton pest 
Helicoverpa armigera (Martin et al., 2003). To my knowledge, the combination of 
organophosphate-based IRS with pyrethroid-impregnated LLINs has not yet been 
investigated in field trials.  
 
4.6.5 Considerations on the WHO tube bioassay  
In this study resistance was assessed by WHO tube bioassay whose guidelines define 
the threshold of resistance at 98% when performing 1-hour exposure to single doses 
of insecticides that are defined as twice the concentration that kills 99.9% of a 
susceptible population (LD99.9) (WHO, 2016b). 
When performing WHO test, there are several variables that may affect mortality rates 
contributing to variable results, including factors related with mosquito rearing such 
as age and fitness, and quality control issues with the papers such as uneven 
impregnation, usage and inappropriate conditions of storage affecting insecticide 
stability.  
In this study, despite working with susceptible laboratory colonies, in some instances 
we recorded mortality below 98% after 1 h of exposure to diagnostic doses of 
permethrin, DDT and bendiocarb. Therefore, in compliance with WHO guidelines, 
only experiments in which GAL4/+ controls showed 95-100% mortality were included 
in the analysis. Experimental mosquitoes are reared at near optimal conditions of 
temperature, humidity, density, and availability of food which results in a generally 
bigger size and increased fitness compared to field populations. This may partly 
explain the issue with reduced mortality at WHO diagnostic doses. Furthermore, the 
efficacy of papers is known to decline over time, especially when pyrethroids are 
tested (WHO, 2016b). Thus, although according to WHO guidelines papers can be 
reused up to 6 times (equivalent of the exposure of 150 mosquitoes) (WHO, 2016b), 
in our experiments fresh papers were used which were stored for a maximum of three 
days. Despite alleviating the problem, even fresh permethrin papers showed 
decreased performance which leads us to suggest that diagnostic dose for this 
insecticide (0.75%) may need to be revised. Similarly, issues with some of the 
bendiocarb- and DDT-impregnated papers showing a decreased efficacy against 
susceptible populations, could be explained by technical issues during paper 
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manufacturing at the Universiti Sains Malaysia, reference centre for paper production 
(WHO, 2016b). 
Besides possible issues with quality of papers, factors such as size, age, fitness or 
behaviour of the mosquitoes tested may cause variability in the results when using 
the WHO bioassay. In our experiments, mosquitoes overexpressing P450s and blank 
controls were reared together and selected as pupa on the same days. No obvious 
differences in size or fitness were noticed between the two populations, although we 
did not specifically assay this. In terms of optimal age for testing, even within the WHO 
recommended range of age, 3-5-day-old, field resistant mosquitoes show remarkably 
different mortality rates when exposed to deltamethrin, permethrin and propoxur, with 
2-3 day-old mosquitoes displaying similarly high levels of resistance that are 
consistently higher than 5-day-old mosquitoes (Chouaibou et al., 2012). In this study, 
we tested 2-5 day-old females, but often this range of age was reduced to 2-3, 3-4 or 
4-5 day-old since, in the condition of rearing used, mosquitoes pupated synchronously 
over two days. This may have contributed to the variability within replicates and 
experiments. Furthermore, “the uptake of [a discriminating concentration] depends on 
the time of actual tarsal contact” with the insecticide (WHO, 2016b). The WHO tube 
setup does not ensure continuous contact with the insecticide-impregnated paper as 
this adheres to the tube wall leaving the top and bottom uncovered where mosquitoes 
can rest without being exposed. Thus, the length of time spent in these areas is 
expected to affect results due to altered exposure. Here, this is particularly relevant 
in experiments where exposure time was reduced to 20-25 minutes, which may 
explain the higher variability found in these experiments. Moreover, reducing the time 
of exposure to 20-25 minutes amplifies the effect of excito-repellency (Kawada et al., 
2014) that some of the compounds (e.g. pyrethroids) induce which leads mosquitoes 
to fly frantically instead of resting on the paper further reducing the total exposure.  
 
4.6.6 Conclusions and Future Directions  
This study provides the first in vivo evidence of the ability of single Cyp6 genes, 
Cyp6m2 and Cyp6p3, to cause resistance to a diverse range of insecticides in An. 
gambiae. Also, for the first time in in vivo transgenic experiments, levels of resistance 
identified here are those defined by the WHO, so data are directly comparable to 
those obtained from field mosquitoes using the WHO tube bioassay.  
Upcoming work will include investigating the effect that pre-exposure to the synergist 
PBO has on the resistance phenotype. PBO in known to inhibit P450-mediated 
 Chapter 4 – Multi-tissue Cyp6 overexpression  
141 
 
metabolism enhancing insecticide potency and is used as preliminary screening to 
ascertain the involvement of metabolic resistance in the field-caught resistant 
mosquitoes (Feyereisen, 2015). Such experiments would indicate whether CYP6M2 
and CYP6P3 are affected similarly by PBO when metabolising different insecticide 
classes and to what extent. It would also show whether the WHO-recommended PBO 
concentration (4%) (WHO, 2016b) is sufficient to increase mortality in the resistant 
populations created in this study that display remarkably high levels of P450 
overexpression. 
While fluorescence assessment of drivers’ activity showed expression of at all life 
stages, CYP6 overexpression and its effect on resistance has only been assessed in 
adults. Therefore, future work should include validating overexpression in other life 
stages and testing resistance to larvicides in aquatic stages.  
In addition, genetically stable resistant mosquitoes were created that can be 
implemented in the pipeline for assessing new active compounds, such as 
insecticides, pro-insecticides, synergists and sterilising agents, in a solely metabolic 
resistance background. The implementation of these lines in such pipeline is 
discussed in Chapter 5. 
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5. Chapter 5  
General Discussion   
 
5.1 Effect of tissue-specific vs ubiquitous Cyp6 
overexpression  
Identifying the tissues involved in insecticide metabolism is key to defining 
physiological insecticide detoxification pathways, which, in turn, greatly assists the 
quest to discover new active compounds and formulations with chemistries that evade 
detoxification. The work presented here demonstrates that location of overexpression 
of top resistance candidates Cyp6m2 and Cyp6p3 is critical in causing WHO levels of 
resistance, as this has only been obtained when single P450s are overexpressed 
ubiquitously but not tissue-specifically in the midgut or oenocytes. Overexpression 
confined to these tissues was initially targeted because of their proposed role in 
detoxification and the immediate availability of corresponding GAL4 drivers; while 
achieving ubiquitous overexpression required the characterisation and validation of a 
novel endogenous promoter driving expression in multiple tissues. 
Knowledge on tissue-specific distribution of P450 overexpression is very limited in 
mosquitoes, therefore it is difficult to predict what body parts may be specifically linked 
to Cyp6m2- and Cyp6p3-mediated detoxification. To date, only one study investigated 
the expression of resistance-associated genes in dissected body parts (Malpighian 
tubules, midgut, abdomen integument, and carcass) of resistant An. gambiae 
populations (Ingham et al., 2014). In this study, Cyp6m2 overexpression did not show 
tissue-specificity, while Cyp6p3 was significantly overexpressed in the midgut of 
resistant mosquitoes in relation to the whole body.  
A limited number of studies in other insects have implicated different tissues in 
metabolism-mediated resistance which include the midgut, Malpighian tubules and 
oenocytes. In An. gambiae, the involvement of the oenocytes in resistance was 
supported by the natural enrichment of the P450 cofactor CPR (Lycett et al., 2006) as 
well as that of resistance-associated P450 genes such as Cyp4g16 and Cyp4g17 
(Ingham et al., 2014; Balabanidou et al., 2016). Consistent with a role in detoxification, 
oenocyte-specific CPR knockdown, which affects the function of all P450s, caused 
increased sensitivity to permethrin in susceptible An. gambiae (Lycett et al., 2006). 
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Nevertheless, our data show that overexpression of candidate resistance P450 genes 
in this tissue does not alter resistance to the four classes of insecticides under the 
conditions tested. Recently, Balabanidou et al. (2016) found that Cyp4g16 and 
Cyp4g17 are specifically localised in An. gambiae oenocytes, and the former is 
essential for cuticular hydrocarbon production. In line with this finding, stable 
oenocyte-specific knockdown of either gene via transgenic RNAi imposed a 
remarkable fitness cost and drastically increased susceptibility to desiccation in An. 
gambiae (Lynd et al., unpublished). In related work, Balabanidou et al. (2016) also 
demonstrated that the rate of insecticide penetration was greater in susceptible 
mosquitoes, which correlated with resistant An. gambiae displaying a thicker cuticle 
compared to susceptible mosquitoes. In light of these recent findings, the phenotype 
observed by Lycett et al. (2006) as a result of CPR knockdown may be in fact due to 
fitness costs associated with defective cuticle which determines an increase in 
insecticide internalisation or increased desiccation sensitivity. Similar conclusions 
were recently reached by Yu et al. (2016) after the RNAi-mediated knock down of 
Cyp4g102 in Locusta migratoria.  
The P450-cofactor CPR is also highly expressed in the mosquito midgut (Lycett et al., 
2006), and together with the high native expression of Cyp6m2 and Cyp6p3 
(Stevenson et al., 2011; Baker et al., 2011) supports an involvement of this tissue in 
conferring resistance. Furthermore, transcripts from other genes of the CYP6P family, 
including Cyp6p3, were found enriched in the midgut of resistant strains (Ingham et 
al., 2014). Despite this, we found that overexpression of Cyp6m2 or Cyp6p3 confined 
to this tissue does not affect resistance to all insecticides under the conditions tested. 
Consistent with this, fluorescence assessment of the activity of the A10 and A8 drivers 
used to obtain widespread expression, revealed absence of expression in the midgut. 
The emergence of resistance derived from overexpression induced by these 
ubiquitous drivers thus supports the notion that the midgut does not play a major 
detoxification role, at least via overexpression of these specific P450s tested and in 
the absence of other factors. 
Finally, the involvement of Malpighian tubules in detoxification has also been 
suggested by P450 gene enrichment in this organ in An. gambiae (Baker et al., 2011; 
Ingham et al., 2014). Furthermore, the P450-cofactor CPR was also found abundantly 
in the mosquito Malpighian tubules (Lycett et al., 2006). However, as described above 
for the midgut, the absence of expression driven by the A10 and A8 lines in Malpighian 
tubules, with corresponding resistance observed to different classes of insecticides in 
Cyp6-overexpressing mosquitoes, would also suggest a non-essential role in P450-
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mediated detoxification for this tissue. At least for the insecticides tested, taken 
together, this evidence suggests that the midgut and oenocytes are not essential for 
Cyp6m2- or Cyp6p3-mediated detoxification, while the role of the Malpighian tubules 
remains not fully explored. Nevertheless, these tissues may still be relevant for other 
P450s that are specifically enriched in these locations, or play synergistic roles with 
other resistance mechanisms. Perhaps significantly, Yang et al. (2007) found that 
transgenic overexpression of endogenous Cyp6g1 specifically induced in the 
Malpighian tubules, but not in the brain or in the fat body, caused resistance to DDT 
in D. melanogaster. In the future, an Anopheles Malpighian-specific driver would be 
invaluable to further investigate the potential role of these excretory organs.  
Functional analysis in D. melanogaster has also shown tissue-specific roles in 
insecticide detoxification when Anopheles genes are heterologously expressed. For 
example, Daborn et al. (2012) found no difference in the DDT resistance phenotype 
emerging from the overexpression of An. gambiae Gste2 when driven by a ubiquitous 
driver or a driver specific for the midgut, Malpighian tubules and fat body. Implicating 
roles for the latter tissues in resistance mediated by GSTs. However, when 
investigating the effect of overexpression of An. funestus Cyp6p9a/b genes, Riveron 
et al. (2013) found that resistance to pyrethroids emerged only when overexpression 
was driven ubiquitously but not by the midgut, Malpighian and fat body driver. This 
suggests the presence of gene-specific responses that are dependent on location of 
expression. If individual enzymes are specifically associated with certain tissues to 
produce a resistance phenotype, it is possible that the minimum pattern of 
overexpression required for Cyp6m2 or Cyp6p3 to cause resistance may differ or may 
not require all the tissues where the PUBc_GAL4 driver is active. Similarly, different 
insecticides may be detoxified in different tissues that require different enzymes or 
enzyme classes. Tissue specialisation in insecticide metabolism may derive from 
unequal exposure to xenobiotics. The fate of insecticides after uptake by the mosquito 
and the detoxification pathways they undergo are not well defined and they are likely 
to depend on the administration route, with ingested insecticides encountering 
different tissues compared to those that are topically acquired (Yang et al., 2007). In 
this scenario, lack of resistance observed in our studies when Cyp6s are 
overexpressed in the midgut may be due to the mode of exposure to the insecticide 
(contact), and this tissue may be relevant when xenobiotics are instead ingested. An 
example of this would be the increased susceptibility to permethrin observed in P. 
xylostella after droplet-feeding larvae Cyp6bg1 dsRNA droplets (Bautista et al., 2009).  
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Owing to their generally lipophilic nature, insecticides may be transported around the 
mosquito tightly bound to lipoproteins (Shaw, 1991) and therefore not access all 
tissues equally, which would result in their compartmentalisation in the mosquito 
body. If this is the case, it is expected that certain tissues may have specific 
detoxification roles compared to others.  
Examples of tissue specialisation in insecticide metabolism demonstrated by gene 
functional analysis include the brain and the Malpighian tubules. Central nervous 
system-specific overexpression of T. castaneum Cyp6bq9 gene in D. melanogaster 
transgenics determined acquisition of resistance to deltamethrin (Zhu et al., 2010). 
Since the nervous system is the target of most insecticides, it would be interesting to 
explore the phenotype resulting from overexpression in this location. Another single 
tissue that have not been investigated in this study and may play a significant role in 
insecticide metabolism is the fat body. Promoters targeting these locations are 
available in An. gambiae, thus experiments similar to those conducted here could be 
performed to investigate the contribution of these tissues. 
This study suggests that not only location of overexpression is relevant but also levels 
of overexpression are critical for resistance, with high levels of Cyp6m2 or Cyp6p3 
overexpression required in more than one tissue for the mosquito to acquire WHO-
levels of resistance to insecticides. However, as mentioned, the data on 
overexpression in the whole mosquitoes does not implicate specific tissues.  
 
5.2 Detection of insecticide resistance in adult mosquitoes  
This study provides the first in vivo evidence that WHO-levels of resistance in An. 
gambiae can be produced by the overexpression of single P450 genes. The WHO 
tube bioassay is the recommended surveillance tool to detect resistance in mosquito 
populations (WHO, 2016b). As such, data produced in this work were obtained under 
standardised conditions that are directly comparable to those obtained by other 
laboratories and/or in the field.  
WHO-defined resistance refers to the percentage mortality recorded 24 h after 1 h of 
exposure to papers impregnated with diagnostic single doses of insecticides (WHO, 
2016b). The discriminating concentrations used to impregnate papers correspond to 
two-times the dose that kills 99.9% of a susceptible population (LD99.9) (WHO, 2016b). 
As such, detection of resistance at discriminating doses does not necessarily 
correlate with insecticide failure in the field and assessment of “intensity” of resistance 
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is now considered necessary to determine operational implications (Bagi et al., 2015; 
WHO, 2016b). Therefore, in the revised version of the WHO guidelines, testing 5x 
and 10x concentrations is suggested to assess strength of resistance, with the 
assumption that identification of resistance at 5x, and particularly at 10x 
concentration, predicts operational failure (WHO, 2016b).  
An alternative method to determine intensity of resistance is the CDC bottle bioassay 
(CDC, 2012), which is based on incubating mosquitoes in glass bottles coated with 
ascending insecticide concentrations. However, when we attempted to build dose-
response curves in susceptible GAL4/+ populations using this technique, data were 
highly inconsistent among doses and replicates. We believe this was due to difficulties 
in obtaining a uniform coating of the bottles. Eventually the test was discarded as the 
coating and washing protocols were too laborious, and results variable. For simplicity 
and consistency, we attempted to assess whether the oenocytes and midgut driven 
expression caused an observable resistance phenotype at lower insecticide 
exposures than the standard WHO assay.  This modified WHO tube test involved 
decreasing the exposure time to yield a lower dose. As discussed in Chapter 4, 
although trends were observed, no significant difference was detected in the tissue 
specific lines, but again the high variability in results may mask small differences in 
resistance that would require many more repeats to yield a small significant 
difference.  
With more time, it would be informative to assess the intensity of resistance by 
building dose-response curves LD50 for all the GAL4/UAS mosquitoes. This could be 
achieved using custom papers with grading insecticide doses or using a newly 
designed tarsal assay, where mosquitoes are exposed to custom doses of 
insecticides in disposable Petri dishes. This last method would have been of choice 
because it uses a lower number of mosquitoes per test allowing more technical and 
biological replicates for the same mosquito numbers (i.e. 10 females per replicate 
compared to 25 needed for the WHO tube bioassay). 
 
 Chapter 5 – Discussion  
147 
 
5.3 Comparison of in vitro metabolism with in vivo 
phenotype assays in transgenic Anopheles and 
Drosophila. 
As discussed extensively in this thesis, in vivo gene functional analysis is critical to 
determine causative links between the overexpression of a candidate gene 
associated with resistance and the occurrence of the resistance phenotype. This work 
reports on the first functional analysis of mosquito resistance genes conducted in 
transgenic An. gambiae. Additionally, while the involvement of Cyp6m2 and Cyp6p3 
in conferring resistance to permethrin, deltamethrin, DDT and bendiocarb was 
previously investigated in D. melanogaster transgenics (Edi et al., 2014), this work 
shows for the first time the endogenous role of these genes in altering sensitivity to 
malathion via P450-mediated activation. 
Table 5.1 summarises the phenotypic data obtained in this study in comparison with 
in vitro assays with recombinant An. gambiae CYP6M2 and CYP6P3 and in vivo data 
from previous reports from D. melanogaster transgenic analysis with Cyp6m2 and 
Cyp6p3.   
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Table 5.1 Summary of functional validation experiments of Anopheles resistance candidate genes 
Cyp6m2 and Cyp6p3. Table reports main findings from in vitro depletion experiments with recombinant 
CYP6s and in vivo studies performed in An. gambiae and D. melanogaster models using GAL4/UAS-
mediated overexpression. 
Gene Insecticide 
In vitro 
metabolism*  
 (Yunta et al., unpub.) 
Anopheles 
transgenics  
(this study) 
Drosophila 
transgenics* 
(Edi et al., 2014) 
Cyp6m2 
Permethrin      58.5 ± 2.2    
Deltamethrin  55.4 ± 1.4    
DDT 2.9 ± 2.1     
Bendiocarb  0 ± 11.2     
Malathion  26.8 ± 8.8   N/A 
Cyp6p3 
Permethrin      100.0 ± 0.0     
Deltamethrin  98.2 ± 0.2    
DDT 4.1 ± 5.6     N/A 
Bendiocarb  35.0 ± 2.5     
Malathion  68.8 ± 8.4    N/A 
Green ticks represent presence of in vitro depletion or that of resistance in vivo. Red crosses represent 
lack of in vitro depletion or that of resistance in vivo. 
* Values represent mean % of insecticide depletion ± SD assessed by HPLC analysis. 20% was set as 
cut-off for activity. 
** Results based on LD50 curve analysis for all insecticides except bendiocarb, which was tested at a 
single dose of 0.1 µg.  
 
 
Generation of resistance in An. gambiae is in all cases consistent with the ability of 
the specific P450 tested to metabolise the corresponding insecticide in vitro, i.e. a 
WHO level resistant phenotype in An. gambiae was only recovered when the P450 
tested had been shown to deplete the specific insecticide tested in vitro. These results 
give confidence to in vitro metabolic assays as a primary screen of candidate genes. 
Nevertheless, further genes need to be screened in vivo to strengthen the data. 
Moreover, absence of in vitro metabolism does not necessarily mean lack of 
involvement in resistance, since other P450 interactions may occur (binding or 
secondary metabolism) that are relevant for developing resistance. As such, in vivo 
testing will be an important element for candidate validation in Anopheles.  
When comparing in vivo data obtained in the Drosophila and Anopheles models 
discrepancies do emerge. Drosophila overexpression of CYP6M2 was reported as 
increasing resistance to DDT and bendiocarb (Edi et al., 2014), which are not 
metabolised in vitro by this enzyme (Yunta et al., unpublished; Edi et al., 2014). In 
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contrast, this study demonstrates that overexpression of CYP6M2 does not cause 
WHO levels of resistance to DDT or bendiocarb in An. gambiae, suggesting that this 
P450 does not significantly interact with these insecticides in Anopheles. However, it 
is noteworthy that in vivo results obtained in the two systems are not directly 
comparable as the method used to assess resistance differs in the two insects. While 
data reported here for An. gambiae was obtained by WHO tube bioassay, resistance 
data on D. melanogaster was mostly reported as LD50 values obtained from exposing 
flies to different concentrations of insecticides for 24 h. Concentrations used for testing 
flies are typically lower compared to those used for testing mosquitoes using the WHO 
test, and thus may pick up small differences in resistance phenotype. Whether these 
small differences in resistance in Drosophila give useful information for operational 
field control of mosquitoes may be debatable. 
Incongruity between in vitro insecticide depletion and in vivo data obtained in 
Drosophila was also found when characterising the An. funestus Gste2 gene, which 
was shown not to metabolise deltamethrin in vitro yet resistance emerged in flies 
overexpressing the gene (Riveron et al., 2014b). It would be informative to test this 
gene in Anopheles in comparison since interactions not involving metabolism may 
occur, such as sequestration. 
Overall, using Anopheles transgenics appears to be a more suitable alternative to 
investigate endogenous gene function in vivo compared to the Drosophila model. The 
Anopheles model clearly allows more physiologically relevant and representative 
results by overexpressing endogenous genes. In doing so, it also allows the assay of 
candidate genes difficult or impossible to test in vitro or in Drosophila, such as 
evolutionary diverged cuticle genes, transcription factors regulating genetic pathways, 
or sensory proteins. As examples, recent RNAi investigations revealed the 
involvement of a Maf transcription factor in regulating overexpression of a resistance 
gene pathway (Ingham, 2016) and a putative odorant-binding protein that modifies a 
resistance phenotype (V. Ingham pers. comm.). Owing to their lack of enzymatic 
activity these candidates cannot be readily screened for in vitro activity and their 
assessment in Drosophila may not be physiologically representative, due to lack of 
interacting partners.  
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5.4 Applications of insecticide resistant lines  
The work flow for assessing the efficacy of new active compounds before 
commercialisation includes testing the effect of new chemistries on field-caught 
resistant populations. Naturally resistant An. gambiae populations display multiple 
mechanisms of resistance, usually target-site resistance and up-regulation of multiple 
detoxifying genes. While representative of natural populations, the presence of 
multiple resistance mechanisms along with the natural genetic diversity existing in 
these populations complicates pinpointing the precise molecular basis of resistance 
to new chemistries. Further complications when using recently colonised field 
populations include maintaining their resistance status, which often requires 
periodical selection and generating sufficient numbers to create a stable population. 
Mosquitoes created as part of this work are resistant to permethrin, deltamethrin, and 
bendiocarb in a solely metabolic background, whose resistance is readily obtained 
upon crossing of parental lines that gives large numbers of genetically nearly-identical 
individuals. The genetic markers are fluorescent labels which are easy to score and 
monitor for contamination. They are therefore useful to be implemented in the pipeline 
for discovery of new active compounds, including insecticides, pro-insecticide as well 
as for testing synergists such as PBO or sterilising agents such as pyriproxyfen. 
Indeed, pyriproxyfen metabolism mediated by CYP6M2 and CYP6P3 has been 
recently demonstrated in vitro (Yunta et al., 2016). Furthermore, as P450 
overexpression occurs in all life stages, these resistant lines are also suitable for 
larvicides testing. These resistant mosquitoes are thus currently being used to test a 
series of new and repurposed compounds for the product development consortium 
IVCC to select those compounds that are least liable to CYP6M2- and CYP6P3-
mediated metabolism. 
Owing to their stable, common genetic background, and consistent resistance 
phenotype, these lines are highly suited to directly compare the different techniques 
used to assess resistance in An. gambiae, such as WHO tube, CDC bottle, cone, and 
topical tarsal assays. This would, for example, include investigating relationships 
between defined resistance and diagnostic doses. In particular, testing these lines 
with the cone bioassay, a more realistic assay in which mosquitoes are exposed to 
LLINs or insecticide-sprayed surfaces (to mimic IRS interventions), would be very 
informative in comparison with the resistance phenotypes observed with the current 
universal WHO field test.  
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5.5 New tools for Anopheles transgenesis and in vivo gene 
functional analysis  
This work provides important new tools for transgenesis and gene expression 
manipulation in An. gambiae including a novel endogenous promoter driving 
widespread expression and new docking driver lines.   
Owing to its widespread expression, the PUBc promoter can be used whenever a 
multi-tissue patter of expression is required. This may include its use as an alternative 
marker for efficient screening of large numbers of transgenic individuals or for the use 
of automated screening systems (Marois et al., 2012; Volohonsky et al., 2015) as it 
allows performing mass screening at low magnification. Currently, screening of 
transformant mosquitoes relies on the activity of the 3xP3 promoter which drives 
neuronal expression. In transgenic D. melanogaster, expression in the nervous 
system was found robust in several genomic landing sites (Markstein et al., 2008). 
However, the promoter is still susceptible to position effect as demonstrated by 
fluorescence detection either in the eyes, brain, anal plates, nerve cord, or in all the 
mentioned locations, depending on genomic locus, which may limit transformant 
detection. Due to its broader activity, PUBc may be a more reliable screening marker. 
The A10 and A8 PUBc driver lines, both carrying a single insertion in intergenic 
regions of chromosome 2R, were selected as exemplification of a common PUBc 
pattern of widespread expression at different intensities, higher and lower 
respectively. These drivers represent valuable and versatile tools for gene functional 
analysis in An. gambiae using the GAL4/UAS system as they can be used to obtain 
widespread gain- or loss-of-function of any gene or RNAi template located in suitable 
UAS lines. GAL4-mediated gene silencing experiments can now be performed in a 
widespread fashion, which will for example broaden the efficiency of RNAi-mediated 
knock-down experiments, particularly those for which no tissue specific promoter is 
available. In this context, PUBc driver lines can be also combined with the 
CRISPR/Cas9 system for inducing a more efficient mutagenesis-mediated gene 
silencing by crossing PUBc_GAL4 with previously established UAS:Cas9/gRNA 
transgenic individuals (Xue et al., 2014).  
Using the A10 and A8 drivers, gene expression manipulation can be achieved in a 
similar spatial and temporal manner at two different levels. This is advantageous for 
overexpression of target genes that are toxic, for which a lower level of expression is 
desirable or, vice versa, for genes that are endogenously lowly expressed, for which 
 Chapter 5 – Discussion  
152 
 
signal amplification is needed. Similarly, they potentially allow for manipulation of 
knockdown levels.  
As an alternative use, the efficiency of the A10 line for recombinant protein production 
within the mosquito can be investigated. Currently, mosquito-derived recombinant 
proteins are produced in bacterial or viral systems such as E. coli and Baculovirus. A 
mosquito system would produce less protein, but this should be correctly modified 
and folded, and thus potentially more active and representative. Tagging would also 
be possible to facilitate purification.  
Importantly, A10 and A8 carry two attP sites for RMCE or site-specific integration. 
Indeed, when injecting embryos of a docking line carrying two attP sites, occasional 
cassette integration occurs alongside with cassette exchange as a result of single 
crossover events. Progeny can then be selected by screening for the presence of a 
double or single marker. Integration may be desirable, for example, to insert a UAS 
construct flanking the GAL4 cassette to create stable GAL4/UAS individuals without 
the need of crossing and maintaining two separate lines. On the other hand, the ability 
of replacing the present cassette with any other DNA cargo containing attB sites would 
allow for comparison of direct gene expression at an identical genomic location 
limiting the confounding factor of positional effect (Bateman et al., 2006; Meredith et 
al., 2013). For example, the activity of other promoters could be assessed and directly 
compared to that of PUBc, including the other candidate ubiquitous promoters 
developed in this study; similarly, expression of transgenes from different UAS 
cassettes could be compared when induced by the same driver.  
Taken together, this work provides an integrated system to validate genes in An. 
gambiae. Advantages of the system include the ability to 1) express or silence genes 
in An. gambiae in alternative patterns of expression, including tissue-specifically or 
ubiquitously, at two different levels and in all life stages; 2) express genes that cannot 
be tested in vitro or in D. melanogaster; 3) compare expression data in individuals 
with a nearly-identical genetic background; 4) generate lines relatively rapidly via 
RMCE which allows comparative assessment of gene function by swopping cassettes 
in the same genomic locus. 
 
5.6 Future perspectives for investigating resistance  
The overall aim to this work was to investigate which P450 genes and tissues are 
physiologically relevant for the emergence of insecticide resistance. While, the 
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overexpression of Cyp6m2 and Cyp6p3 have been found directly correlated with 
resistance and location and levels of their expression found to be critical, the key 
tissues involved in detoxification remain a point of ambiguity. Our analysis of 
expression driven by the A10 and A8 lines using a fluorescent reporter revealed that 
the main difference between the two lines is intensity of expression. Nevertheless, a 
detailed analysis of expression using more sensitive techniques such as qPCR or 
Northern blot analysis in dissected tissues may reveal more substantial differences in 
location of expression that could help to pinpoint tissues relevant to detoxification. 
These locations could be then further investigated to validate their involvement in 
resisatnce.  
More broadly, next generation tools for geneme manipulation, such as CRISPR/Cas9, 
are set to facilitate investigations on insecticide resistance. The CRISPR/Cas9 system 
is revolutionising the field of genome editing in insects due to its versatility and 
efficiency. It allows for stable gene knock-outs, through non-homologous end joining 
(NHEJ) of cleaved sites, or gene knock-ins and specific mutations via homology 
directed repair (HDR) if a template flanked by homologous regions is provided. In 
recent years, the CRISPR/Cas9 technology has been successfully applied to 
mosquitoes such as Ae. aegypti (Dong et al., 2015; Kistler et al., 2015), An. stephensi 
(Gantz et al., 2015), An. gambiae (Hammond et al., 2016), and C. quinquefasciatus 
(Itokawa et al., 2016), with first examples of its application in insecticide resistance 
research emerged very recently. However, CRISPR/Cas9 has not been reported for 
the analysis of insecticide resistance in An. gambiae. In the context of this study, if 
multiple, defined mechanisms of resistance are to be examined, resistant mosquitoes 
created as part of this work can be modified to bear specific target-site mutations (kdrR 
and/or ace-1R). This would allow examination of the contributions of single or multiple 
mechanisms of insecticide insensitivity to the overall resistance phenotype. 
In D. melanogaster, a point mutation was induced in the AchE receptor using 
CRISPR/Cas9 and found to be sufficient to confer resistance to spinosad (Zimmer et 
al., 2016). With the abundance of genomic data being generated for An. gambiae, 
similar experiments could be conducted to validate the role of novel polymorphisms 
associated with resistance and/or the cumulative effect of multiple point mutations.  
Recently, Itokawa et al. (2016) demonstrated that the CRISPR/Cas9-mediated 
disruption of the P450 gene Cyp9m10 in pyrethroid-resistant C. quinquefasciatus 
larvae results in an increased sensitivity to permethrin. Similar experiments may be 
conducted to assess the effects of the knockout of single P450 genes, including 
 Chapter 5 – Discussion  
154 
 
Cyp6m2 and Cyp6p3, or entire subfamilies in resistant field caught populations. 
Similarly, the effects of gene duplications and multiple copies of P450 genes could be 
assessed.  
CRISPR/Cas9 will also facilitate studies aimed at unveiling the regulation of the 
overexpression of P450 genes in Anopheles. Such experiments may include 
investigating the promoter regions of these genes by inducing point mutations at sites 
critical for gene regulation. Additonally, CRISPR/Cas9 will also greatly ease 
investigations of the genomic context in which P450s are expressed and allow to 
exploit patterns of expression of interest by repositioning their sequences along the 
genome. This could for example involve placing P450 sequences under the control of 
non native promoters driving patterns of expression of interest or substituting genes 
dispalying a desired pattern of expression with the targeted P450 gene.  
There is no doubt in the near future the CRISPR/Cas9 technology will be largely 
employed to design inventive experiments to further explore the molecular bases of 
insecticide resistance in An. gambiae and other disease vectors.
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6. Appendix A 
General Methods  
 
DNA extraction 
Single female mosquitoes were ground with an electrical pestle and genomic DNA 
extracted using DNeasy Blood & Tissue Kit (Qiagen) following manufacturer’s 
protocol. Final elution was performed in 100 μl of dH2O. 
 
Polymerase Chain Reaction (PCR) 
PCR reaction were set up using 2.5 mM dNTPs mix (Sigma), 10 μM primers 
(Integrated DNA Technologies) working solutions, and either DreamTaq DNA 
polymerase (Thermo Scientific), Phire Hot Start II DNA Polymerase (Thermo 
Scientific) or Phusion High-Fidelity DNA Polymerase (Thermo Scientific) according to 
manufacturer’s guidelines using a Biorad T100 thermal cycler. 
 
Agarose gel electrophoresis 
DNA was visualised on 0.8-2% agarose (Bioline) gels prepared in TAE buffer (Severn 
Biotech) and stained with Ethidium Bromide (Sigma) or Midori Green (Gene Flow). 
Samples were loaded using 6x gel loading dye (Thermo Scientific) and bands sized 
using 100 bp, 1 kb or 1 kb plus DNA Ladders (Thermo Scientific). Images were taken 
in a G-Box transilluminator (SynGene) using GeneSnap image acquisition software 
(SynGene).  
 
DNA purification and clean-up   
PCR products were mixed with 600 μl of buffer P4 (66.9 g of Guanidine hydrochloride 
in 33.3 ml of P3, pH 5, volume adjusted at 100 ml with dH2O, 0.22 μm filter sterilised, 
1.5 g diatomaceous earth), passed through a spin column (Wizard MiniColumns, 
Promega) and washed twice with buffer P5 (200 mM NaCl, 20 mM Tris, 5 mM EDTA, 
1 volume ethanol) before being re-suspended in 30 μl of dH2O. 
For purifying DNA from agarose gels the band of interest was cut out the gel and 
incubated in 0.8-1 ml of buffer QG (Sigma) supplemented with 1.5 mg/ml 
diatomaceous earth (Sigma) at 50 ˚C until completely dissolved. Sample was then 
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passed through a spin column, washed twice with buffer P5, and re-suspended in 30 
μl of dH2O. 
 
Ethanol precipitation of DNA 
1/10th volume of 3M sodium acetate was added to the solution of DNA to precipitate 
followed by 2.5 volumes of ice cold ethanol. Solution was then stored at -20 ˚C for 1h 
or overnight to allow for precipitation. DNA pellet was collected after 20-minute 
centrifugation at 4 ˚C, resuspended in 1 ml of 70% ice cold ethanol, and spun for 2 
minutes at 4 ˚C. Supernatant ethanol was removed, pellet air dried and finally 
resuspended in a desired amount of dH2O. 
 
Restriction endonuclease digestion 
All restriction enzyme digestions were carried out using restriction enzymes from New 
England Biolabs according to manufacturer’s instructions.  
 
Ligation of DNA  
To ligate DNA fragments into a plasmid vector 3:1 insert-to-vector molar ratio was 
calculated and 50-100 ng of digested vector used. Ligations were carried out using 
T4 DNA ligase (Thermo Scientific) in a final volume of 10 μl and incubated at 16 ˚C 
overnight or for 1 h at room temperature.  
 
E. coli transformation  
1 μl of the ligation mix was diluted 1:20 and 3 μl of cells added, placed into pre-chilled 
electroporation cuvettes (Sigma) and transformed by electroporation (1.8 KV, 200 Ω, 
25 μF) into MegaX DH10B™ T1R Electrocomp™ Escherichia coli cells (Invitrogen). 
After electroporation, cells were recovered in 1 ml LB-Miller broth (Fisher Scientific) 
and incubated at 37 ˚C for 1 h at 200rpm. 20-100 μl of bacterial culture were then 
plated out in LB-Miller agar plates supplemented with 100 μg/ml ampicillin (Sigma) 
and incubated overnight at 37 ˚C. 
To set up clonal cultures from plasmid extraction, a single colony was collected from 
the plate and transferred into 5 ml (for miniprep) or 100 ml (for midiprep) of LB-Miller 
broth supplemented with 100 μg/ml ampicillin and incubated for 16 h at 37 ˚C with 
200rpm. 
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Gibson Assembly® 
To carry out Gibson cloning (Gibson et al., 2009, 2010) DNA sequences of interest 
were amplified using Phusion High-Fidelity DNA Polymerase (Life Technologies) 
following to manufacturer’s guidelines and vector backbones obtained by restriction 
digestion. All single components were purified before being added to the Gibson 
master mix. Ligations were set up in a total volume of 20-25 µl using 50-100 ng of 
digested backbone plasmid, 0.02-0.1 pmol/µl of each fragment and 2X Gibson 
Assembly® Master Mix (New England Biolabs) and incubated at 50°C for 1 h. 
Ligations were then treated as described above. 
 
Plasmid Minipreps  
Plasmids were purified from 5 ml overnight clonal E. coli cultures using the Merlin 
Miniprep protocol based on diatomaceous earth (Sigma) purification. Bacteria pellet 
was prepared by centrifuging 3 ml of bacterial culture and re-suspended in buffer P1 
(50 mM Tris Base, 10 mM EDTA, pH 8.0). Samples are then lysed with buffer P2 (0.2 
M NaOH, 1% SDS) and P3 (1.25 M Potassium Acetate, pH 5.5), then mixed to buffer 
P4 (66.9 g of Guanidine hydrochloride in 33.3 ml of P3, pH 5, volume adjusted at 100 
ml with dH2O, 0.22 μm filter sterilised, 1.5 g diatomaceous earth) and passed through 
a spin column before being washed twice with buffer P5 (200 mM NaCl, 20 mM Tris, 
5 mM EDTA, 1 volume ethanol) and re-suspended in 30 μl of dH2O. 
 
Plasmid Midipreps 
Plasmids for microinjection were purified from 100 ml overnight clonal E. coli cultures 
using Plasmid Midi Kit (Qiagen) following manufacturer’s instructions. After final 
elution, samples were ethanol precipitated using 1/10th volume of 3M Sodium Acetate 
pH 5.2 and 2.5 volumes of ice cold 100% ethanol, washed in 70% ethanol and re-
suspended in 150 μl of dH2O.  
 
Sequencing  
Sequencing of plasmids and PCR products was performed using Sanger sequencing 
by Source Bioscience. Sequences were manually analysed using BioEdit Sequence 
Alignment Editor (Ibis Biosciences).  
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Mosquito rearing  
Mosquitoes were maintained in insectary conditions (27±2°C, 70±10% humidity) with 
a photoperiod of 12h light:12h dark and 30 minutes of dawn and dusk. Sugar solution 
and water were provided ad libitum and blood meal offered to 10-12-day-old adults 
using human blood through Hemotek membrane feeding system. Eggs were collected 
on Whatman filter paper grade 3 (Sigma) 48 h after blood-feeding. Larval stages were 
reared in 23x23 cm plastic trays using distilled water supplemented with tonic salt 
(Blagdon) and were fed on ground TetraMin© fish food. 
 
Screening of fluorescent mosquitoes  
All mosquitoes were observed with Leica MZ FLIII fluorescence stereo microscope 
fitted with CFP, DsRed and YFP filters (Leica Microsystems). 
Fluorescence pictures were taken using the LAS X Microscope Software integrated 
within a Leica M165 FC fluorescent stereo microscope (Leica Microsystems). 
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7. Appendix B 
 
List of primers  
Table B.1 List of primer sequences used in Chapter 2. 
Primer  Sequence 5’-3’ 
M2fw  TTCTGATATCAAAAATGTTTAGCTTGTTGGATTTCA 
M2rv TTCTCTCGAGCTAAATCTTATCCACCTTCAACCAC 
pJETseqFW CGACTCACTATAGGGAGAGCGGC 
pJETseqRV AAGAACATCGATTTTCCATGGCAG 
P3fw1 TTCTAGATCTAACGATGGAGCTAATTAACGCGGTGCTGG 
P3rv1 GGTACAGCTCCTGATGGATGTCGGC 
P3EcoRIfw  TTCTGAATTCAACGATGGAGCTAATTAACGCGGTCGTGG 
P3rv2 TTCTCTCGAGCTACAACTTTTCCACCTTCAAG 
piggyBacR-R2 TTTGCCTTTCGCCTTATTTTAGA 
Red-seq4R CGAGGGTTCGAAATCGATAA 
M2intFW CGTATAGGGCTGGCGTATCT 
P3intFW GCTGAGAAAGTTCCGCTTCT 
ITRL1R TGACGAGCTTGTTGGTGAGGATTCT 
qM2fw TACGATGACAACAAGGGCAAG 
qM2rv GCGATCGTGGAAGTACTGG 
qP3fw TGTGATTGACGAAACCCTTCGGAAG 
qP3sub ATAGTCCACAGATGGTACGCGGG 
qS7fw AGAACCAGCAGACCACCATC 
qS7rv GCTGCAAACTTCGGCTATTC 
qUBfw CGACTCCGTGGTGGTATCAT 
qUBrv GCACTTGCGGCAAATCATCT 
 
Cyp6m2 sequence alignment  
Figure B.1 Cyp6m2 coding sequence alignment. M2 is the consensus sequence obtained from 
sequencing with pJETseqFW and pJETseqRV primers and present in pUASm2. PB13:CYP6M2 is the 
template plasmid from which the sequence was amplified.  
 
M2              ATGTTTAGCTTGTTGGATTTCACATTTCTGGTGGCGGCACTGGCCGCCGGCTTGTACTAC 
PB13:CYP6M2     ATGTTTAGCTTGTTGGATTTCACATTTCTGGTGGCGGCACTGGCCGCCGGCTTGTACTAC 
                ************************************************************ 
 
M2              TATCTCGATCGGAAGCGCTCCTACTGGCAGGATCGTGGTGTGCCCGGTCCGAAGGGTGAG 
PB13:CYP6M2     TATCTCGATCGGAAGCGCTCCTACTGGCAGGATCGTGGTGTGCCCGGTCCGAAGGGTGAG 
                ************************************************************ 
 
M2              CTGCTGTTCGGGAACTTTGGCTCGATCGGCACGAAGGAACACATTACCGTGCCGTTTAAG 
PB13:CYP6M2     CTGCTGTTCGGGAACTTTGGCTCGATCGGCACGAAGGAACACATTACCGTGCCGTTTAAG 
                ************************************************************ 
 
M2              AGGATCTACGATGACAACAAGGGCAAGCATCCGTTCGCGGGCATGTATCAGTTCGTGAAG 
PB13:CYP6M2     AGGATCTACGATGACAACAAGGGCAAGCATCCGTTCGCGGGCATGTATCAGTTCGTGAAG 
                ************************************************************ 
 
M2              CCGGTGGCACTGATTACCGATCTGGAGCTGCTGAAGTGTGTGTTTGTGAAGGATTTCCAG 
PB13:CYP6M2     CCGGTGGCACTGATTACCGATCTGGAGCTGCTGAAGTGTGTGTTTGTGAAGGATTTCCAG 
                ************************************************************ 
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M2              TACTTCCACGATCGCGGTACGTTCTACAATGAGCGGGATGATCCACTGTCGGCGCATCTG 
PB13:CYP6M2     TACTTCCACGATCGCGGTACGTTCTACAATGAGCGGGATGATCCACTGTCGGCGCATCTG 
                ************************************************************ 
 
M2              TTCAATCTGGAGGGTCAGAAGTGGCGCTCGCTGCGCAACAAACTCTCGCCCACGTTCACG 
PB13:CYP6M2     TTCAATCTGGAGGGTCAGAAGTGGCGCTCGCTGCGCAACAAACTCTCGCCCACGTTCACG 
                ************************************************************ 
 
M2              TCCGGCAAGATGAAGATGATGTTCCCCACGATCGTGACTGCCGGCAAACAGTTTAAGGAC 
PB13:CYP6M2     TCCGGCAAGATGAAGATGATGTTCCCCACGATCGTGACTGCCGGCAAACAGTTTAAGGAC 
                ************************************************************ 
 
M2              TTTATGGAGGAAACGGTGCTGCGTGAGAACGAGTTCGAGCTGAAGGATCTGCTGGCACGG 
PB13:CYP6M2     TTTATGGAGGAAACGGTGCTGCGTGAGAACGAGTTCGAGCTGAAGGATCTGCTGGCACGG 
                ************************************************************ 
 
M2              TTCACGACGGACGTGATCGGGATGTGTGCGTTCGGCATTGAGTGTAACAGTATGCGCAAT 
PB13:CYP6M2     TTCACGACGGACGTGATCGGGATGTGTGCGTTCGGCATTGAGTGTAACAGTATGCGCAAT 
                ************************************************************ 
 
M2              CCGGATGCGGAGTTCCGTGCGATGGGTCGCAAGATCTTTGAGATCTCGCCCGGTACGTTC 
PB13:CYP6M2     CCGGATGCGGAGTTCCGTGCGATGGGTCGCAAGATCTTTGAGATCTCGCCCGGTACGTTC 
                ************************************************************ 
 
M2              AAGACGATGATGATGAATGGAATGCCCGAGTTGGCAAAGATGCTGCGCATGACACAAACC 
PB13:CYP6M2     AAGACGATGATGATGAATGGAATGCCCGAGTTGGCAAAGATGCTGCGCATGACACAAACC 
                ************************************************************ 
 
M2              GACAAGGATGTGTCGGACTTTTTCATGAACGCGGTGCGGGACACGATCAACTATCGCGTG 
PB13:CYP6M2     GACAAGGATGTGTCGGACTTTTTCATGAACGCGGTGCGGGACACGATCAACTATCGCGTG 
                ************************************************************ 
 
M2              AAGAACAACGTGCAGCGGAATGATTTCGTCGATCTGCTGATCAAGATGATGAGCAAAGAC 
PB13:CYP6M2     AAGAACAACGTGCAGCGGAATGATTTCGTCGATCTGCTGATCAAGATGATGAGCAAAGAC 
                ************************************************************ 
 
M2              GGAGAGAAGTCGGACGAGGATTCGCTAACGTTCAACGAAATTGCTGCACAGGCGTTTGTG 
PB13:CYP6M2     GGAGAGAAGTCGGACGAGGATTCGCTAACGTTCAACGAAATTGCTGCACAGGCGTTTGTG 
                ************************************************************ 
 
M2              TTTTTCCTGGCCGGGTTTGAGACTTCGTCGACTCTCCTCACATGGACGCTGTACGAGCTG 
PB13:CYP6M2     TTTTTCCTGGCCGGGTTTGAGACTTCGTCGACTCTCCTCACATGGACGCTGTACGAGCTG 
                ************************************************************ 
 
M2              GCGCTGAATCCAGAGGTACAGGAGAAAGGTCGTGAGTGTGTGAGAGAAATCCTGCAAAAG 
PB13:CYP6M2     GCGCTGAATCCAGAGGTACAGGAGAAAGGTCGTGAGTGTGTGAGAGAAATCCTGCAAAAG 
                ************************************************************ 
 
M2              CACAACGGAGAGATGTCGTACGATGCGGTCGTGGAAATGAAGTATCTTGATCAAATTCTT 
PB13:CYP6M2     CACAACGGAGAGATGTCGTACGATGCGGTCGTGGAAATGAAGTATCTTGATCAAATTCTT 
                ************************************************************ 
 
M2              AATGAATCACTGCGCAAATATCCACCAGTCCCGGTACATTTCCGTGTGGCTTCGAAAGAC 
PB13:CYP6M2     AATGAATCACTGCGCAAATATCCACCAGTCCCGGTACATTTCCGTGTGGCTTCGAAAGAC 
                ************************************************************ 
 
M2              TACCACGTCCCCGGTACGAAATCCGTCCTGGAGGCCGGTACAGCCGTCATGATCCCAGTG 
PB13:CYP6M2     TACCACGTCCCCGGTACGAAATCCGTCCTGGAGGCCGGTACAGCCGTCATGATCCCAGTG 
                ************************************************************ 
 
M2              CATGCCATCCATCACGATCCGGAAGTGTTCCCCAACCCCGAACAGTTCGATCCGGAGCGT 
PB13:CYP6M2     CATGCCATCCATCACGATCCGGAAGTGTTCCCCAACCCCGAACAGTTCGATCCGGAGCGT 
                ************************************************************ 
 
M2              TTCAGTCCGGAGCAGGAGGCAAAGCGTCACCCGTACGCTTGGACACCGTTCGGAGAGGGT 
PB13:CYP6M2     TTCAGTCCGGAGCAGGAGGCAAAGCGTCACCCGTACGCTTGGACACCGTTCGGAGAGGGT 
                ************************************************************ 
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M2              CCGAGGATATGTGTTGGGCTGCGATTCGGTATGATGCAGGCCCGTATAGGGCTGGCGTAT 
PB13:CYP6M2     CCGAGGATATGTGTTGGGCTGCGATTCGGTATGATGCAGGCCCGTATAGGGCTGGCGTAT 
                ************************************************************ 
 
M2              CTGCTGGATGGGTTCCGGTTTGCACCAAGCTCGAAAACCGTCATCCCGATGGAACTCTCT 
PB13:CYP6M2     CTGCTGGATGGGTTCCGGTTTGCACCAAGCTCGAAAACCGTCATCCCGATGGAACTCTCT 
                ************************************************************ 
 
M2              AAGGAAAGTTTCATTATGGCACCGAAGGGTGGGCTGTGGTTGAAGGTGGATAAGATTTAG 
PB13:CYP6M2     AAGGAAAGTTTCATTATGGCACCGAAGGGTGGGCTGTGGTTGAAGGTGGATAAGATTTAG 
                ************************************************************ 
 
 
Cyp6p3 sequence alignment  
Figure B.2 Cyp6p3 coding sequence alignment. P3 is the consensus sequence obtained from 
sequencing with pJETseqFW and pJETseqRV primers and present in pUASp3. pCW:17α-Cyp6p3 is the 
template plasmid from which the sequence was amplified which lacks the first 24 bp from the native 
sequence (shown in small letters). Grey shaded sequence was amplified from Kisumu cDNA and fused 
with the rest of the sequence amplified from the plasmid template.  
 
P3              atggagctaattaacgcggtgctgGCCGCGTTCATCTTCGCAGTGTCGATCGTGTATCTG 
pCW:17α-Cyp6p3                          GCCGCGTTCATCTTCGCAGTGTCGATCGTGTATCTG 
                                        ************************************ 
 
P3              TTCATACGCAATAAGCATAACTATTGGAAGGACAATGGGTTTCCGTACGCGCCGAATCCA 
pCW:17α-Cyp6p3  TTCATACGCAATAAGCATAACTATTGGAAGGACAATGGGTTTCCGTACGCGCCGAATCCA 
                ************************************************************ 
 
P3              CACTTTCTGTTCGGGCATGCGAAGGGCCAGGCCCAGACGCGGCACGGCGCCGACATCCAT 
pCW:17α-Cyp6p3  CACTTTCTGTTCGGGCATGCGAAGGGCCAGGCCCAGACGCGGCACGGCGCCGACATCCAT 
                ************************************************************ 
 
P3              CAGGAGCTGTACCGATACTTCAAGCAGCGGGGCGAACGGTACGGCGGCATTAGCCAGTTT 
pCW:17α-Cyp6p3  CAGGAGCTGTACCGATACTTCAAGCAGCGGGGCGAACGGTACGGCGGCATTAGCCAGTTT 
                ************************************************************ 
 
P3              ATCGTGCCCTCGGTGCTGGTGATCGACCCGGAGCTGGCGAAGACGATCCTGGTGAAGGAT 
pCW:17α-Cyp6p3  ATCGTGCCCTCGGTGCTGGTGATCGACCCGGAGCTGGCGAAGACGATCCTGGTGAAGGAT 
                ************************************************************ 
 
P3              TTTAACGTGTTTCACGATCACGGCGTGTTTACCAATGCAAAGGACGACCCGCTCACGGGA 
pCW:17α-Cyp6p3  TTTAACGTGTTTCACGATCACGGCGTGTTTACCAATGCAAAGGACGACCCGCTCACGGGA 
                ************************************************************ 
 
P3              CATCTGTTCGCACTGGAGGGTCAACCGTGGCGGTTGATGCGCCAGAAGCTTACGCCGACG 
pCW:17α-Cyp6p3  CATCTGTTCGCACTGGAGGGTCAACCGTGGCGGTTGATGCGCCAGAAGCTTACGCCGACG 
                ************************************************************ 
 
P3              TTCACCTCGGGCCGGATGAAGCAAATGTTCGGCACAATATGGGATGTGGGGCTTGAGCTG 
pCW:17α-Cyp6p3  TTCACCTCGGGCCGGATGAAGCAAATGTTCGGCACAATATGGGATGTGGGGCTTGAGCTG 
                ************************************************************ 
 
P3              GAAAAGTGTATGGAGCAAAGCTACAACCAACCGGAGGTTGAGATGAAGGATATCCTGGGC 
pCW:17α-Cyp6p3  GAAAAGTGTATGGAGCAAAGCTACAACCAACCGGAGGTTGAGATGAAGGATATCCTGGGC 
                ************************************************************ 
 
P3              CGTTTTACGACGGACGTGATTGGGACGTGCGCGTTCGGCATCGAGTGCAATACACTTAAG 
pCW:17α-Cyp6p3  CGTTTTACGACGGACGTGATTGGGACGTGCGCGTTCGGCATCGAGTGCAATACACTTAAG 
                ************************************************************ 
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P3              ACGACAGACTCGGAGTTCCGCAAGTACGGCAACAAGGCGTTCGAGTTGAATACGATGATC 
pCW:17α-Cyp6p3  ACGACAGACTCGGAGTTCCGCAAGTACGGCAACAAGGCGTTCGAGTTGAATACGATGATC 
                ************************************************************ 
 
P3              ATGATGAAGACTTTCCTCGCGTCGTCCTACCCGACGCTGGTGCGCAATCTGCACATGAAG 
pCW:17α-Cyp6p3  ATGATGAAGACTTTCCTCGCGTCGTCCTACCCGACGCTGGTGCGCAATCTGCACATGAAG 
                ************************************************************ 
 
P3              ATCACGTACAACGATGTGGAGCGATTCTTCCTGGACATCGTGAAGGAAACGGTCGACTAC 
pCW:17α-Cyp6p3  ATCACGTACAACGATGTGGAGCGATTCTTCCTGGACATCGTGAAGGAAACGGTCGACTAC 
                ************************************************************ 
 
P3              CGGGAGGCGAACAACGTGAAGCGGAACGACTTCATGAACCTGATGCTGCAGATCAAGAAC 
pCW:17α-Cyp6p3  CGGGAGGCGAACAACGTGAAGCGGAACGACTTCATGAACCTGATGCTGCAGATCAAGAAC 
                ************************************************************ 
 
P3              AAGGGCAAGCTGGACGATAGTGATGACGGTAGTGTGGGCAAGGGAGAGGTCGGCATGACA 
pCW:17α-Cyp6p3  AAGGGCAAGCTGGACGATAGTGATGACGGTAGTGTGGGCAAGGGAGAGGTCGGCATGACA 
                ************************************************************ 
 
P3              CAGAACGAGCTAGCGGCCCAGGCGTTTGTGTTTTTCCTGGCGGGTTTTGAGACGTCGTCC 
pCW:17α-Cyp6p3  CAGAACGAGCTAGCGGCCCAGGCGTTTGTGTTTTTCCTGGCGGGTTTTGAGACGTCGTCC 
                ************************************************************ 
 
P3              ACCACACAAAGCTTCTGTCTGTACGAGCTGGCAAAGAACCCGGACATCCAGGAGCGGCTG 
pCW:17α-Cyp6p3  ACCACACAAAGCTTCTGTCTGTACGAGCTGGCAAAGAACCCGGACATCCAGGAGCGGCTG 
                ************************************************************ 
 
P3              AGAGAGGAAATTAATCGAGCTATTGCAGAGAACGGTGGAGAGGTGACGTACGACGTGGTC 
pCW:17α-Cyp6p3  AGAGAGGAAATTAATCGAGCTATTGCAGAGAACGGTGGAGAGGTGACGTACGACGTGGTC 
                ************************************************************ 
 
P3              ATGAACATAAAGTATTTGGACAATGTGATTGACGAAACCCTTCGGAAGTACCCACCGGTG 
pCW:17α-Cyp6p3  ATGAACATAAAGTATTTGGACAATGTGATTGACGAAACCCTTCGGAAGTACCCACCGGTG 
                ************************************************************ 
 
P3              GAATCGTTAACCCGCGTACCATCTGTGGACTATCTCATCCCCGGCACAAAGCATGTGATC 
pCW:17α-Cyp6p3  GAATCGTTAACCCGCGTACCATCTGTGGACTATCTCATCCCCGGCACAAAGCATGTGATC 
                ************************************************************ 
 
P3              CCGAAGCGAACACTGGTGCAAATTCCAGCCTACGCGATTCAACGCGATCCGGACCACTAT 
pCW:17α-Cyp6p3  CCGAAGCGAACACTGGTGCAAATTCCAGCCTACGCGATTCAACGCGATCCGGACCACTAT 
                ************************************************************ 
 
P3              CCCGACCCGGAACGGTTCAATCCTGATCGATTCCTACCGGAGGAAGTGAAAAAACGACAC 
pCW:17α-Cyp6p3  CCCGACCCGGAACGGTTCAATCCTGATCGATTCCTACCGGAGGAAGTGAAAAAACGACAC 
                ************************************************************ 
 
P3              CCGTTCACGTTCATCCCATTCGGCGAGGGACCACGCATCTGCATTGGGCTGCGGTTTGGC 
pCW:17α-Cyp6p3  CCGTTCACGTTCATCCCATTCGGCGAGGGACCACGCATCTGCATTGGGCTGCGGTTTGGC 
                ************************************************************ 
 
P3              TTGATGCAAACCAAGGTGGGATTGATTACGCTGCTGAGAAAGTTCCGCTTCTCGCCGTCC 
pCW:17α-Cyp6p3  TTGATGCAAACCAAGGTGGGATTGATTACGCTGCTGAGAAAGTTCCGCTTCTCGCCGTCC 
                ************************************************************ 
 
P3              GCGCGTACGCCCGAACGGGTAGAATACGATCCGAAAATGATAACCATAGCGCCGAAAGCG 
pCW:17α-Cyp6p3  GCGCGTACGCCCGAACGGGTAGAATACGATCCGAAAATGATAACCATAGCGCCGAAAGCG 
                ************************************************************ 
 
P3              GGCAACTACTTGAAGGTGGAAAAGTTGTAG 
pCW:17α-Cyp6p3  GGCAACTACTTGAAGGTGGAAAAGTTGTAG 
                ****************************** 
 
 
Appendix B  
163 
 
qPCR files  
qPCR raw data and data analysis are reported in files named: GAL4mid-M2 adult 
whole.xlsx; GAL4mid-M2 adult carcasses.xlsx; GAL4mid-M2 adult midguts.xlsx; 
GAL4mid-P3 adult whole.xlsx; GAL4mid-P3 adult carcasses.xlsx; GAL4mid-P3 adult 
midguts.xlsx; GAL4oeno-M2 adult whole.xlsx; GAL4oeno-M2 pupae whole.xlsx; 
GAL4oeno-M2 L4 larvae whole.xlsx; GAL4oeno-M2 adult carcasses.xlsx; GAL4oeno-
M2 adult abdomens.xlsx; GAL4oeno-P3 adult whole.xlsx; GAL4oeno-P3 pupae 
whole.xlsx; GAL4oeno-P3 L4 larvae whole.xlsx; GAL4oeno-P3 adult carcasses.xlsx; 
GAL4oeno-P3 adult abdomens.xlsx 
 
Bioassay files 
Bioassay raw data and analysis are reported in files named: GAL4midxM2.xlsx; 
GAL4midxP3; GAL4oenoxM2; GAL4oenoxP3. 
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List of primers  
Table C.1 Primer sequences used in Chapter 3. 
Primer name Sequence 5’-3’ 
seq5’UTR-rv TGCACCACAGTCACAGCTCACTGC 
seqINTRON-fw GAATTCGCGGAAGCAGACCGAGCC 
seqINTRON-rv ACATCAAAAATGTGTTTAACAAGAAC 
1971-int-rv ATCCAATTAAACCTACGTCAATCAA 
AttB3-seqR  CTTTATGCTTCCGGCTCGTA 
pUB5-GAL4-FW GTTTTCGTTTATATTTACAGATAAAATATGAAGCTACTGTCTTCTATCGAACAAGCATG 
1971-int-fw TTGATTGACGTAGGTTTAATTGGAT 
GAL4-seq-2F AGATCCACAACATCCCGTTT 
GAL4-pSL-RV CAGCTGCAGGCGGCCGCCATATGCAAGATCTTTACTCTTTTTTTGGGTTTGGTGGG 
pSL1180-1 GTGCTGCAAGGCGATTAAGT 
M13fw CGTTGTAAAACGACGGCCAGT 
RT-GAL4-2R GTCAGATGTGCCCTAGTCAGC 
p9_pSL_fw ACGTGAGTAGTTAAGATACATTGGGCTAGCATGGTATTGCCAGCCTCAGACGCGAGAGAG 
p9_GAL4_rv TAGAAGACAGTAGCTTCATGATATCTTTCGCTGCACCTTTCACTTTCCACGGG 
GAL4_p9_fw AGTGAAAGGTGCAGCGAAAGATATCATGAAGCTACTGTCTTCTATCGAACAAGC 
GAL4_sequ_2F AGATCCACAACATCCCGTTT 
GAL4_SV40_rv GAAGTAAGGTTCCTTCACAAAGATCTTACTCTTTTTTTGGGTTTGGTGGGGTATC 
SV40_GAL4_fw CCACCAAACCCAAAAAAAGAGTAAGATCTTTGTGAAGGAACCTTACTTCTGTGG 
SV40_pSL_rv CATTTAGCCGATCAATTCTAGTCACATATGAGACATGATAAGATACATTGATGAGTTTGG 
pSL-Gypsy1-FW GAGGTAATTATAACCCGGGCCCTATATATGACTAGAATTGATCGGCTAAATGGTATGGCA 
Gypsy1-pUB5-RV GAAATATTTTTTTATTCGCTAGCCAATGTATCTTAACTACTCACGTAATAAGTGTGCG 
Gypsy1-pUB5-FW GAGTAGTTAAGATACATTGGCTAGCGAATAAAAAAATATTTCTTAATAATATTCTAAC 
pUB5-GAL4-RV GAAGACAGTAGCTTCATATTTTATCTGTAAATATAAACGAAAACAAC 
pUB5-GAL4-FW GTTTTCGTTTATATTTACAGATAAAATATGAAGCTACTGTCTTCTATCGAACAAGCATG 
GAL4-pSL-RV CAGCTGCAGGCGGCCGCCATATGCAAGATCTTTACTCTTTTTTTGGGTTTGGTGGG 
pSL-pUB3-FW TAATTATAACCCGGGCCCTATATATGAGATCTTTCGTTGAATAAAGCATATTGAAGCTTC 
pUB3-Gypsy2-RV AGCCGATCAATTCTAGTCATATGCCGTCGAAATTGTTTTACAATGACAATTTT 
pUB3-Gypsy2-FW GTAAAACAATTTCGACGGCATATGACTAGAATTGATCGGCTAAATGGTATGGCA 
Gypsy2-attP-RV GTCAGTCGCGCGAGCGCGCCGCGGCAATGTATCTTAACTACTCACGTAATAAGTGTGCG 
Gypsy2-attP-FW AGTAGTTAAGATACATTGCCGCGGCGCGCTCGCGCGACTGACGGTCGTAAGCAC 
attP-pSL-RV AGCTGCAGGCGGCCGCCATATGCACGAAGCCCCGGCGGCAACCCTCAGCG 
SpeI-6459-EcoRV-fw TTCTACTAGTTCCGTTTAGGTAGAGAACTT 
SpeI-6459-EcoRV-rv TTCTGATATCACGATAAACAAAATAGACAC 
SpeI-2182-EcoRV-fw TTCTACTAGTAAGACAAATCGGCCCGTGCT 
SpeI-2182-EcoRV-rv TTCTGATATCTTTCTACAATAGAAAGTGGG 
SpeI-6782-EcoRV-fw TTCTACTAGTGGCTATTCCGATGCCTTTTT 
SpeI-6782-EcoRV-rv TTCTGATATCTTTTGATGGATCTGGTCTGG 
SpeI-3864-EcoRV-fw TTCTACTAGTTCTAGCGAGGCATGGCAGGA 
SpeI-3864-EcoRV-rv TTCTGATATCTGTTGCGTTCCGGTGGAAAA 
SpeI-4654-EcoRV-fw TTCTACTAGTATAGAATGTCGGTGCCCA 
SpeI-4654-EcoRV-rv TTCTGATATCTGCAATATTATCCCTGTT 
SpeI-12167-EcoRV-fw TTCTACTAGTATGGTATTGCCAGCCTCA 
SpeI-12167-EcoRV-rv TTCTGATATCTTTCGCTGCACCTTTCAC 
SpeI-10572-EcoRV-fw TTCTACTAGTTCTGTACGATCGATGCTA 
SpeI-10572-EcoRV-rv TTCTGATATCTGGTTAGGTATGACGGCC 
SpeI-11050-EcoRV-fw TTCTACTAGTTTGTTCGTGTGATCGATC 
SpeI-11050-EcoRV-rv TTCTGATATCGATTAGTGCGGTAGGACG 
AflII-2587-EcoRV-fw TTCTCTTAAG TTAACATCTGCTGGATATTA 
AflII-2587-EcoRV-rv TTCTGATATC CGTTTCCGGGTTTCCGTTCC 
NheI-1823-EcoRV-fw TTCTGCTAGCTCGGTTTAAATAAAAACATT    
AflII-1823-EcoRV-rv TTCTGATATCCGTCAAAAGTCCACGGGCAC 
AflII-11426-EcoRV-fw TTCTCTTAAGGCAAAAAGAATCAAATAGTA 
AflII-11426-EcoRV-rv TTCTGATATCTCTGCCAACTTGAGCAGCGC 
SpeI-2629-EcoRV-fw TTCTACTAGTCGTTCGAAACCGCCCAAC 
SpeI-2629-EcoRV-rv TTCTGATATCTCTGCACGCGGTCGTTGT 
SpeI-10364-EcoRV-fw TTCTACTAGTACATTTACCCTATTCTCA 
SpeI-10364-EcoRV-rv TTCTGATATCTTTGCAACGGACTGAACG 
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SpeI-10975-EcoRV-fw TTCTACTAGTAAAAACACACATAGTTGG 
SpeI-10975-EcoRV-rv TTCTGATATCCTCACGTGCCGACACTCG 
ITRL1F ATCAGTGACACTTACCGCATTGACA 
ITRR1F TACGCATGATTATCTTTAACGTA 
A10_insert_rv  ACATGTTTTCGCATTGAATCTG 
A10_R_check_rv  AACCTTCCAGCAATCCACAC 
A8_L_check_rv ATGGTTCGCTGTGTTGTTCA 
A8_R_check_fw2  CATCACGCTTTCATGCATGC 
piggyBacR-R2 TTTGCCTTTCGCCTTATTTTAGA 
Red-seq4R CGAGGGTTCGAAATCGATAA 
P6_int_rv TCTGATCATACGGTTCACGTTC 
ITRL1R TGACGAGCTTGTTGGTGAGGATTCT 
 
 
Sequencing files  
The full sequence of plasmid pPUBc_GAL4 (p155) is reported in a file named 
p155sequence.docx. This includes sequences of the following fragments: Gypsy1 
(Gyp1), PUBc 5’ region (PUB5), GAL4, SV40, PUBc 3’ region (PUB3), Gypsy2 
(Gyp2), and attP-right (attPr). 
 
Sequences of candidate ubiquitous genes are reported in files named: 
AGAP004654.docx; AGAP012167.docx; AGAP010572.docx; AGAP011050.docx; 
AGAP003864.docx; AGAP006459.docx; AGAP006782.docx. 
 
Sequences of candidate Malpighian tubule-specific genes are reported in files named:  
AGAP002587.docx; AGAP001823.docx; AGAP002629.docx; AGAP010975.docx 
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Expression of candidate genes from MozAtlas  
Figure C.1 Expression levels of candidate ubiquitous (A) and Malpighian tubule-specific (B) genes in 
the carcass, head, Malpighian tubules, midgut, ovaries and salivary glands of adult female An. gambiae 
mosquitoes. Data was retrieved from the MozAtlas database where it is expressed as log2 fluorescence 
values obtained from microarray experiments (Baker et al., 2011). 
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Table C.2 Results of the One-way ANOVA with multiple pairwise comparison analysis to assess 
statistical differences between relative activity of putative ubiquitous promoters. 
 
Dunnett's multiple comparisons test 95% CI of diff. Significance 
pUAS-Luc vs. pBPnucl -81.88 to 67.14 ns 
pUAS-Luc vs. pPGI -153.8 to -4.827 * 
pUAS-Luc vs. pLTV1 -116.4 to 32.66 ns 
pUAS-Luc vs. pALDred -114.6 to 34.38 ns 
pUAS-Luc vs. pAGAP003864 -96.05 to 86.47 ns 
pUAS-Luc vs. pSUI1 -177.6 to 4.943 ns 
pUAS-Luc vs. pATPcar -103.7 to 78.77 ns 
pUAS-Luc vs. pPUBc -429.1 to -272.8 **** 
 
Tukey's multiple comparisons test 95% CI of diff. Significance 
pBPnucl vs. pPGI -160.1 to 16.16 ns 
pBPnucl vs. pLTV1 -122.6 to 53.65 ns 
pBPnucl vs. pALDred -120.9 to 55.37 ns 
pBPnucl vs. pAGAP003864 -105.4 to 110.5 ns 
pBPnucl vs. pSUI1 -186.9 to 28.99 ns 
pBPnucl vs. pATPcar -113.1 to 102.8 ns 
pBPnucl vs. pPUBc -436.0 to -251.2 **** 
pBPnucl vs. pUAS-Luc -80.76 to 95.50 ns 
pPGI vs. pLTV1 -50.64 to 125.6 ns 
pPGI vs. pALDred -48.92 to 127.3 ns 
pPGI vs. pAGAP003864 -33.39 to 182.5 ns 
pPGI vs. pSUI1 -114.9 to 101.0 ns 
pPGI vs. pATPcar -41.09 to 174.8 ns 
pPGI vs. pPUBc -364.1 to -179.2 **** 
pPGI vs. pUAS-Luc -8.793 to 167.5 ns 
pLTV1 vs. pALDred -86.41 to 89.85 ns 
pLTV1 vs. pAGAP003864 -70.88 to 145.0 ns 
pLTV1 vs. pSUI1 -152.4 to 63.47 ns 
pLTV1 vs. pATPcar -78.57 to 137.3 ns 
pLTV1 vs. pPUBc -401.6 to -216.7 **** 
pLTV1 vs. pUAS-Luc -46.28 to 130.0 ns 
pALDred vs. pAGAP003864 -72.60 to 143.3 ns 
pALDred vs. pSUI1 -154.1 to 61.76 ns 
pALDred vs. pATPcar -80.29 to 135.6 ns 
pALDred vs. pPUBc -403.3 to -218.4 **** 
pALDred vs. pUAS-Luc -48.00 to 128.3 ns 
pAGAP003864 vs. pSUI1 -206.2 to 43.11 ns 
pAGAP003864 vs. pATPcar -132.3 to 116.9 ns 
pAGAP003864 vs. pPUBc -457.7 to -234.7 **** 
pAGAP003864 vs. pUAS-Luc -103.1 to 112.7 ns 
pSUI1 vs. pATPcar -50.81 to 198.5 ns 
pSUI1 vs. pPUBc -376.1 to -153.2 **** 
pSUI1 vs. pUAS-Luc -21.62 to 194.3 ns 
pATPcar vs. pPUBc -450.0 to -227.0 **** 
pATPcar vs. pUAS-Luc -95.45 to 120.4 ns 
pPUBc vs. pUAS-Luc 258.5 to 443.4 **** 
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Figure C.2 Agarose gel electrophoresis showing insertion sites in A8 and A10 line confirmed by PCR 
using a primer binding in the predicted genomic location and the other annealing to the transgenic 
construct. A10: genomic regions external to the left (L) and right (R) piggyBac arms at the insertion site 
in the A10 line. A8: genomic regions external to the left (L) and right (R) piggyBac arms at the insertion 
site in the A8 line. Ladder is GeneRuler 100 bp (Thermo Scientific). Expected product sizes are: 516 bp 
for A10L, 447 for A10R, 358 bp for A8L, and 132 bp for A8R. Sequence obtained for A8L was ~150 bp 
shorter than expected due to miss-annealing of the primer onto the left arm of the piggyBac.  
 
 
 
 
Figure C.3 Agarose gel electrophoresis showing results for inverse-PCR on regions flanking the 
piggyBac left arm after TaqαI digestion and self-ligation of genomic DNA isolated from isofemale lines. 
Ladder is GeneRuler 1 kb Plus (Thermo Scientific). 
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Figure C.4 Example of phenotype variegation in the PUBc_GAL4 lines. mCherry phenotypes in L2-3 
larvae derived from PUBc_GAL4 F1 transformant males. These are also representative of the 
phenotypes observed in the progeny of single laying females.  
 
 
 
Microinjection experiments that did not yield transgenics  
Table C.3 List of microinjections of ubiquitous candidate promoters into G3 wild type embryos. 
Experiment 
date 
 
Plasmid 
Injected 
Concentration 
injected DNA 
(ng/μl) 
 
No. 
eggs 
No. larvae 
hatched 
(%) 
Transient 
CFP 
expression 
(%) 
No. F0 
adults 
20/11/15 PUBc_GAL4 250 332 14 (4%) NS 13 
25-27/11/15 
PUBc_GAL4 250 308 21 (7%) 0 (0%) 17 
Un-injected N/A 106 97 (91.5%) N/A N/A 
Inj. buffer N/A 194 2 (1%) N/A N/A 
Other operator  250 157 7 (5%) 3 (43%) 4 
16-17/12/15 
PUBc_GAL4 250 686 166 (24%) NS 118 
Un-injected  N/A 58 48 (83%) N/A N/A 
Inj. buffer N/A 116 60 (52%) N/A N/A 
18-19/01/16 
PUBc_GAL4 300 784 185 (24%) 10 (5%) 127 
Inj. buffer N/A 56 4 (7%) N/A N/A 
04-05/02/16 PGI_GAL4 300 935 380 (41%) NS 262 
N/A: not applicable; NS: not screened.  
 
Table C.4 List of microinjections of Malpighian-specific candidate promoters into the A11 docking lines. 
Experiment 
date 
 
Plasmid 
Injected 
Concentration 
injected DNA 
(ng/μl) 
No. 
eggs 
No. larvae 
hatched 
(%) 
Transient 
CFP 
expression 
(%) 
No. F0 
adults 
01-02/10/15 P14 250 508 N/A NS 20 
15/10/15 P14 300 429 31 (7%) NS 17 
16/10/15 P16 300 454 34 (7.5%) NS 18 
23/10/15 P16 300 155 6 (3%) NS N/A 
10/11/15 P16 300 118 9 (8%) 4 3 
17-18/11/15 VATG (P6) 300 611 31 (5%) NS 22 
23-24/11/15 VATG (P6) 300 571 18 (3%) NS 10 
07-08/12/15 VATG (P6) 265 677 120 (18%) 9 88 
17-18/02/16 P14 350 763 223 (29%) NS 143 
N/A: not applicable; NS: not screened.  
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9. Appendix D 
 
qPCR files  
qPCR raw data and data analysis are reported in files named: A10xM2adults.xlsx; 
A10xP3adults.xlsx; A8xM2adults.xlsx; A8xP3adults.xlsx. 
 
Bioassay files  
Bioassay raw data and analysis are reported in files named: A10xM2.xlsx; 
A10xP3.xlsx; A8xM2.xlsx; A8xP3.xlsx; Malathion all crosses
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